<html lang="en" class="pb-page js" data-request-id="94d6c2dc21f201c0-SJC"><head data-pb-dropzone="head"><style type="text/css" nonce="94d6c2dc21f201c0-SJC">@font-face {font-family: "Source Sans Pro";src: url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.ttf) format("truetype"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.woff) format("woff"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.otf) format("opentype"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.eot) format("embedded-opentype");}.truste_cursor_pointer {cursor: pointer;}.truste_border_none {border: none;}.truste_accessible_link {font-family: "Source Sans Pro", sans-serif;color: #1D4ED8;font-size: 14px;font-weight: 600;text-decoration: underline;}.truste_accessible_link:hover {color: #1D4ED8;text-decoration: none !important;}.truste_accessible_link:focus-visible {outline: none;border-radius: 4px;box-shadow: 0 0 0 1px #FFFFFF, 0 0 0 4px #3699F1;}</style><script src="https://ssl-cdn.janraincapture.com/widget_data/flow.js:7h8bznq6j7bvyvzqcrwvyp8dfb:en-US:20240514181256512029:standard" type="text/javascript"></script><script src="https://cssjs.nejm.org/akamai/capture:login" type="text/javascript"></script><script src="https://ssl-widget-cdn.rpxnow.com/translations/login/en-US" type="text/javascript"></script><script type="text/javascript" id="janrainAuthWidget" src="https://cssjs.nejm.org/akamai/mms-prod.js"></script><script type="text/javascript" src="https://www.nejm.org/ZOYsat3hfKXHRs9G2lIB54vAgu9b5-Ik2L6Gh7TKIZdNTkzqjyxedQlmh-TnOciPf5yMqgwmoEGkqTFjk9boeg=="></script>
            

<meta charset="UTF-8">






    
        
            
        
    
        
            
        
    
        
            
        
    
        
            
        
    
        
    
        
    
        
            
                
                
<title>Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S | New England Journal of Medicine</title>





                
            
        
    







    
        
            
        
    
        
            
        
    
        
            
                
                



                
            
        
    
        
            
        
    
        
    
        
    
        
            
        
    











    








    

    
    

    
    
    
    
        
            
                <link rel="stylesheet" type="text/css" href="/wro/1125813~article-metrics.css">
            
            
            
        
    

    
    
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_nejm_1-994b0160d1eb33dc79517ef0295aab1b.ico" type="image/x-icon">
        
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_16-4aa032aa775940f725817b7ff42f0e2c.png" type="image/png" sizes="16x16">
        
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_32-0a94fa44823476ffa0bb15bdb320fb34.png" type="image/png" sizes="32x32">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_152-d6c3522864a8e483996b7e9c132c901a.png" sizes="152x152">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_180-f2538afc53a365d4cd3f10ab73c56aad.png" sizes="180x180">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_167-8e888012bbdd31a00c3e54bc5b8ca5b6.png" sizes="167x167">
        
    

    
    
            <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/build-5b89b331018866a4a965.css" media="all">
        <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/print-5b89b331018866a4a965.css" media="print">
           <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/build-article-5b89b331018866a4a965.css" media="all" id="article-style-sheet">
    
        <script nonce="94d6c2dc21f201c0-SJC">
        try {
            document.documentElement.classList.add('js');
        } catch (e) {
        }
    </script>
     
    

















    
        
            
                
                
                
                    
                    <!-- TrustArc Scripts -->
<script async="async" src="https://consent.trustarc.com/notice?domain=nejm.com&amp;c=teconsent&amp;js=nj&amp;noticeType=bb&amp;gtm=1&amp;text=true&amp;pcookie" crossorigin="" id="truste_0.9920004016942016"></script>
<script src="https://consent.trustarc.com/autoblockasset/core.min.js?domain=nejm.com"></script>
<script src="https://consent.trustarc.com/autoblockoptout?domain=nejm.com"></script>
<!-- /TrustArc Scripts -->
<!-- BlueConic Scripts -->
<script src="https://bc.nejm.org/script.js"></script>
    <!-- /BlueConic Scripts -->
<!-- Printing Meta Tags -->
    <meta name="articleType" content="Original Article">
<meta name="Specialties" content="Infectious Disease">
<meta name="topics" content="Vaccines|Coronavirus">
<meta name="articleCategory" content="Research"><script type="text/javascript">var mmsData = {"access":{"isFreeCountry":"n"},"ad":{"category":"article"},"imageChallenge":{"id":null},"article":{"doi":"10.1056/NEJMoa2117608","title":"Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S","category":"Research","type":"Original Article","topics":"Vaccines|Coronavirus","specialties":"Infectious Disease","seriesTitle":"","viewType":"Full","age":"2Years-1990","issueDate":"2022-03-03T00:00Z","isFree":"y","broadTopics":"","perspectiveTopics":"","granularTopics":"","methodologicalArea":"","isOnlineFirst":"n","isCurrentIssue":"n","metaTags":"\u003cmeta name\u003d\"articleType\" content\u003d\"Original Article\"/\u003e\n\u003cmeta name\u003d\"Specialties\" content\u003d\"Infectious Disease\"/\u003e\n\u003cmeta name\u003d\"topics\" content\u003d\"Vaccines|Coronavirus\"/\u003e\n\u003cmeta name\u003d\"articleCategory\" content\u003d\"Research\"/\u003e"},"page":{"activity":"showFullText","url":"www.nejm.org/doi/full/10.1056/NEJMoa2117608","viewType":"desktop","journal":"NEJM"},"user":{"ucid":null,"audienceSegment":null,"specialtyGroupCode":null,"meterCountRemaining":null,"totalMeterCount":null},"object":[]};</script>
    <script type="text/javascript">var mmsDataAdd = {"user":{"customerType":"null","accessInstitutionID":"null"}};</script>
    <!-- Prehiding snippet for Adobe Target with asynchronous Launch deployment -->
    <!-- placeholder id=null, description=Adobe-Target-Prehiding-Snippet --><!--
  Adobe Target - Prehiding Snippet
  v2.0.0
-->
<script nonce="94d6c2dc21f201c0-SJC">
function tgtNoFlicker(e,n,t,o,i,c,l,r){function d(){return n.getElementsByTagName("head")[0]}function a(e,t){if(e){var o=n.getElementById(t);o&&e.removeChild(o)}}function f(e,o){!function(e,t,o){if(e){var i=n.createElement("style");i.id=t,i.innerHTML=o,e.appendChild(i)}}(d(),t,e),setTimeout(function(){a(d(),t)},o)}var m;n.location.href.indexOf(c)>-1?f(l,r):f(o,i),n.location.href.indexOf("mboxDisable")>-1?(a(d(),t),console.log("[TARGET] - Disabled, removing prehiding style")):(m=function(e){e&&(a(d(),t),console.log("[TARGET] - Blocked, removing prehiding style"))},fetch("//cdn.tt.omtrdc.net/cdn/target-vec.js",{method:"HEAD",mode:"no-cors"}).then(e=>m(!1)).catch(e=>m(!0)))}

tgtNoFlicker(window, document, 'at-body-style', 'div[data-location-name="Anonymous Module"], div[data-location-name="Anonymous Banner"], main > div.page-body > div > div > div > div.col-md-2-3.o-col.o-col--primary > div[class*="u-hide"], main > div.page-body > div > div > div > div.col-md-1-3.o-col.o-col--secondary > aside, header > h1#mainContent, a.m-article__link[href*="/10.1056/NEJMoa2116747"] > span.m-article__blurb > p, li.g-nejm-group__user-tool-secondary {opacity: 0 !important}', 3000);

tgtNoFlicker(window, document, 'at-mbox-style', '.N-ad-global-top-right, #N-ad-myNEJM-contextual-top, .N-ad-recentArticles, #N-ad-article-rightRail-1, #N-ad-siteWide-rightRail-1, #N-ad-imageChallenge-rightRail-2 {opacity: 0 !important}', 3000);
</script><!-- /Prehiding snippet for Adobe Target with asynchronous Launch deployment -->
    <!-- Launch Header Embed Code -->
    <script src="//assets.adobedtm.com/launch-ENcd6450fae3ae4870becbe6a2b01ab2e1.min.js" async="" type="ta-blocked" data-ta-blocked="1"></script>
    <!-- /Launch Header Embed Code -->

                    
                
            
        
    
        
            
                
                
                
                    
                    <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="New England Journal of Medicine"><meta name="dc.Title" content="Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S"><meta name="dc.Creator" content="Jerald Sadoff"><meta name="dc.Creator" content="Glenda Gray"><meta name="dc.Creator" content="An Vandebosch"><meta name="dc.Creator" content="Vicky CÃ¡rdenas"><meta name="dc.Creator" content="Georgi Shukarev"><meta name="dc.Creator" content="Beatriz Grinsztejn"><meta name="dc.Creator" content="Paul A. Goepfert"><meta name="dc.Creator" content="Carla Truyers"><meta name="dc.Creator" content="Ilse Van Dromme"><meta name="dc.Creator" content="Bart Spiessens"><meta name="dc.Creator" content="Johan Vingerhoets"><meta name="dc.Creator" content="Jerome Custers"><meta name="dc.Creator" content="Gert Scheper"><meta name="dc.Creator" content="Merlin L. Robb"><meta name="dc.Creator" content="John Treanor"><meta name="dc.Creator" content="Martin F. Ryser"><meta name="dc.Creator" content="Dan H. Barouch"><meta name="dc.Creator" content="Edith Swann"><meta name="dc.Creator" content="Mary A. Marovich"><meta name="dc.Creator" content="Kathleen M. Neuzil"><meta name="dc.Creator" content="Lawrence Corey"><meta name="dc.Creator" content="Jeffrey Stoddard"><meta name="dc.Creator" content="Karin Hardt"><meta name="dc.Creator" content="Javier Ruiz-GuiÃ±azÃº"><meta name="dc.Creator" content="Mathieu Le Gars"><meta name="dc.Creator" content="Hanneke Schuitemaker"><meta name="dc.Creator" content="Johan Van Hoof"><meta name="dc.Creator" content="Frank Struyf"><meta name="dc.Creator" content="Macaya Douoguih"><meta name="dc.Description" content="The Ad26.COV2.S vaccine was highly effective against severeâcritical coronavirus disease 2019 (Covid-19), hospitalization, and death in the primary phase 3 efficacy analysis.We conducted the final ..."><meta name="Description" content="The Ad26.COV2.S vaccine was highly effective against severeâcritical coronavirus disease 2019 (Covid-19), hospitalization, and death in the primary phase 3 efficacy analysis.We conducted the final ..."><meta name="dc.Publisher" content="Massachusetts Medical Society"><meta name="dc.Date" scheme="WTN8601" content="2022-03-03"><meta name="dc.Type" content="research-article"><meta name="dc.Format" content="text/HTML"><meta name="dc.Identifier" scheme="doi" content="10.1056/NEJMoa2117608"><meta name="dc.Identifier" scheme="publisher-id" content="NJ202203033860908"><meta name="dc.Language" content="EN"><meta name="dc.Relation" content="YXQYoa2117608"><meta name="dc.Coverage" content="world"><meta name="dc.Rights" content="Copyright Â© 2022 Massachusetts Medical Society. All rights reserved.">




<link rel="meta" type="application/atom+xml" href="https://doi.org/10.1056%2FNEJMoa2117608">
<link rel="meta" type="application/rdf+json" href="https://doi.org/10.1056%2FNEJMoa2117608">
<link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1056%2FNEJMoa2117608">


                    
                
            
        
    
        
            
                
                
                
                
                
            
        
    
        
            
                
                
                
                    
                    





<meta name="robots" content="noarchive">





    





    
    
        
        <meta name="twitter:title" content="Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S | NEJM">
        <meta property="og:title" content="Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S | NEJM">
    


    <meta property="og:type" content="article">


    
    
        <meta property="og:url" content="https://www.nejm.org/doi/full/10.1056/NEJMoa2117608">
    
    


    
    
        <meta property="og:image" content="https://www.nejm.org/cms/asset/2a351918-67a8-4aaa-b189-a3113a0fef95/nejmoa2117608_f1.jpg">
        <meta name="twitter:image" content="https://www.nejm.org/cms/asset/2a351918-67a8-4aaa-b189-a3113a0fef95/nejmoa2117608_f1.jpg">
    



    <meta property="og:site_name" content="The New England Journal of Medicine">


    
    
        
        <meta property="og:description" content="The Ad26.COV2.S vaccine was highly effective against severeâcritical coronavirus disease
2019 (Covid-19), hospitalization, and death in the primary phase 3 efficacy analysis.
We conducted the final...">
        <meta name="twitter:description" content="The Ad26.COV2.S vaccine was highly effective against severeâcritical coronavirus disease
2019 (Covid-19), hospitalization, and death in the primary phase 3 efficacy analysis.
We conducted the final...">
    


    
    
        <meta property="og:image:width" content="2640">
    


    
    
        <meta property="og:image:height" content="2556">
    


    <meta name="twitter:card" content="summary">


    <meta name="twitter:site" content="@NEJM">


<meta name="viewport" content="width=device-width,initial-scale=1"><meta name="citation_fulltext_world_readable" content="">
    <meta name="publication_doi" content="10.1056/NEJMoa2117608">


    















                    
                
            
        
    
        
    
        
    
        
            
                
                
                
                
                
            
        
    




<meta name="format-detection" content="telephone=no">

<meta http-equiv="X-UA-Compatible" content="IE=edge">
    




    
        
        
        <link rel="canonical" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2117608">
    
    







<meta name="pbContext" content=";requestedJournal:journal:nejm;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:doi\:10.1056/NEJMoa2117608;wgroup:string:MMS NextGen Website Group;issue:issue:doi\:10.1056/nejm_2022.386.issue-9;pageGroup:string:Publication Pages;subPage:string:Full Text;website:website:mms-site;journal:journal:nejms">
        <script id="altmetric-embed-js" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-288192a491f0ad9cc434f05ea175659426f5ab0cfd6befb3f3592f96bb90b0d1.js"></script><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-933-8e181dff8b36ea01dc4c.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-34-6ea546d794fb7a1cea52.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-743-ddd329e1530654ec0846.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-305-9eee37798fdfe5196307.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-388-bb098c62445f518c0b46.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-556-8e58ca05fb5497e541ef.css"><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/0-dfd243c732a07d3608f6.js"></script><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/7-10d355ba95f7ec1fddf2.js"></script><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/11-04bf2a0da30146b4a5d0.js"></script><link rel="stylesheet" href="https://quilt-cdn.janrain.com/HEAD/providers.css" type="text/css"><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><link rel="preconnect" href="https://use.typekit.net"><meta http-equiv="P3P" content="CP=&quot;NOI DSP ADM OUR IND OTC&quot;"><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><link id="altmetric-embed-css" rel="stylesheet" type="text/css" href="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed-59614f5c46b49b21eeef3bb28c4fb38d1e7069e8d014752fcb66e84942556802.css"></head>
    

    



    
        
        
        
            <body class="pb-ui website-mms-site loaded">
            






    
    
        





    
    
        
        
    
    
    







<input type="hidden" id="isRoMode" name="isRoMode" value="false">

        <div id="pb-page-content" data-ng-non-bindable="">
                
            <div data-pb-dropzone="main" data-pb-dropzone-name="Main">
                
                    
                        



        
        <header data-sticky="false" class="ng-header js_stickyAd"><a href="#mainContent" class="ng-skipToMainContent">Skip to main content</a><div class="ng-header_topAd"><div class="ng-header_topAd-content d-flex justify-content-center align-items-center">



        
        <div id="DTM_Position_Topbanner" class="ad">
 <!--emptycomment-->
</div>
</div></div><div class="ng-header_journal-navbar"><div class="ng-header_journal-navbar-content"><div class="container-fluid"><div class="row"><div class="ng-header_journal-navbar_left col-lg-8 col-sm-12 pr-lg-0 d-flex align-items-center"><div data-location="nejm_group_product_nav" class="ng-header_journalNavMenu">



        
        <nav data-location="nejm_group_product_nav" role="navigation" class="ng-journalNavMenu">
<ul class="ng-journalNavMenu_list">
<li class="ng-journalNavMenu_list-item"><a href="/" class="ng-journalNavMenu_mainLink active" aria-current="page" aria-label="The New England Journal of Medicine selected item"><span class="ng-journalNavMenu_mainLink-text d-lg-block d-none">The New England Journal of Medicine</span><span class="ng-journalNavMenu_mainLink-text d-lg-none d-block">NEJM</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://evidence.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Evidence</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://ai.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> AI</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://catalyst.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Catalyst</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://www.jwatch.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Journal Watch</span></a></li>
</ul>
</nav>

</div></div><div class="ng-header_journal-navbar_right col-lg-4 pl-lg-0 d-none d-xl-flex align-items-center justify-content-end"><div class="ng-header_loginBar d-xl-flex align-items-lg-center">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa2117608" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div></div></div></div></div></div><div class="ng-header_instBanner d-none d-lg-block"></div><div class="ng-header_logoBar"><div class="container-fluid"><div class="row"><div data-location="logo" class="ng-header_logoBar_left col-lg-4 col-6 d-flex align-items-center justify-content-start"><a href="/" title="The New England Journal of Medicine homepage" class="ng-header_logo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/nejm-logo-166667e91992a5212bc723b03e45d39f.svg" alt="The New England Journal of Medicine homepage" width="366" height="58" class="ng-header_logo-image"></a></div><div class="ng-header_logoBar_right ng-header_navBar col-lg-8 col-sm-12 p-lg-0 align-items-center justify-content-end"><div class="ng-header_navBar-content"><div class="container-fluid"><div class="row"><div class="ng-header_instBanner-md col-12 d-block d-lg-none"></div><div class="ng-header_loginBar-md col-12 d-block d-xl-none">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa2117608" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div><div class="ng-header_navBar_left col-lg-8 col-sm-12 d-flex align-items-center"><div class="ng-header_stickyLogo mr-32"><a href="/" title="The New England Journal of Medicine homepage" class="ng-header_stickyLogo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/nejm-small-logo-070df7a3f4d8cfa2e71c3c45bb4b172f.svg" alt="The New England Journal of Medicine homepage" class="ng-header_stickyLogo-image"></a></div><div class="ng-header_mainMenu">









    
    
        <div data-widget-def="menuWidget" data-widget-id="97fb3983-db63-4b0b-97dd-d9bb7929fce1" data-location="main_nav">
        



        
        <nav class="ng-menu"><ul class="ng-menu_list ng-simple-menu"><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/toc/nejm/current" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">current issue</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/toc/nejm/current" class="ng-simple-menu_list-link">VIEW CURRENT ISSUE</a></li><li class="ng-simple-menu_list-item"><a href="/toc/nejm/recently-published" class="ng-simple-menu_list-link">BROWSE RECENTLY PUBLISHED</a></li><li class="ng-simple-menu_list-item"><a href="/loi/nejm" class="ng-simple-menu_list-link">BROWSE ALL ISSUES</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/medical-specialties" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">SPECIALTIES</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/browse/specialty/cardiology" class="ng-simple-menu_list-link">Cardiology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/clinical-medicine" class="ng-simple-menu_list-link">Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/endocrinology" class="ng-simple-menu_list-link">Endocrinology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/gastroenterology" class="ng-simple-menu_list-link">Gastroenterology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/hematology-oncology" class="ng-simple-menu_list-link">Hematology/Oncology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/infectious-disease" class="ng-simple-menu_list-link">Infectious Disease</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/nephrology" class="ng-simple-menu_list-link">Nephrology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/neurology-neurosurgery" class="ng-simple-menu_list-link">Neurology/Neurosurgery</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/obstetrics-gynecology" class="ng-simple-menu_list-link">Obstetrics/Gynecology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/pediatrics" class="ng-simple-menu_list-link">Pediatrics</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/pulmonary-critical-care" class="ng-simple-menu_list-link">Pulmonary/Critical Care</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/surgery" class="ng-simple-menu_list-link">Surgery</a></li><li class="ng-simple-menu_list-item"><a href="/medical-specialties" class="ng-simple-menu_list-link">View All Specialties</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/topics" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">TOPICS</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/ai-in-medicine" class="ng-simple-menu_list-link">AI in Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/climate-change" class="ng-simple-menu_list-link">Climate Change</a></li><li class="ng-simple-menu_list-item"><a href="/coronavirus" class="ng-simple-menu_list-link">Coronavirus</a></li><li class="ng-simple-menu_list-item"><a href="/equity" class="ng-simple-menu_list-link">Efforts toward Equity</a></li><li class="ng-simple-menu_list-item"><a href="/firearm-injury-prevention" class="ng-simple-menu_list-link">Firearm Injury Prevention</a></li><li class="ng-simple-menu_list-item"><a href="/nam" class="ng-simple-menu_list-link">From the National Academy of Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/fundamentals-of-medical-ethics" class="ng-simple-menu_list-link">Fundamentals of Medical Ethics</a></li><li class="ng-simple-menu_list-item"><a href="/gray-matters" class="ng-simple-menu_list-link">Gray Matters</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/health-policy" class="ng-simple-menu_list-link">Health Policy</a></li><li class="ng-simple-menu_list-item"><a href="/medicine-and-society" class="ng-simple-menu_list-link">Medicine and Society</a></li><li class="ng-simple-menu_list-item"><a href="/nutrition-in-medicine" class="ng-simple-menu_list-link">Nutrition in Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/outbreaks" class="ng-simple-menu_list-link">Outbreaks Center</a></li><li class="ng-simple-menu_list-item"><a href="/race-and-medicine" class="ng-simple-menu_list-link">Race and Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/recognizing-historical-injustices" class="ng-simple-menu_list-link">Recognizing Historical Injustices and the Journal</a></li><li class="ng-simple-menu_list-item"><a href="/tobacco-use-reduction" class="ng-simple-menu_list-link">Tobacco Use Reduction</a></li><li class="ng-simple-menu_list-item"><a href="/topics" class="ng-simple-menu_list-link">View All Topics</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/multimedia" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">MULTIMEDIA</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/rss-feed" class="ng-simple-menu_list-link">Podcasts</a></li><li class="ng-simple-menu_list-item"><a href="/double-take" class="ng-simple-menu_list-link">Double Takes</a></li><li class="ng-simple-menu_list-item"><a href="https://illustrated-glossary.nejm.org/" class="ng-simple-menu_list-link">Illustrated Glossary</a></li><li class="ng-simple-menu_list-item"><a href="/image-challenge" class="ng-simple-menu_list-link">Image Challenge</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/images-in-clinical-medicine" class="ng-simple-menu_list-link">Images in Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/interactive-medical-case" class="ng-simple-menu_list-link">Interactive Medical Cases</a></li><li class="ng-simple-menu_list-item"><a href="/plain-language-research-summaries" class="ng-simple-menu_list-link">Plain Language/Research Summaries</a></li><li class="ng-simple-menu_list-item"><a href="/multimedia/quick-take-video" class="ng-simple-menu_list-link">Quick Takes</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/videos-in-clinical-medicine" class="ng-simple-menu_list-link">Videos in Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/multimedia" class="ng-simple-menu_list-link">View All Multimedia</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/learning" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">LEARNING/CME</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/continuing-medical-education" class="ng-simple-menu_list-link">Weekly CME</a></li><li class="ng-simple-menu_list-item"><a href="/cme-ce/obesity" class="ng-simple-menu_list-link">Obesity CME/CE</a></li><li class="ng-simple-menu_list-item"><a href="/learning" class="ng-simple-menu_list-link">VIEW ALL LEARNING/CME</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item"><a href="/author-center/home" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">AUTHOR CENTER</span></a></li></ul></nav>

        </div>
    

</div><button aria-label="Search" class="ng-header_searchBtn searchBtnNav d-block ml-24"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button></div><div class="ng-header_loginBar ng-header_loginBar-sticky col-4">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa2117608" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div></div></div></div></div><div class="ng-header_logoBar_right-lg col-lg-8 col-6 d-flex align-items-center justify-content-end d-xl-none"><button aria-label="Search" class="ng-header_searchBtn d-flex justify-content-end"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button><div class="ng-header_openCloseBtns d-flex align-items-center justify-content-end"><button aria-label="Open" class="ng-header_openBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#burger"></use></svg></span></button><button aria-label="Close" class="ng-header_closeBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></button></div></div><div class="ng-header_quickSearch col-12"><div class="ng-header_quickSearch-content">



        
        <div class="ng-quick-search js-ng-quick-search"><form action="/search" method="get" class="ng-quick-search_form js-form"><div class="ng-quick-search_inputArea js-inputArea"><input type="search" name="q" placeholder="Enter keyword, author, title or citation" autocomplete="off" value="" required="required" class="ng-quick-search_allField ng-large-text-input js-allField js-allField-def-tmpl ui-autocomplete-input"><button type="submit" aria-label="Search Button" class="ng-quick-search_iconBtn d-xl-none d-block js-submitBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" style="display: none;"></ul></div><div class="ng-quick-search_btnsArea d-none d-xl-flex align-items-center justify-content-end"><a href="/search/advanced" class="ng-quick-search_advSearchLink ng-btn_link js-advancedSearchLink">Advanced Search</a><button type="submit" class="ng-quick-search_textBtn ng-btn_secondary ng-btn_iconRight js-submitBtn"><span class="ng-btn_text">SEARCH</span><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-right"></use></svg></span></button></div></form></div>
</div></div></div></div></div></header><div class="ng-header_overlay"></div><div class="ng-header_after">









    
    
        <div data-widget-def="literatumAd" data-widget-id="4931ddbd-d46e-4597-b4fd-92549e9847ca" id="ad-global-banner-FULLx64-1">
        



        
        



    

    

    
        
    



        </div>
    

</div>

                    
                        



        
        <div>









    
    
        <main data-widget-def="axelPublicationContent" data-widget-id="fcdb5261-d6a2-4a9c-81d5-3a3e2304e9c1" id="mainContent">
        



        
        <div class="article-tools__savePopup"><div class="ng-save"><input type="hidden" value="/action/getSavedTags" class="getKeywordsServiceUrl"><input type="hidden" value="/action/mmsSaveItemsService?itemType=article" class="saveServiceUrl"><input type="hidden" value="article" class="saveType"><input type="hidden" value="10.1056/NEJMoa2117608" class="inputDoi"><input type="hidden" value="J. Sadoff and Others" class="inputAuthor"><input type="hidden" value="N Engl J Med 2022;386:847-860" class="inputCitation"><input type="hidden" value="02-09-2022" class="inputEPubDate"><input type="hidden" value="March 2022" class="inputCoverDate"><input type="hidden" value="Original Article" class="inputContentType"><input type="hidden" value="Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S" class="inputArticleTitle"><input type="hidden" value="/browse/nejm-article-type/original-article" class="inputContentTypeUrl"><button type="button" id="saveArticleShowPopupBtn" aria-hidden="true" tabindex="-1" class="ng-save-btn ng-btn_secondary isLoggedOut">Save</button></div></div><div class="article-tools__articleAlertPopup"><div id="articleAlertModal" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><h5 id="articleAlertModalTitle" class="ng-modal_title modal-title">Create an E-mail Alert for This Article</h5><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body"></div></div></div></div></div><div class="ng-do-media_popup"><div id="doPopup" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body"></div></div></div></div></div><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/mms-nextgen/mms/releasedAssets/css/build-article-5b89b331018866a4a965.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail" data-type="research-article" vocab="http://schema.org/" typeof="ScholarlyArticle" lang="en" dir="ltr"><header data-extent="frontmatter" data-location="header_article"><div class="core-container"><div data-article-access="free" data-article-access-type="free" class="meta-panel"><div class="meta-panel__left-content"><div class="meta-panel__type"><a href="/browse/nejm-article-type/original-article">Original Article</a></div></div><div class="meta-panel__right-content"><div class="meta-panel__share">









    
    
        <div data-widget-def="UX3share" data-widget-id="eee5f139-16f2-48f8-97ea-1b114367da16" data-location="share_tools_article">
        



        
        <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js" nonce="94d6c2dc21f201c0-SJC"></script><div class="share"><div class="share__block share__inline-links"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="d-flex list-unstyled a2a a2a_kit a2a_default_style mb-0 a2a_kit_size_32" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Facebook" data-interactiontype="social" class="share__link a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-facebook"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="X (formerly Twitter)" data-interactiontype="social" class="share__link a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-twitter"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Linked In" data-interactiontype="social" class="share__link a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-linkedin"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Email" data-interactiontype="content_email_click" class="share__link a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-email"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" data-interactiontype="social" class="share__link a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-bluesky"></use></svg></span></a></li><div style="clear: both;"></div></ul></div></div>

        </div>
    

</div></div></div><h1 property="name">Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S</h1><div class="core-relations my-3"></div><div class="contributors"><span class="authors"><span class="heading">Authors</span>: <span role="list"><span property="author" typeof="Person" role="listitem"><span property="givenName">Jerald</span> <span property="familyName">Sadoff</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Glenda</span> <span property="familyName">Gray</span>, <span property="honorificSuffix">M.B., B.Ch.</span> <a class="orcid-id" href="https://orcid.org/0000-0003-4649-1477" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0003-4649-1477</a></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">An</span> <span property="familyName">Vandebosch</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Vicky</span> <span property="familyName">CÃ¡rdenas</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Georgi</span> <span property="familyName">Shukarev</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Beatriz</span> <span property="familyName">Grinsztejn</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Paul A.</span> <span property="familyName">Goepfert</span>, <span property="honorificSuffix">M.D.</span></span><span data-displayed-on="all">, <span data-action="reveal" tabindex="0" role="listitem">+22</span> </span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Carla</span> <span property="familyName">Truyers</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Ilse</span> <span property="familyName">Van Dromme</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Bart</span> <span property="familyName">Spiessens</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Johan</span> <span property="familyName">Vingerhoets</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Jerome</span> <span property="familyName">Custers</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Gert</span> <span property="familyName">Scheper</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Merlin L.</span> <span property="familyName">Robb</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">John</span> <span property="familyName">Treanor</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Martin F.</span> <span property="familyName">Ryser</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Dan H.</span> <span property="familyName">Barouch</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Edith</span> <span property="familyName">Swann</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Mary A.</span> <span property="familyName">Marovich</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Kathleen M.</span> <span property="familyName">Neuzil</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Lawrence</span> <span property="familyName">Corey</span>, <span property="honorificSuffix">M.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0002-2179-2436" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0002-2179-2436</a></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Jeffrey</span> <span property="familyName">Stoddard</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Karin</span> <span property="familyName">Hardt</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Javier</span> <span property="familyName">Ruiz-GuiÃ±azÃº</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Mathieu</span> <span property="familyName">Le Gars</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Hanneke</span> <span property="familyName">Schuitemaker</span>, <span property="honorificSuffix">Ph.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0001-8563-2266" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0001-8563-2266</a></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Johan</span> <span property="familyName">Van Hoof</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Frank</span> <span property="familyName">Struyf</span>, <span property="honorificSuffix">M.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0001-9988-0260" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0001-9988-0260</a></span></span><span data-hidden-on="all">, and <span property="author" typeof="Person" role="listitem"><span property="givenName">Macaya</span> <span property="familyName">Douoguih</span>, <span property="honorificSuffix">M.D.</span></span></span>, for <span property="author" typeof="Person" role="listitem">the ENSEMBLE Study Group<sup><a href="#fn1" role="doc-noteref">*</a></sup></span><span data-displayed-on="none" data-on-display="all" aria-hidden="true"> <span data-action="hide" tabindex="0" role="listitem">-22</span></span></span></span><a href="#tab-contributors" class="to-authors-affiliations" data-id="article-authors-viewall">Author Info &amp; Affiliations</a></div><div class="core-self-citation"><div class="core-date-published">Published <span property="datePublished">February 9, 2022</span></div><div property="isPartOf" typeof="Periodical"><span property="name">N Engl J Med</span> 2022<span property="isPartOf" typeof="PublicationVolume">;<span property="volumeNumber">386</span></span>:<span property="pageStart">847</span>-<span property="pageEnd">860</span></div><div class="doi">DOI: 10.1056/NEJMoa2117608</div><div class="core-enumeration"><a href="/toc/nejm/386/9"><span property="isPartOf" typeof="PublicationVolume">VOL. <span property="volumeNumber">386</span></span> <span property="isPartOf" typeof="PublicationIssue">NO. <span property="issueNumber">9</span></span></a></div><div><a href="#tab-information">Copyright Â© 2022</a></div></div><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__metrics info-panel__item"></div></div><div data-location="tools_article" class="info-panel__right-content"><div class="info-panel__article_tools info-panel__item">



        
        <div data-permission="/servlet/linkout?type=rightslink&amp;url=publisherName%3Dmassmed%26author%3DJerald%2BSadoff%252C%2BGlenda%2BGray%252C%2BAn%2BVandebosch%252C%2Bet%2Bal%26publication%3Dnejm%26orderBeanReset%3Dtrue%26volumeNum%3D386%26issueNum%3D9%26contentID%3D10.1056%252FNEJMoa2117608%26title%3DFinal%2BAnalysis%2Bof%2BEfficacy%2Band%2BSafety%2Bof%2BSingle-Dose%2BAd26.COV2.S%26publicationDate%3D03%252F03%252F2022" class="article-tools"><button id="articleToolsAlertBtn" data-url="/action/addCitationAlert?doi=10.1056%2FNEJMoa2117608" data-toggle="" data-target="#articleAlertModal" aria-label="Sign in or create account to add an article alert" data-interactiontype="article_alert" class="article-tools__citation btn btn--slim isLoggedOut"><span title="" data-toggle="tooltip" class="d-inline-block" data-original-title="Sign in or create account to add an article alert"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#alerts"></use></svg></span></span></button><button id="articleToolsSaveBtn" data-toggle="modal" data-target="#saveArticle" aria-label="Sign in or create account to save this article" data-interactiontype="article_tools_save_click" class="article-tools__favorite btn btn--slim isLoggedOut"><span title="" data-toggle="tooltip" class="d-inline-block" data-original-title="Sign in or create account to save this article"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#bookmarkFilled"></use></svg></span></span></button><a href="/servlet/linkout?type=rightslink&amp;url=publisherName%3Dmassmed%26author%3DJerald%2BSadoff%252C%2BGlenda%2BGray%252C%2BAn%2BVandebosch%252C%2Bet%2Bal%26publication%3Dnejm%26orderBeanReset%3Dtrue%26volumeNum%3D386%26issueNum%3D9%26contentID%3D10.1056%252FNEJMoa2117608%26title%3DFinal%2BAnalysis%2Bof%2BEfficacy%2Band%2BSafety%2Bof%2BSingle-Dose%2BAd26.COV2.S%26publicationDate%3D03%252F03%252F2022" target="_blank" title="" data-toggle="tooltip" aria-label="Permissions" data-interactiontype="article_tools_permissions_click" class="article-tools__permissions btn btn--slim" data-original-title="Permissions"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#permissions"></use></svg></span></a><a href="/about-nejm/reprints" title="" data-toggle="tooltip" aria-label="Reprints" data-interactiontype="article_tools_reprints_click" class="article-tools__reprints btn btn--slim" data-original-title="Reprints"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#reprints"></use></svg></span></a><a href="/cms/asset/2bc3d421-4b36-4f1b-aeee-40b27d5ab782/nejmoa2117608.pptx" target="_blank" title="" data-toggle="tooltip" aria-label="Download Slides" data-interactiontype="article_tools_slide_set_download" data-multimedia-type="Article Slideset" data-multimedia-filename="nejmoa2117608.pptx" class="article-tools__downloadSlides btn btn--slim" data-original-title="Download Slides"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#download"></use></svg></span></a><div class="article-tools__permissionsPopup"><div id="permissionsModal" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><h5 id="permissionsModalTitle" class="ng-modal_title modal-title">Permissions</h5><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body">For permission requests, please contact NEJM Reprints at <a href="mailto:reprints@nejm.org">reprints@nejm.org</a></div></div></div></div></div></div>
</div><div class="info-panel__citations info-panel__item"><a href="#tab-citations" class="btn btn--slim" aria-label="View Citations" data-toggle="tooltip" data-original-title="View Citations" data-interactiontype="article_tools_citation_download" data-multimedia-type="Citation"><i aria-hidden="true" class="icon-format_quote"></i></a></div><div class="info-panel__formats info-panel__item"><a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa2117608" class="btn btn--pdf btn--slim" aria-label="View PDF" data-toggle="tooltip" data-original-title="View PDF" data-behavior="trackDownloadEvent" data-doi="10.1056/NEJMoa2117608" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2117608.pdf"><i aria-hidden="true" class="icon-PDF"></i></a></div></div></div></div></header><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Contents</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><ul><li><a href="#summary-abstract" aria-current="true">Abstract</a></li><li><a href="#sec-1" aria-current="false">Methods</a></li><li><a href="#sec-2" aria-current="false">Results</a></li><li><a href="#sec-3" aria-current="false">Discussion</a></li><li class="bordered"><a href="#backnotes" aria-current="false">Notes</a></li><li><a href="#supplementary-materials" aria-current="false">Supplementary Material</a></li><li><a href="#bibliography" aria-current="false">References</a></li></ul></nav></div><nav id="article_collateral_menu"><ul data-core-nav="collateral" class="collateral-pill" style="margin-top: 0px;"><li><a href="#core-collateral-info" data-id="article-nav-menubar-info" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Information &amp; Authors"><i aria-hidden="true" class="icon-info"></i><span class="sr-only">Information &amp; Authors</span></a></li><li><a href="#core-collateral-metrics" data-id="article-nav-menubar-metrics" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Metrics &amp; Citations"><i aria-hidden="true" class="icon-timeline"></i><span class="sr-only">Metrics &amp; Citations</span></a></li><li><a href="#core-collateral-fulltext-options" data-id="article-nav-menubar-metrics" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="View Options"><i aria-hidden="true" class="icon-eye"></i><span class="sr-only">View Options</span></a></li><li><a href="#core-collateral-references" data-id="article-nav-menubar-references" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="References"><i aria-hidden="true" class="icon-references"></i><span class="sr-only">References</span></a></li><li><a href="#core-collateral-media" data-id="article-nav-menubar-media" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Media"><i aria-hidden="true" class="icon-photo"></i><span class="sr-only">Media</span></a></li><li><a href="#core-collateral-tables" data-id="article-nav-menubar-tables" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Tables"><i aria-hidden="true" class="icon-tables"></i><span class="sr-only">Tables</span></a></li><li><a href="#core-collateral-share" data-id="article-nav-menubar-share" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Share"><i aria-hidden="true" class="icon-share"></i><span class="sr-only">Share</span></a></li></ul></nav></div></div><div data-core-wrapper="content"><div id="abstracts" data-extent="frontmatter" data-location="articleTab_article"><div class="core-container"><section id="summary-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Abstract</h2><section id="abs-sec-1"><h3>Background</h3><div role="paragraph">The Ad26.COV2.S vaccine was highly effective against severeâcritical coronavirus disease 2019 (Covid-19), hospitalization, and death in the primary phase 3 efficacy analysis.</div></section><section id="abs-sec-2"><h3>Methods</h3><div role="paragraph">We conducted the final analysis in the double-blind phase of our multinational, randomized, placebo-controlled trial, in which adults were assigned in a 1:1 ratio to receive single-dose Ad26.COV2.S (5Ã10<sup>10</sup> viral particles) or placebo. The primary end points were vaccine efficacy against moderate to severeâcritical Covid-19 with onset at least 14 days after administration and at least 28 days after administration in the per-protocol population. Safety and key secondary and exploratory end points were also assessed.</div></section><section id="abs-sec-3"><h3>Results</h3><div role="paragraph">Median follow-up in this analysis was 4 months; 8940 participants had at least 6 months of follow-up. In the per-protocol population (39,185 participants), vaccine efficacy against moderate to severeâcritical Covid-19 at least 14 days after administration was 56.3% (95% confidence interval [CI], 51.3 to 60.8; 484 cases in the vaccine group vs. 1067 in the placebo group); at least 28 days after administration, vaccine efficacy was 52.9% (95% CI, 47.1 to 58.1; 433 cases in the vaccine group vs. 883 in the placebo group). Efficacy in the United States, primarily against the reference strain (B.1.D614G) and the B.1.1.7 (alpha) variant, was 69.7% (95% CI, 60.7 to 76.9); efficacy was reduced elsewhere against the P.1 (gamma), C.37 (lambda), and B.1.621 (mu) variants. Efficacy was 74.6% (95% CI, 64.7 to 82.1) against severeâcritical Covid-19 (with only 4 severeâcritical cases caused by the B.1.617.2 [delta] variant), 75.6% (95% CI, 54.3 to 88.0) against Covid-19 leading to medical intervention (including hospitalization), and 82.8% (95% CI, 40.5 to 96.8) against Covid-19ârelated death, with protection lasting 6 months or longer. Efficacy against any severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was 41.7% (95% CI, 36.3 to 46.7). Ad26.COV2.S was associated with mainly mild-to-moderate adverse events, and no new safety concerns were identified.</div></section><section id="abs-sec-4"><h3>Conclusions</h3><div role="paragraph">A single dose of Ad26.COV2.S provided 52.9% protection against moderate to severeâcritical Covid-19. Protection varied according to variant; higher protection was observed against severe Covid-19, medical intervention, and death than against other end points and lasted for 6 months or longer. (Funded by Janssen Research and Development and others; ENSEMBLE ClinicalTrials.gov number, <a href="http://clinicaltrials.gov/show/NCT04505722" target="_blank">NCT04505722</a>.)</div></section></section></div></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text" data-location="articleTab_article"><div class="core-container"><div role="paragraph">The Ad26.COV2.S vaccine (Johnson &amp; JohnsonâJanssen) is a recombinant, replication-incompetent human adenovirus type 26 (Ad26) vector encoding a full-length, membrane-bound severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein in a prefusion stabilized conformation.<sup><a href="#core-r1" role="doc-biblioref" data-xml-rid="r1 r2" id="body-ref-r2" href-manipulated="true">1,2</a></sup> Primary analysis of the phase 3 ENSEMBLE trial, performed when preset criteria had been met and conducted during the early emergence of variants and for a median follow-up of 58 days, showed 66.9% efficacy against moderate to severeâcritical (i.e., severe or critical) coronavirus disease 2019 (Covid-19) and greater than 85% efficacy against severeâcritical disease.<sup><a href="#core-r3" role="doc-biblioref" data-xml-rid="r3" id="body-ref-r3-1" href-manipulated="true" aria-label="Reference 3">3</a></sup> Here, we report the final analysis of the double-blind phase of ENSEMBLE, which was conducted in accordance with the protocol when data for more than 90% of the participants had been unblinded.</div><section id="sec-1" data-type="methods"><h2>Methods</h2><section id="sec-1-1"><h3>Trial Design and Oversight</h3><div role="paragraph">We have reached the stage in this ongoing multinational, randomized, double-blind, placebo-controlled, phase 3 trial at which crossover vaccination of the participants in the control group has occurred. The trial was designed and conducted and the data were analyzed and interpreted by the sponsor (Janssen Research and Development) and collaborators (see the Supplementary Methods section in the <a href="#ap2">Supplementary Appendix</a>, available with the full text of this article at NEJM.org). The trial-site investigators collected and contributed to the interpretation of the data. All the data were available to the authors, who vouch for the accuracy and completeness of the data and for the fidelity of the trial to the <a href="#ap1">protocol</a>, available at NEJM.org. Medical writers funded by the sponsor assisted in drafting the manuscript.</div></section><section id="sec-1-2"><h3>Trial Participants</h3><div role="paragraph">Participants were adults who were 18 years of age or older and were in good or stable health, without coexisting conditions or with stable and well-controlled coexisting conditions. Key exclusion criteria were previous receipt of a Covid-19 vaccine or abnormal immune system function (see the Supplementary Methods section). After emergency use authorization, participants who received placebo during the double-blind phase became eligible for vaccination with Ad26.COV2.S (crossover vaccination), provided they had not received another Covid-19 vaccine outside the trial. This crossover shortened the follow-up time in the projected double-blind phase of the trial.</div></section><section id="sec-1-3"><h3>Procedures</h3><div role="paragraph">Trial procedures are described in the Supplementary Methods section. Participants were randomly assigned in a 1:1 ratio with the use of randomly permuted blocks in an interactive Web-response system to receive Ad26.COV2.S (5Ã10<sup>10</sup> viral particles) or saline placebo as an intramuscular injection (0.5 ml). The investigators at the trial sites and the participants remained unaware of the group assignments until the unblinding or crossover visit.</div><div role="paragraph">Primary and key secondary efficacy evaluations were based on centrally confirmed Covid-19 cases (confirmed molecularly with the use of m-2000 SARS-CoV-2 real-time reverse-transcriptase polymerase chain reaction [RT-PCR], Abbott); cases were clinically assessed independently by a clinical severity adjudication committee. Participants responded to a twice-weekly questionnaire assessing whether they had Covid-19 symptoms, which were reported with the use of the electronic Symptoms of Infection with Coronavirus-19 questionnaire. Additional details are provided in the Supplementary Methods section.</div></section><section id="sec-1-4"><h3>Efficacy Assessments</h3><div role="paragraph">The two primary end points were vaccine efficacy against the first occurrence of centrally RT-PCRâconfirmed moderate to severeâcritical Covid-19 with onset at least 14 days after administration and at least 28 days after administration in the per-protocol population (Table S1 in the <a href="#ap2">Supplementary Appendix</a>). Covid-19 case definitions and protocol-defined secondary and exploratory end points (e.g., efficacy according to SARS-CoV-2 lineage) are provided in the Supplementary Methods.</div></section><section id="sec-1-5"><h3>Safety Assessments</h3><div role="paragraph">Serious adverse events and suspected adverse events of special interest are recorded throughout the trial. During the double-blind phase of the trial, a safety subpopulation that included approximately 6000 participants recorded solicited local and systemic adverse events in an electronic diary for 7 days after administration and unsolicited adverse events for 28 days after administration.</div></section><section id="sec-1-6"><h3>Statistical Analysis</h3><div role="paragraph">The full analysis population included all the participants who underwent randomization and received a dose of trial vaccine or placebo. The at-risk population excluded participants who had a Covid-19 case with an onset before day 15 or before day 29 for the vaccine efficacy evaluations at least 14 days after administration or at least 28 days after administration, respectively. Efficacy analyses were conducted in the per-protocol population, which included participants who received vaccine or placebo in the double-blind phase; participants who were seropositive or RT-PCRâpositive at baseline were excluded from the per-protocol population. Safety analyses were conducted with the full analysis population. Participant data were censored on unblinding or receipt of a Covid-19 vaccine outside the trial.</div><div role="paragraph">Statistical hypothesis testing was conducted in accordance with the prespecified scheme for the control of familywise type I error as indicated with adjusted 95% confidence intervals. End points that had already been inferentially evaluated in the primary analysis were summarized descriptively with 95% confidence intervals. Other prespecified end points not included in the prespecified scheme for familywise type I error control (such as exploratory end points) are summarized with descriptive 95% confidence intervals. Nonprespecified end points are designated as post hoc. Exact Poisson regression was used for analyses of efficacy and associated calculations of confidence intervals.<sup><a href="#core-r4" role="doc-biblioref" data-xml-rid="r4" id="body-ref-r4" href-manipulated="true" aria-label="Reference 4">4</a></sup> Cumulative incidence was estimated with KaplanâMeier methods to evaluate time to the first occurrence of Covid-19 and vaccine efficacy over time.</div><div role="paragraph">The frequency of serious adverse events was tabulated for the full analysis population; the frequency and severity of solicited and unsolicited adverse events were tabulated in the safety subpopulation.</div></section></section><section id="sec-2" data-type="results"><h2>Results</h2><section id="sec-2-1"><h3>Participants</h3><div role="paragraph">Trial enrollment began on September 21, 2020, and the data cutoff for the final analysis was July 9, 2021, with the end of the double-blind period varying among countries. Table S2 shows case numbers in each country according to viral lineage, and <a href="#f1">Figure 1</a> shows the detection of viral lineages over time according to country. Emergency use authorization for Ad26.COV2.S occurred on February 27, 2021; crossover began after approval of protocol amendment 4, with the first participant in the placebo group vaccinated on March 10, 2021. The characteristics of the participants at baseline were balanced between trial groups (Table S3) and were generally representative of the population at risk for Covid-19 in the United States (Table S4). Worldwide, 19.5% of the participants in the trial were 65 years of age or older, and 42.0% had coexisting conditions.</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 1</div><nav><a href="#f1" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f1.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f1" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f1" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f1.jpg"><img src="/cms/10.1056/NEJMoa2117608/asset/2a351918-67a8-4aaa-b189-a3113a0fef95/assets/images/large/nejmoa2117608_f1.jpg" height="2556" width="2640" aria-labelledby="f1" loading="lazy"></a><figcaption><div class="caption">Cases of Covid-19 According to SARS-CoV-2 Lineage (Full Analysis Population).</div><div class="notes"><div role="doc-footnote">The distribution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages among cases of coronavirus disease 2019 (Covid-19) is shown for each country in the trial over time during the double-blind phase of the trial. The reference sequence is defined as the SARS-CoV-2 Wuhan-Hu-1 sequence but with the D614G amino acid variation. At the time of the trial, sequences categorized as âotherâ were those with substitutions not resulting in another SARS-CoV-2 lineage or variant. âOther+E484Kâ refers to sequences with E484K but no other substitutions resulting in another SARS-CoV-2 lineage or variant. Next-generation sequencing was performed with the use of the Swift Biosciences SNAP Assay, version 2. Amino acid variants are defined as changes from the reference sequence. The last available visit date across countries was July 1 through 9, 2021, and the last available date of onset for a primary end-point case was June 26 (Argentina), March 24 (Brazil), April 22 (Chile), June 23 (Colombia), May 27 (Mexico), July 1 (Peru), July 5 (South Africa), and April 16 (United States). None of the cases were caused by the eta, kappa, theta, or C.36.3 variant. The alpha, beta, gamma, and delta variants were variants of concern according to World Health Organization definitions at the time of the analysis.</div></div></figcaption></figure></div><div role="paragraph">In total, 43,788 participants underwent randomization and received vaccine or placebo, and 39,185 participants who were seronegative for SARS-CoV-2 at baseline were included in the per-protocol analysis population for the double-blind phase (Fig. S1). At the time of the final analysis, 97% of the participants had completed the double-blind phase or had withdrawn prematurely. Median follow-up was 121 days (range, 1 to 284), and 35,788 (91.3%) and 8940 (22.8%) of the participants in the per-protocol population had follow-up of at least 2 months and at least 6 months, respectively, in the double-blind phase. Follow-up was nearly identical in the full analysis population (median, 123 days [range, 0 to 284]; 40,260 [91.9%] and 11,290 [25.8%] of the participants had follow-up of â¥2 months and â¥6 months, respectively).</div></section><section id="sec-2-2"><h3>Efficacy against Moderate to SevereâCritical Covid-19</h3><div role="paragraph">In the per-protocol at-risk population, 484 moderate to severeâcritical Covid-19 cases with onset at least 14 days after administration were noted in the vaccine group, as compared with 1067 in the placebo group (vaccine efficacy, 56.3%; 95% confidence interval [CI], 51.3 to 60.8) (<a href="#t1">Table 1</a>). Vaccine efficacy against moderate to severeâcritical Covid-19 with onset at least 28 days after administration was 52.9% (95% CI, 47.1 to 58.1). The primary end point captured most symptomatic disease with onset at least 28 days after administration, with only 10 cases of mild Covid-19 occurring in the vaccine group and 12 in the placebo group, resulting in efficacy of 52.4% (95% CI, 46.6 to 57.6) against any symptomatic infection.</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Table 1</div><nav><a href="#t1" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2117608_t1.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="t1" class="table"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#t1" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2117608_t1.jpg"><img src="/cms/10.1056/NEJMoa2117608/asset/59220ea1-bb1a-4ce8-a3c7-c549dbbc3aec/assets/images/large/nejmoa2117608_t1.jpg" height="2505" width="2615" loading="lazy"></a></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">End Point</th><th class="txxx-borders" colspan="5"><span>â¥14 Days after Administration<a href="#t1fn2" role="doc-noteref">â </a></span></th><th class="txxr-borders" colspan="5"><span>â¥28 Days after Administration<a href="#t1fn3" role="doc-noteref">â¡</a></span></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders" colspan="2"><span>Ad26.COV2.S<br>(N=19,400)</span></th><th class="xxxx-borders" colspan="2"><span>Placebo<br>(N=19,398)</span></th><th class="xxxx-borders">Vaccine Efficacy (95% CI)</th><th class="xxxx-borders" colspan="2"><span>Ad26.COV2.S<br>(N=19,113)</span></th><th class="xxxx-borders" colspan="2"><span>Placebo<br>(N=18,924)</span></th><th class="xxxr-borders">Vaccine Efficacy (95% CI)</th></tr><tr class="head3" data-type="row head3"><td class="xxlx-borders hanging02">&nbsp;</td><th class="xxxx-borders">no. of cases</th><th class="xxxx-borders">person-yr</th><th class="xxxx-borders">no. of cases</th><th class="xxxx-borders">person-yr</th><th class="xxxx-borders">%</th><th class="xxxx-borders">no. of cases</th><th class="xxxx-borders">person-yr</th><th class="xxxx-borders">no. of cases</th><th class="xxxx-borders">person-yr</th><th class="xxxr-borders">%</th></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Moderate to severeâcritical Covid-19<a href="#t1fn4" role="doc-noteref">Â§</a></td><td class="xxxx-borders shading">484</td><td class="xxxx-borders shading">6685.6</td><td class="xxxx-borders shading">1067</td><td class="xxxx-borders shading">6440.2</td><td class="xxxx-borders shading">56.3 (51.3 to 60.8)</td><td class="xxxx-borders shading">433</td><td class="xxxx-borders shading">6658.4</td><td class="xxxx-borders shading">883</td><td class="xxxx-borders shading">6400.4</td><td class="xxxr-borders shading">52.9 (47.1 to 58.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">18â59 yr</td><td class="xxxx-borders">381</td><td class="xxxx-borders">4682.1</td><td class="xxxx-borders">847</td><td class="xxxx-borders">4514.2</td><td class="xxxx-borders">56.6 (51.0 to 61.7)</td><td class="xxxx-borders">340</td><td class="xxxx-borders">4663.8</td><td class="xxxx-borders">716</td><td class="xxxx-borders">4486.7</td><td class="xxxr-borders">54.3 (48.0 to 60.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">â¥60 yr</td><td class="xxxx-borders shading">103</td><td class="xxxx-borders shading">2003.5</td><td class="xxxx-borders shading">220</td><td class="xxxx-borders shading">1926.0</td><td class="xxxx-borders shading">55.0 (42.9 to 64.7)</td><td class="xxxx-borders shading">93</td><td class="xxxx-borders shading">1994.6</td><td class="xxxx-borders shading">167</td><td class="xxxx-borders shading">1913.7</td><td class="xxxr-borders shading">46.6 (30.7 to 59.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Symptomatic Covid-19 of any severity<a href="#t1fn5" role="doc-noteref">Â¶</a></td><td class="xxxx-borders">495</td><td class="xxxx-borders">6683.8</td><td class="xxxx-borders">1082</td><td class="xxxx-borders">6437.4</td><td class="xxxx-borders">55.9 (51.0 to 60.5)</td><td class="xxxx-borders">443</td><td class="xxxx-borders">6656.8</td><td class="xxxx-borders">895</td><td class="xxxx-borders">6398.3</td><td class="xxxr-borders">52.4 (46.6 to 57.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Mild<a href="#t1fn6" role="doc-noteref">â</a></td><td class="xxxx-borders shading">11</td><td class="xxxx-borders shading">6683.8</td><td class="xxxx-borders shading">15</td><td class="xxxx-borders shading">6437.4</td><td class="xxxx-borders shading">29.4 (â64.6 to 70.7)</td><td class="xxxx-borders shading">10</td><td class="xxxx-borders shading">6656.8</td><td class="xxxx-borders shading">12</td><td class="xxxx-borders shading">6398.3</td><td class="xxxr-borders shading">19.9 (â102.3 to 69.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Moderate<a href="#t1fn6" role="doc-noteref">â</a></td><td class="xxxx-borders">429</td><td class="xxxx-borders">6685.6</td><td class="xxxx-borders">862</td><td class="xxxx-borders">6440.2</td><td class="xxxx-borders">52.1 (46.1 to 57.4)</td><td class="xxxx-borders">388</td><td class="xxxx-borders">6658.4</td><td class="xxxx-borders">707</td><td class="xxxx-borders">6400.4</td><td class="xxxr-borders">47.2 (40.2 to 53.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Severeâcritical<a href="#t1fn5" role="doc-noteref">Â¶</a></td><td class="xxxx-borders shading">56</td><td class="xxxx-borders shading">6774.6</td><td class="xxxx-borders shading">205</td><td class="xxxx-borders shading">6625.2</td><td class="xxxx-borders shading">73.3 (63.9 to 80.5)</td><td class="xxxx-borders shading">46</td><td class="xxxx-borders shading">6733.8</td><td class="xxxx-borders shading">176</td><td class="xxxx-borders shading">6542.1</td><td class="xxxr-borders shading">74.6 (64.7 to 82.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Any SARS-CoV-2 infection<a href="#t1fn5" role="doc-noteref">Â¶</a><a href="#t1fn7" role="doc-noteref">**</a><a href="#t1fn8" role="doc-noteref">â â </a></td><td class="xxxx-borders">â</td><td class="xxxx-borders">â</td><td class="xxxx-borders">â</td><td class="xxxx-borders">â</td><td class="xxxx-borders">â</td><td class="xxxx-borders">1038</td><td class="xxxx-borders">6560.8</td><td class="xxxx-borders">1699</td><td class="xxxx-borders">6257.5</td><td class="xxxr-borders">41.7 (36.3 to 46.7)<a href="#t1fn9" role="doc-noteref">â¡â¡</a></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Asymptomatic SARS-CoV-2 infection<a href="#t1fn5" role="doc-noteref">Â¶</a><a href="#t1fn8" role="doc-noteref">â â </a></td><td class="xxxx-borders shading">â</td><td class="xxxx-borders shading">â</td><td class="xxxx-borders shading">â</td><td class="xxxx-borders shading">â</td><td class="xxxx-borders shading">â</td><td class="xxxx-borders shading">498</td><td class="xxxx-borders shading">6581.0</td><td class="xxxx-borders shading">669</td><td class="xxxx-borders shading">6289.3</td><td class="xxxr-borders shading">28.9 (20.0 to 36.8)<a href="#t1fn9" role="doc-noteref">â¡â¡</a></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Covid-19 leading to medical intervention<a href="#t1fn5" role="doc-noteref">Â¶</a><a href="#t1fn10" role="doc-noteref">Â§Â§</a></td><td class="xxxx-borders">18</td><td class="xxxx-borders">6783.9</td><td class="xxxx-borders">74</td><td class="xxxx-borders">6656.7</td><td class="xxxx-borders">76.1 (56.9 to 87.7)<a href="#t1fn6" role="doc-noteref">Â¶</a></td><td class="xxxx-borders">16</td><td class="xxxx-borders">6739.8</td><td class="xxxx-borders">64</td><td class="xxxx-borders">6567.1</td><td class="xxxr-borders">75.6 (54.3 to 88.0)<a href="#t1fn9" role="doc-noteref">â¡â¡</a></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Death from any cause<a href="#t1fn11" role="doc-noteref">Â¶Â¶</a></td><td class="xxxx-borders shading">19</td><td class="xxxx-borders shading">6787.0</td><td class="xxxx-borders shading">45</td><td class="xxxx-borders shading">6669.3</td><td class="xxxx-borders shading">58.5 (27.6 to 77.1)</td><td class="xxxx-borders shading">19</td><td class="xxxx-borders shading">6742.4</td><td class="xxxx-borders shading">37</td><td class="xxxx-borders shading">6577.3</td><td class="xxxr-borders shading">49.9 (10.6 to 72.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Covid-19ârelated death<a href="#t1fn11" role="doc-noteref">Â¶Â¶</a></td><td class="xxxx-borders">3</td><td class="xxxx-borders">6786.9</td><td class="xxxx-borders">19</td><td class="xxxx-borders">6668.4</td><td class="xxxx-borders">84.5 (47.3 to 97.1)</td><td class="xxxx-borders">3</td><td class="xxxx-borders">6742.2</td><td class="xxxx-borders">17</td><td class="xxxx-borders">6576.4</td><td class="xxxr-borders">82.8 (40.5 to 96.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging02 shading" data-xml-align="left">Covid-19 according to FDA harmonized definition<a href="#t1fn6" role="doc-noteref">â</a><a href="#t1fn12" role="doc-noteref">ââ</a></td><td class="xbxx-borders shading">492</td><td class="xbxx-borders shading">6684.7</td><td class="xbxx-borders shading">1067</td><td class="xbxx-borders shading">6440.5</td><td class="xbxx-borders shading">55.6 (50.5 to 60.2)</td><td class="xbxx-borders shading">441</td><td class="xbxx-borders shading">6657.3</td><td class="xbxx-borders shading">884</td><td class="xbxx-borders shading">6399.6</td><td class="xbxr-borders shading">52.0 (46.2 to 57.3)</td></tr></tbody></table></div><figcaption><div class="caption">Vaccine Efficacy against Covid-19 with Onset at Least 14 Days and at Least 28 Days after the Administration of Vaccine or Placebo (Per-Protocol at-Risk Population).<a href="#t1fn1" role="doc-noteref">*</a></div><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="t1fn1" role="paragraph">All coronavirus disease 2019 (Covid-19) cases were centrally confirmed unless stated otherwise and occurred in participants who had been seronegative at baseline, had negative results on reverse-transcriptaseâpolymerase-chain-reaction (RT-PCR) testing before 14 or 28 days after administration of vaccine or placebo, and were considered to be at risk for Covid-19. The follow-up time for each participant was defined as the time from administration until onset of a Covid-19 episode or the end of the double-blind period (July 9, 2021). Mild Covid-19 cases were defined by a positive RT-PCR test result and at least one of the following signs or symptoms: fever (body temperature, â¥38.0Â°C), sore throat, malaise, headache, myalgia, gastrointestinal symptoms, cough, chest congestion, runny nose, wheezing, skin rash, eye irritation or discharge, chills, loss of taste or smell, red or bruised-looking feet or toes, and shaking chills or rigors. Moderate Covid-19 cases were defined by a positive RT-PCR test result and two or more of the following symptoms: fever (body temperature, â¥38.0Â°C), heart rate of at least 90 beats per minute, shaking chills or rigors, sore throat, cough, malaise, headache, myalgia, gastrointestinal symptoms, loss of taste or smell, and red or bruised-looking feet or toes; or one or more of the following symptoms: respiratory rate of at least 20 breaths per minute, abnormal oxygen saturation (but &gt;93% while breathing room air at sea level), clinical or radiologic evidence of pneumonia, radiologic evidence of deep-vein thrombosis, and shortness of breath or difficulty breathing. Severeâcritical Covid-19 cases were defined by a positive RT-PCR test result and one or more of the following features: signs of severe systemic illness (respiratory rate, â¥30 breaths per minute; heart rate, â¥125 beats per minute; oxygen saturation, â¤93% while breathing room air at sea level; or ratio of partial pressure of oxygen [in mm Hg] to fraction of inspired oxygen, &lt;300); respiratory failure (leading to receipt of high-flow oxygen, noninvasive ventilation, mechanical ventilation, or extracorporeal membrane oxygenation [ECMO]); shock; significant acute renal, hepatic, or neurologic dysfunction; admission to an intensive care unit; or death.</div></div><div role="doc-footnote" data-has="label"><div class="label">â </div><div id="t1fn2" role="paragraph">The at-risk population excluded participants who were RT-PCRâpositive between day 1 and day 14.</div></div><div role="doc-footnote" data-has="label"><div class="label">â¡</div><div id="t1fn3" role="paragraph">The at-risk population excluded participants who were RT-PCRâpositive between day 1 and day 28.</div></div><div role="doc-footnote" data-has="label"><div class="label">Â§</div><div id="t1fn4" role="paragraph">The primary end points were the first occurrence of centrally RT-PCRâconfirmed moderate to severeâcritical Covid-19 with onset at least 14 days after administration and at least 28 days after administration. One participant had a moderate case of Covid-19 and later had a severe case; the adjudication committee considered these to be two separate infections.</div></div><div role="doc-footnote" data-has="label"><div class="label">Â¶</div><div id="t1fn5" role="paragraph">This end point was a confirmatory secondary end point.</div></div><div role="doc-footnote" data-has="label"><div class="label">â</div><div id="t1fn6" role="paragraph">This end point was a supportive secondary end point.</div></div><div role="doc-footnote" data-has="label"><div class="label">**</div><div id="t1fn7" role="paragraph">This category includes undetected cases that were subsequently detected through a positive serologic result (according to the clinical severity adjudication committee), which did not count as either symptomatic cases (because they were RT-PCRânegative) or asymptomatic cases.</div></div><div role="doc-footnote" data-has="label"><div class="label">â â </div><div id="t1fn8" role="paragraph">Data on this end point were not obtained for cases in which onset occurred after 14 days after administration.</div></div><div role="doc-footnote" data-has="label"><div class="label">â¡â¡</div><div id="t1fn9" role="paragraph">The 95% confidence intervals for vaccine efficacy against any severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, asymptomatic infections, and Covid-19 leading to medical intervention were adjusted for multiplicity on the basis of prespecified procedures for familywise type I error control. All other confidence intervals have not been adjusted for multiplicity and should not be used to infer statistical significance.</div></div><div role="doc-footnote" data-has="label"><div class="label">Â§Â§</div><div id="t1fn10" role="paragraph">Medical intervention included hospitalization as adjudicated by the clinical severity adjudication committee, admission to an intensive care unit, mechanical ventilation, and ECMO, linked to objective measures such as decreased oxygenation and findings on radiography or computed tomography.</div></div><div role="doc-footnote" data-has="label"><div class="label">Â¶Â¶</div><div id="t1fn11" role="paragraph">This end point was an exploratory end point.</div></div><div role="doc-footnote" data-has="label"><div class="label">ââ</div><div id="t1fn12" role="paragraph">At the time the protocol was written, the Food and Drug Administration (FDA) harmonized Covid-19 definition was a positive RT-PCR test result plus any of the following symptoms: fever or chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, and diarrhea.</div></div></div></figcaption></figure></div><div role="paragraph">The KaplanâMeier cumulative incidence curves for moderate to severeâcritical Covid-19 separated after 14 days (<a href="#f2">Figure 2A</a>); vaccine efficacy persisted through approximately 6 to 7 months after administration with a modest decline, after which wide confidence intervals and low numbers of at-risk participants preclude interpretation (<a href="#f2">Figure 2B</a>). This apparent reduction in efficacy may be related to the emergence of more neutralization-resistant variants toward the end of the trial (<a href="#f1">Figure 1</a>), as evidenced by the absence of a decline in efficacy against minor, âotherâ viral sequences (i.e., SARS-CoV-2 with substitutions not considered to result in another lineage or variant) (Fig. S2). Because efficacy results for the primary end point were similar at 14 or more days and at 28 or more days after administration, only the latter results are shown for secondary and exploratory end points.</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 2</div><nav><a href="#f2" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f2.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f2" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f2" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f2.jpg"><img src="/cms/10.1056/NEJMoa2117608/asset/265bbfd3-9d04-45e3-999e-edd40e9251fd/assets/images/large/nejmoa2117608_f2.jpg" height="2659" width="2640" aria-labelledby="f2" loading="lazy"></a><figcaption><div class="caption">Cumulative Incidence of Moderate to SevereâCritical Covid-19 and Vaccine Efficacy over Time (Per-Protocol Population).</div><div class="notes"><div role="doc-footnote">Panel A shows the KaplanâMeier cumulative incidence of molecularly confirmed moderate to severeâcritical Covid-19 with onset at least 1 day after administration of vaccine or placebo. Shading indicates the 95% confidence interval. Panel B shows vaccine efficacy against moderate to severeâcritical Covid-19 over time; dark gray shading indicates the 95% pointwise confidence interval, and light gray shading the 95% simultaneous confidence interval. The graph includes 95% of the events that occurred before day 189, with the hazard smoothed over 21 days. Participants were seronegative at baseline, as determined by reverse-transcriptaseâpolymerase-chain-reaction (RT-PCR) and serologic tests.</div></div></figcaption></figure></div></section><section id="sec-2-3"><h3>Efficacy According to Viral Lineage</h3><div role="paragraph">New viral lineages emerged and became dominant in most countries in the trial during the analysis period, with some variants occurring predominately in one country (e.g., B.1.351 [beta] in South Africa, C.37 [lambda] in Peru, and B.1.621 [mu] in Colombia) (<a href="#f1">Figure 1</a>). Vaccine efficacy was 70.2% (95% CI, 35.3 to 87.6) against moderate to severeâcritical Covid-19 caused by the B.1.1.7 (alpha) variant; 69.0% (95% CI, 59.1 to 76.8) against moderate to severeâcritical Covid-19 caused by SARS-CoV-2 classified as âother,â with efficacy remaining stable through 195 days of follow-up; and 58.2% (95% CI, 35.0 to 73.7) against moderate to severeâcritical Covid-19 caused by the reference strain (B.1.D614G). Overall efficacy was 44.4% (95% CI, 34.6 to 52.8) against SARS-CoV-2 lineages other than the reference strain (<a href="#f3">Figure 3</a>), including 51.9% (95% CI, 19.1 to 72.2) against the beta variant and 36.5% (95% CI, 14.1 to 53.3) against the P.1 (gamma) variant; at the end of the double-blind period, there was no observed difference between vaccine and placebo with respect to the 21 cases caused by the B.1.617.2 (delta) variant in South Africa (vaccine efficacy, â5.7%; 95% CI, â177.7 to 59.2). The KaplanâMeier curves suggest that efficacy against the circulating reference strain and beta variant began 14 days and 25 days after immunization, respectively, and began immediately on exposure to the alpha variant, which emerged at least 2 months after vaccination of the participants in the vaccine group was completed (<a href="#f1">Figure 1</a>). KaplanâMeier curves were plotted to the end of the double-blind phase, independent of whether cases were occurring in both groups. An additional variant analysis was conducted for cases that occurred during the double-blind period but were sequenced after database lock; results were consistent with those of the initial analysis (Fig. S3).</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 3</div><nav><a href="#f3" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f3.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f3" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f3" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f3.jpg"><img src="/cms/10.1056/NEJMoa2117608/asset/8dc13911-fa0b-4a22-9c69-fd33169ea821/assets/images/large/nejmoa2117608_f3.jpg" height="3148" width="2640" aria-labelledby="f3" loading="lazy"></a><figcaption><div class="caption">Vaccine Efficacy against Moderate to SevereâCritical Covid-19 According to SARS-CoV-2 Lineage (Per-Protocol Population).</div><div class="notes"><div role="doc-footnote">Shown is vaccine efficacy against moderate to severeâcritical Covid-19 with onset at least 14 days after administration (Panel A) and at least 28 days after administration (Panel B). SARS-CoV-2 in the category of âLineages other than the reference strainâ were all variants of concern or interest, with âotherâ sequences excluded. At the time of the trial, sequences categorized as âotherâ were those with substitutions not resulting in another SARS-CoV-2 lineage or variant. âOther+E484Kâ refers to sequences with E484K but no other substitutions resulting in another SARS-CoV-2 lineage or variant. Vaccine efficacy was not calculated if fewer than 6 cases were observed for an end point. Confidence intervals have not been adjusted for multiplicity and should not be used to infer statistical significance.</div></div></figcaption></figure></div></section><section id="sec-2-4"><h3>Efficacy against SevereâCritical Covid-19</h3><div role="paragraph">For severeâcritical Covid-19, overall vaccine efficacy was 74.6% (95% CI, 64.7 to 82.1) (<a href="#t1">Table 1</a>). The cumulative incidence curves, which began to separate approximately 7 days after administration (<a href="#f4">Figure 4</a>), with no evidence of waning for approximately 6 to 7 months after administration.</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 4</div><nav><a href="#f4" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f4.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f4" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f4" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f4.jpg"><img src="/cms/10.1056/NEJMoa2117608/asset/9ae468ee-5f05-4f1e-8a57-2947f1f3dc0b/assets/images/large/nejmoa2117608_f4.jpg" height="2737" width="2640" aria-labelledby="f4" loading="lazy"></a><figcaption><div class="caption">Cumulative Incidence of SevereâCritical Covid-19 and Vaccine Efficacy over Time (Per-Protocol Population).</div><div class="notes"><div role="doc-footnote">Panel A shows the KaplanâMeier cumulative incidence of molecularly confirmed severeâcritical Covid-19 with onset at least 1 day after administration of vaccine or placebo. Shading indicates the 95% confidence interval. Panel B shows vaccine efficacy against severeâcritical Covid-19 over time; dark gray shading indicates the 95% pointwise confidence interval, and light gray shading the 95% simultaneous confidence interval. The graph includes 95% of the events that occurred before day 189, with the hazard smoothed over 21 days. Participants were seronegative at baseline, as determined by RT-PCR and serologic tests.</div></div></figcaption></figure></div><div role="paragraph">Vaccine efficacy against severeâcritical Covid-19 was 93.1% (95% CI, 54.4 to 99.8) for the reference strain; 71.8% (95% CI, 56.3 to 82.3) for nonâreference strain SARS-CoV-2 lineages, including âotherâ sequences with the E484K mutation; 78.4% (95% CI, 34.5 to 94.7) for the beta variant; 63.6% (95% CI, 18.8 to 85.1) for the gamma variant; 67.6% (95% CI, â29.8 to 94.4) for the lambda variant; and 79.5% (95% CI, 38.5 to 94.9) for the mu variant. Only six cases of severeâcritical Covid-19 caused by the alpha variant and four caused by the delta variant were reported (Fig. S4).</div></section><section id="sec-2-5"><h3>Additional Secondary and Exploratory Efficacy End Points</h3><div role="paragraph">Vaccine efficacy against moderate to severeâcritical Covid-19 with onset at least 28 days after administration in all participants regardless of serostatus at baseline, excluding participants in whom Covid-19 developed before day 29 (at-risk population), was 53.2% (95% CI, 47.5 to 58.4). Vaccine efficacy against moderate to severeâcritical Covid-19 with onset 1 day after administration was 52.6% (95% CI, 47.6 to 57.2).</div><div role="paragraph">Vaccine efficacy against Covid-19 with onset at least 28 days after administration that led to medical intervention (including hospitalization) was 75.6% (adjusted 95% CI, 54.3 to 88.0) (<a href="#t1">Table 1</a>) and lasted 6 to 7 months (Fig. S5). Efficacy against severeâcritical Covid-19 leading to medical intervention (including hospitalization) was approximately 90% initially and tapered to 70% by approximately 6 weeks, remaining at that level for 5 to 6 months. On the basis of available sequences, 3 such cases were caused by the reference strain (all in the placebo group) and 44 were caused by variants (11 in the vaccine group and 33 in the placebo group; vaccine efficacy, 67.5%; 95% CI, 34.1 to 85.2) (Fig. S6). The severity and duration of symptoms, the effect on Covid-19 lasting longer than 28 days, and vaccine efficacy against any infection, including asymptomatic infection, are described in the Supplementary Results (Figs. S7 through S10).</div><div role="paragraph">Among the 2131 participants in the vaccine group who were seropositive for SARS-CoV-2 nucleocapsid (N) protein at baseline as compared with the 18,924 participants in the placebo group who were seronegative at baseline, observed vaccine efficacy against moderate to severeâcritical Covid-19 was 97.7% (post hoc 95% CI, 93.3 to 99.5) (Table S5); the small number of cases (3) in the vaccine group precludes analysis of this end point according to viral lineage. Previous infection alone, in an analysis involving seropositive and seronegative placebo recipients, was found to provide 90.4% (95% CI, 83.2 to 95.1) protection against moderate to severeâcritical Covid-19.</div><div role="paragraph">Vaccine efficacy against Covid-19ârelated death was 82.8% (95% CI, 40.5 to 96.8) (<a href="#t1">Table 1</a>), with protection sustained through at least 6 months after administration. At least 28 days after administration, 3 Covid-19ârelated deaths occurred in the vaccine group (all in participants who were â¥60 years of age), as compared with 17 in the placebo group.</div></section><section id="sec-2-6"><h3>Efficacy in Subgroups</h3><div role="paragraph">In subgroup analyses, vaccine efficacy against moderate to severeâcritical Covid-19 in participants with human immunodeficiency virus (HIV) infection was found to be 23.5% (95% CI, â78.3 to 68.2). Vaccine efficacy against moderate to severeâcritical disease varied according to country: 33.1 (95% CI, 6.3 to 52.5) in Peru, 45.3 (95% CI, 29.1 to 58.0) in Brazil, 49.3 (95% CI, 26.9 to 65.3) in South Africa, and 69.7 (95% CI, 60.7 to 76.9) in the United States. Data on additional subgroup analyses are provided in the Supplementary Results (Figs. S11 and S12 and Table S6).</div></section><section id="sec-2-7"><h3>Safety</h3><div role="paragraph">The safety subpopulation included 3356 participants in the vaccine group and 3380 in the placebo group. Overall, more solicited adverse events occurred in the vaccine group than in the placebo group during the 7-day period after administration. Grade 3 local and systemic solicited adverse events during the 7-day period were similar to those reported in the primary analysis (Fig. S13). In general, lower reactogenicity was observed among older adults than among younger adults. Among the 155 participants in the vaccine group who were seropositive for SARS-CoV-2 at baseline (safety subpopulation), 60.0% and 52.9% reported a solicited local or systemic adverse event, respectively, similar to the percentages among the 3201 baseline-seronegative participants (54.5% and 60.6%, respectively). Grade 3 or higher solicited local adverse events were rare among vaccine recipients, regardless of their serostatus at baseline (occurring among 1.3% of those who were seropositive and 0.6% of those who were seronegative). Grade 3 or higher systemic adverse events occurred in 1.3% of seropositive vaccine recipients and 2.3% of seronegative vaccine recipients.</div><div role="paragraph">Unsolicited events of grade 3 or higher severity (safety subpopulation) and unsolicited events of grade 3 or higher that were considered by the investigators to be related to vaccine or placebo (full analysis population and safety subpopulation) are summarized in Tables S7 and S8. Serious adverse events that were not related to Covid-19 (full analysis population) occurred in 223 participants (1.0%) in the vaccine group and in 265 participants (1.2%) in the placebo group. Additional information on serious adverse events is provided in Table S9.</div><div role="paragraph">Imbalances in adverse events that occurred during a 28-day risk window after administration are described in the Supplementary Results (Table S10). At the time of the final analysis with prolonged follow-up, imbalances were seen for tinnitus (15 cases in the vaccine group vs. 4 in the placebo group), urticaria (13 vs. 6), convulsion (9 vs. 4), pulmonary embolism (10 vs. 5), and deep-vein thrombosis (11 vs. 3); no imbalances were observed for the GuillainâBarrÃ© syndrome (1 case per group) or Bellâs palsy (2 cases in the vaccine group and 1 in the placebo group) (Table S10). No cases of capillary leak syndrome, myocarditis, or encephalitis were reported. Thrombosis with thrombocytopenia was defined as an adverse event of special interest (Supplementary Methods). One event, which occurred in a 25-year-old man within 28 days after administration of Ad26.COV2.S, occurred in association with positivity for anti-PF4 antibodies and met the Centers for Disease Control and Prevention (CDC) tier 1â2 and Brighton Collaboration level 1 criteria for vaccine-induced immune thrombotic thrombocytopenia (VITT, also known as thrombosis with thrombocytopenia syndrome).</div><div role="paragraph">At the time of the final analysis, 83 deaths had been reported in the double-blind phase (28 in the vaccine group and 55 in the placebo group, with 5 and 22, respectively, related to Covid-19 in the full analysis population). All deaths were considered by the investigators to be unrelated to the vaccine or placebo.</div></section></section><section id="sec-3" data-type="discussion"><h2>Discussion</h2><div role="paragraph">In the final analysis of the double-blind portion of our phase 3 trial, median follow-up was 4 months, with 8940 participants having at least 6 months of follow-up. A single dose of the Ad26.COV2.S vaccine remained effective (52.9%) in preventing moderate to severeâcritical Covid-19 and all symptomatic Covid-19 (52.4%), despite the emergence of variants during the trial. Efficacy against severeâcritical disease remained higher (74.6%) than efficacy against moderate to severeâcritical disease, with a lower point estimate for variants (93.1% efficacy against the reference strain and 71.8% efficacy against nonâreference strain lineages, including âotherâ sequences with the E484K mutation), indicating that Ad26.COV2.S induces higher levels of protection in proportion to the severity of the disease and the nature of the viral mutation.</div><div role="paragraph">During the placebo-controlled period, which differed between countries on the basis of when the participants became aware of the trial-group assignments, the incidence of SARS-CoV-2 infection was highly variable geographically and over time as new viral variants emerged. The reduction in overall efficacy in the final analysis as compared with the primary analysis<sup><a href="#core-r3" role="doc-biblioref" data-xml-rid="r3" id="body-ref-r3-2" href-manipulated="true" aria-label="Reference 3">3</a></sup> (vaccine efficacy for the primary end point at least 28 days after administration, 66.1% in the primary analysis and 52.9% in the final analysis) was most likely due to lower vaccine efficacy against variants that appeared outside the United States (Latin America) in this multinational trial after the primary analysis â for example, 10.1% against the lambda variant and 36.5% against the gamma variant. Regional emergence of variants such as lambda and gamma contributed to the lower vaccine efficacy that was observed for some subgroups (e.g., Asian, Hispanic, and American Indian or Alaskan Native populations). In the United States, where the alpha variant emerged after the reference strain, vaccine efficacy against moderate to severeâcritical Covid-19 was 69.7%.</div><div role="paragraph">The efficacy findings in this trial are consistent with durable immune responses being elicited by Ad26.COV2.S<sup><a href="#core-r5" role="doc-biblioref" data-xml-rid="r5" id="body-ref-r5" href-manipulated="true" aria-label="Reference 5">5</a></sup> and with immediate efficacy against the alpha variant occurring at least 60 days after vaccination. Furthermore, the onset of protection differed between the original strain (14 days) and the more neutralization-resistant beta variant (25 days). The higher vaccine efficacy observed against the more resistant beta variant<sup><a href="#core-r6" role="doc-biblioref" data-xml-rid="r6" id="body-ref-r6" href-manipulated="true" aria-label="Reference 6">6</a></sup> as compared with the lower efficacy against the less resistant lambda variant suggests that other factors also played a role in protection.</div><div role="paragraph">Conclusions about vaccine efficacy against symptomatic Covid-19 caused by the delta variant, including severeâcritical Covid-19 (with only 4 cases among the participants), were not possible in this trial because of the wide confidence intervals. Real-world data from several studies<sup><a href="#core-r7" role="doc-biblioref" data-xml-rid="r7 r8 r9 r10" id="body-ref-r10-1" href-manipulated="true">7-10</a></sup> â some of which analyzed more severe symptomatic disease, against which this vaccine has higher efficacy â have shown varying degrees of efficacy of Ad26.COV2.S against symptomatic delta-variant infection. Effectiveness ranged from 60% to 94% against hospitalization,<sup><a href="#core-r7" role="doc-biblioref" data-xml-rid="r7 r8 r10 r11 r12" id="body-ref-r12-1" href-manipulated="true">7,8,10â12</a></sup> 13% to 78% against SARS-CoV-2 infection,<sup><a href="#core-r8" role="doc-biblioref" data-xml-rid="r8 r9 r12 r13 r14" id="body-ref-r14" href-manipulated="true">8,9,12â14</a></sup> and 52% to 82% against death after SARS-CoV-2 infection<sup><a href="#core-r9" role="doc-biblioref" data-xml-rid="r9 r10" id="body-ref-r10-3" href-manipulated="true">9,10</a></sup> during periods and in regions in which the delta variant was prominent.</div><div role="paragraph">Vaccine efficacy against symptomatic Covid-19 in participants with HIV infection in our trial was low, at 23.5%, with wide confidence intervals. However, in a large phase 3B study involving 477,234 participants, vaccine effectiveness was 73% against hospitalization and 65% against death among the approximately 37,000 participants living with HIV infection.<sup><a href="#core-r10" role="doc-biblioref" data-xml-rid="r10" id="body-ref-r10-4" href-manipulated="true" aria-label="Reference 10">10</a></sup></div><div role="paragraph">We observed that participants with previous asymptomatic infection (defined by serologic positivity for SARS-CoV-2 N protein and an absence of history of symptomatic Covid-19) can benefit from immunization with a Covid-19 vaccine. In a post hoc analysis, previous infection alone provided 90.4% protection against symptomatic infection, and after administration of Ad26.COV2.S in seropositive participants, 97.7% protection was observed in a comparison with seronegative placebo recipients; these findings extended observations from previous immunologic studies.<sup><a href="#core-r15" role="doc-biblioref" data-xml-rid="r15 r16 r17" id="body-ref-r17" href-manipulated="true">15-17</a></sup></div><div role="paragraph">When Covid-19 developed in participants who had received Ad26.COV2.S, they had lower severity of illness, shorter duration of illness, and lower viral loads than placebo recipients. In addition, vaccination with Ad26.COV2.S led to fewer medical interventions (including hospitalization) than placebo (vaccine efficacy against medical intervention â¥28 days after administration, 75.6%). Vaccine efficacy against Covid-19ârelated death was 82.8% with onset at least 28 days after administration, and the three Covid-19ârelated deaths among vaccine recipients occurred in participants 60 years of age or older who were seronegative at baseline and had coexisting conditions associated with an increased risk of severe Covid-19.</div><div role="paragraph">Serious adverse events were rare: serious adverse events not associated with Covid-19 occurred in approximately 1% of the participants in each group during the double-blind period. Tinnitus was observed in postauthorization surveillance and is classified as âvery rareâ in the fact sheet associated with the label.<sup><a href="#core-r18" role="doc-biblioref" data-xml-rid="r18" id="body-ref-r18-1" href-manipulated="true" aria-label="Reference 18">18</a></sup> Of the very rare events occurring after vaccination that were identified after marketing began,<sup><a href="#core-r18" role="doc-biblioref" data-xml-rid="r18 r19" id="body-ref-r19" href-manipulated="true">18,19</a></sup> no cases of anaphylaxis or capillary leak syndrome occurred, and one case of VITT<sup><a href="#core-r20" role="doc-biblioref" data-xml-rid="r20 r21 r22" id="body-ref-r22" href-manipulated="true">20-22</a></sup> meeting the CDC and Brighton Collaboration criteria occurred in this trial. With 3 to 4 cases per million vaccinations being reported in the postmarketing period, we would not expect to see more than 1 case of VITT in a clinical trial involving more than 43,000 participants (21,898 of whom received Ad26.COV2.S).</div><div role="paragraph">Strengths of the current analysis included a longer follow-up period than in our primary analysis that extends our primary findings, as well as the analysis of vaccine efficacy across geographic regions, across diverse populations, and against infection with variants. A limitation of the trial was the premature discontinuation of follow-up in the placebo-controlled phase and variable follow-up times among countries, depending on when approval of the postâemergency use authorization amendment occurred (which permitted group assignments to be revealed to participants and those in the placebo group to be vaccinated). Therefore, for the delta and omicron variants, limited or no data were obtained in the double-blind phase of the study. Going forward, vaccine effectiveness for new variants will need to come from studies involving real-world evidence.</div><div role="paragraph">On the basis of the reported results at the end of the double-blind phase, the efficacy of Ad26.COV2.S against moderate to severeâcritical disease and against severeâcritical disease was lower than that observed in clinical trials assessing messenger RNA vaccines.<sup><a href="#core-r23" role="doc-biblioref" data-xml-rid="r23 r24" id="body-ref-r24" href-manipulated="true">23,24</a></sup> The recently noted incidence of breakthrough infections with the omicron variant in vaccine-primed persons,<sup><a href="#core-r25" role="doc-biblioref" data-xml-rid="r25" id="body-ref-r25" href-manipulated="true" aria-label="Reference 25">25</a></sup> regardless of the primary vaccine regimen, suggests that a booster may be required for all primary vaccine regimens. Recent data from a study involving South African health care workers conducted during the omicron wave indicate 85% efficacy of Ad26.COV2.S against hospitalization when given as a single priming dose followed by a booster 6 to 9 months later.<sup><a href="#core-r26" role="doc-biblioref" data-xml-rid="r26" id="body-ref-r26" href-manipulated="true" aria-label="Reference 26">26</a></sup></div><div role="paragraph">Overall, our findings indicate that a single dose of Ad26.COV2.S provided protection against severe disease and hospitalization, which could be important in regions requiring mass vaccination or in populations with poor adherence to two-dose prime regimens, and support the use of Ad26.COV2.S in the ongoing effort against the global Covid-19 pandemic.</div></section>



        
        
</div></section><section id="backmatter" data-extent="backmatter" data-location="articleTab_article"><div class="core-container"><section id="backnotes" data-location="notes_article"><h2>Notes</h2><div data-type="published/updated" role="paragraph">This article was published on February 9, 2022, at NEJM.org.</div><div data-type="data-sharing" role="paragraph">A <a href="#ap4">data sharing statement</a> provided by the authors is available with the full text of this article at NEJM.org.</div><div role="paragraph">Supported by <span class="named-content" data-type="funder">Janssen Research and Development, an affiliate of Janssen Vaccines and Prevention and part of the Janssen pharmaceutical companies of Johnson &amp; Johnson</span>, and in whole or in part by federal funds from the Biomedical Advanced Research and Development Authority, part of the Office of the Assistant Secretary for Preparedness and Response at the Department of Health and Human Services, under Other Transaction Agreement HHSO100201700018C, and from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health. The NIAID provides grant funding to the <span class="named-content" data-type="funder">HIV Vaccine Trials Network (HVTN) Leadership and Operations Center</span>(UM1 AI68614), the HVTN <span class="named-content" data-type="funder">Statistics and Data Management Center</span> (UM1 AI68635), the <span class="named-content" data-type="funder">HVTN Laboratory Center</span> (UM1 AI68618), the <span class="named-content" data-type="funder">HIV Prevention Trials Network (HPTN) Leadership and Operations Center</span>(UM1 AI68619), the <span class="named-content" data-type="funder">AIDS Clinical Trials Group (ACTG) Leadership and Operations Center</span>(UM1 AI68636), the <span class="named-content" data-type="funder">Infectious Diseases Clinical Research Consortium Leadership Group</span> (UM1 AI148684) and <span class="named-content" data-type="funder">Vaccine and Therapeutic Evaluation Units</span> (UM1 AI148576, UM1 AI148373, UM1 AI148685, UM1 AI148452).</div><div role="paragraph"><a href="#ap3">Disclosure forms</a> provided by the authors are available with the full text of this article at NEJM.org.</div><div role="paragraph">We thank all the participants in this trial, the staff members at the trial locations, the members of the data and safety monitoring board, all the investigators at the clinical sites, the members of the clinical severity adjudication committee (Janet S. Lee, Brian T. Garibaldi, Charles Shey Wiysonge, Anoma Nellore, Timothy E. Albertson, Christian Sandrock, and Victor F. Tapson), the COV3001 study team (Richard Gorman, Carmen A. Paez, James Kublin, Simbarashe G. Takuva, Alex Greninger, Pavitra Roychoudhury, Robert W. Coombs, Keith R. Jerome, Kimberly L. Taylor, Flora Castellino, Xiaomi Tong, Corrina Pavetto, Teletha Gipson, Tina Tong, Marina Lee, James Zhou, Michael Fay, Daniel Wolfe, Peter B. Gilbert, Ollivier Hyrien, Alex Luedtke, Hein Fennema, Kim Offergeld, Nancy Cauwenberghs, Tamzin Tanner, Kelly McQuarrie, Chimeremma Nnadi, Obiageli Sogbetun, Nina Ahmad, Ian De Proost, Cyrus Hoseyni, Paul Coplan, Najat Khan, Peter Ronco, Sanne Roels, Daniel Backenroth, Jennifer Bogert, Fei Chen, Pei-Ling Chu, Kimberly Cooper, Hilde Delanghe, John T. Jones, Monika Peeters, Willem Talloen, Jose Pinheiro, Ilse Scheys, Pallavi Shetti, Nathalie Vaissiere, Jose Salas, Molli Imola Sandor, Jiajun Xu, Dawn Furey, Jodi Meck, Boerries Brandenburg, Jenny Hendriks, Jarek Juraszek, Marit de Groot, Griet Van Roey, and Dirk Heerwegh), and Catherine DeBrosse and Jill E. Kolesar (Cello Health CommunicationsâMedErgy) for writing and editorial assistance, funded by Janssen Global Services, with an earlier version of the manuscript.</div></section><section id="supplementary-materials" class="core-supplementary-materials"><h2>Supplementary Material</h2><div role="list"><div id="ap1" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Protocol</span> <span class="core-filename">(nejmoa2117608_protocol.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2117608/suppl_file/nejmoa2117608_protocol.pdf" download="nejmoa2117608_protocol.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2117608_protocol.pdf" data-doi="10.1056/NEJMoa2117608">Download</a></li><li>8.31 MB</li></ul></div></div><div id="ap2" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Supplementary Appendix</span> <span class="core-filename">(nejmoa2117608_appendix.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2117608/suppl_file/nejmoa2117608_appendix.pdf" download="nejmoa2117608_appendix.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2117608_appendix.pdf" data-doi="10.1056/NEJMoa2117608">Download</a></li><li>4.21 MB</li></ul></div></div><div id="ap3" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Disclosure Forms</span> <span class="core-filename">(nejmoa2117608_disclosures.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2117608/suppl_file/nejmoa2117608_disclosures.pdf" download="nejmoa2117608_disclosures.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2117608_disclosures.pdf" data-doi="10.1056/NEJMoa2117608">Download</a></li><li>933.64 KB</li></ul></div></div><div id="ap4" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Data Sharing Statement</span> <span class="core-filename">(nejmoa2117608_data-sharing.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2117608/suppl_file/nejmoa2117608_data-sharing.pdf" download="nejmoa2117608_data-sharing.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2117608_data-sharing.pdf" data-doi="10.1056/NEJMoa2117608">Download</a></li><li>71.33 KB</li></ul></div></div></div></section><section id="bibliography" class="core-reference-list" role="doc-bibliography" data-location="references_article"><h2>References</h2><div role="list" data-method="clamp" id="collapsible-text"><div role="listitem" data-has="label"><div class="label">1.</div><div id="r1" class="citations"><div class="citation"><div class="citation-content">Bos R, Rutten L, van der Lubbe JEM, et al. Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses. <em>NPJ Vaccines</em> 2020;5:91-91.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r2"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41541-020-00243-x" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33083026/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000573260900001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Ad26+vector-based+COVID-19+vaccine+encoding+a+prefusion-stabilized+SARS-CoV-2+Spike+immunogen+induces+potent+humoral+and+cellular+immune+responses.&amp;publication_year=2020&amp;journal=NPJ+Vaccines&amp;pages=91-91&amp;doi=10.1038%2Fs41541-020-00243-x&amp;pmid=33083026" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">2.</div><div id="r2" class="citations"><div class="citation"><div class="citation-content">Sadoff J, Le Gars M, Shukarev G, et al. Interim results of a phase 1â2a trial of Ad26.COV2.S Covid-19 vaccine. <em>N Engl J Med</em> 2021;384:1824-1835.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r2"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_3_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2117608&amp;key=10.1056%2FNEJMoa2034201&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33440088/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000640382300001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Interim+results+of+a+phase+1%E2%80%932a+trial+of+Ad26.COV2.S+Covid-19+vaccine.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1824-1835&amp;doi=10.1056%2FNEJMoa2034201&amp;pmid=33440088" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">3.</div><div id="r3" class="citations"><div class="citation"><div class="citation-content">Sadoff J, Gray G, Vandebosch A, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. <em>N Engl J Med</em> 2021;384:2187-2201.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r3" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_4_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2117608&amp;key=10.1056%2FNEJMoa2101544&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33882225/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000642260000001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+single-dose+Ad26.COV2.S+vaccine+against+Covid-19.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=2187-2201&amp;doi=10.1056%2FNEJMoa2101544&amp;pmid=33882225" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r3" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r3-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] efficacy against severeâcritical disease. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r3-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] as compared with the primary analysis </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">4.</div><div id="r4" class="citations"><div class="citation"><div class="citation-content">Nauta J. <em>Statistics in clinical vaccine trials</em>. New York: Springer-Verlag, 2011.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r4"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/978-3-642-14691-6" target="_blank">Crossref</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Statistics+in+clinical+vaccine+trials&amp;publication_year=2011&amp;doi=10.1007%2F978-3-642-14691-6" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">5.</div><div id="r5" class="citations"><div class="citation"><div class="citation-content">Barouch DH, Stephenson KE, Sadoff J, et al. Durable humoral and cellular immune responses 8 months after Ad26.COV2.S vaccination. <em>N Engl J Med</em> 2021;385:951-953.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r5"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_6_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2117608&amp;key=10.1056%2FNEJMc2108829&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34260834/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000674415500001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Durable+humoral+and+cellular+immune+responses+8+months+after+Ad26.COV2.S+vaccination.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=951-953&amp;doi=10.1056%2FNEJMc2108829&amp;pmid=34260834" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">6.</div><div id="r6" class="citations"><div class="citation"><div class="citation-content">Alter G, Yu J, Liu J, et al. Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans. <em>Nature</em> 2021;596:268-272.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r6"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-021-03681-2" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34107529/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000668492400001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Immunogenicity+of+Ad26.COV2.S+vaccine+against+SARS-CoV-2+variants+in+humans.&amp;publication_year=2021&amp;journal=Nature&amp;pages=268-272&amp;doi=10.1038%2Fs41586-021-03681-2&amp;pmid=34107529" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">7.</div><div id="r7" class="citations"><div class="citation"><div class="citation-content">Grannis SJ, Rowley EA, Ong TC, et al. Interim estimates of COVID-19 vaccine effectiveness against COVID-19âassociated emergency department or urgent care clinic encounters and hospitalizations among adults during SARS-CoV-2 B.1.617.2 (Delta) variant predominance â nine states, JuneâAugust 2021. <em>MMWR Morb Mortal Wkly Rep</em> 2021;70:1291-1293.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r7" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.15585/mmwr.mm7037e2" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34529642/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000696621100005" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Interim+estimates+of+COVID-19+vaccine+effectiveness+against+COVID-19%E2%80%93associated+emergency+department+or+urgent+care+clinic+encounters+and+hospitalizations+among+adults+during+SARS-CoV-2+B.1.617.2+%28Delta%29+variant+predominance+%E2%80%94+nine+states%2C+June%E2%80%93August+2021.&amp;publication_year=2021&amp;journal=MMWR+Morb+Mortal+Wkly+Rep&amp;pages=1291-1293&amp;doi=10.15585%2Fmmwr.mm7037e2&amp;pmid=34529642" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r7" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] Real-world data from several studies </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] from 60% to 94% against hospitalization, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">8.</div><div id="r8" class="citations"><div class="citation"><div class="citation-content">Polinski JM, Weckstein AR, Batech M, et al. Effectiveness of the single-dose Ad26.COV2.S COVID vaccine. September 16, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.09.10.21263385v2" target="_blank">https://www.medrxiv.org/content/10.1101/2021.09.10.21263385v2</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r8" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+the+single-dose+Ad26.COV2.S+COVID+vaccine.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r8" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] Real-world data from several studies </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] from 60% to 94% against hospitalization, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r14" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] 13% to 78% against SARS-CoV-2 infection, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">9.</div><div id="r9" class="citations"><div class="citation"><div class="citation-content">Cohn BA, Cirillo PM, Murphy CC, Krigbaum NY, Wallace AW. SARS-CoV-2 vaccine protection and deaths among US veterans during 2021. <em>Science</em> 2022;375:331-336.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r9" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.abm0620" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34735261/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000745036100036" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+vaccine+protection+and+deaths+among+US+veterans+during+2021.&amp;publication_year=2022&amp;journal=Science&amp;pages=331-336&amp;doi=10.1126%2Fscience.abm0620&amp;pmid=34735261" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r9" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] Real-world data from several studies </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r14" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] 13% to 78% against SARS-CoV-2 infection, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] against death after SARS-CoV-2 infection </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">10.</div><div id="r10" class="citations"><div class="citation"><div class="citation-content">Bekker L-G, Garrett N, Goga A, et al. Effectiveness of the Ad26.Cov2.S vaccine in health care workers in South Africa. <em>SSRN</em>. November 17, 2021 (<a href="https://ssrn.com/abstract=3979291">https://ssrn.com/abstract=3979291</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r10" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+the+Ad26.Cov2.S+vaccine+in+health+care+workers+in+South+Africa&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r10" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] Real-world data from several studies </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] from 60% to 94% against hospitalization, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] against death after SARS-CoV-2 infection </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] participants living with HIV infection. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">11.</div><div id="r11" class="citations"><div class="citation"><div class="citation-content">de Gier B, Kooijman M, Kemmeren J, et al. COVID-19 vaccine effectiveness against hospitalizations and ICU admissions in the Netherlands, April-August 2021. September 17, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.09.15.21263613v1" target="_blank">https://www.medrxiv.org/content/10.1101/2021.09.15.21263613v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r12-1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=COVID-19+vaccine+effectiveness+against+hospitalizations+and+ICU+admissions+in+the+Netherlands%2C+April-August+2021.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">12.</div><div id="r12" class="citations"><div class="citation"><div class="citation-content">Rosenberg ES, Dorabawila V, Easton D, et al. Covid-19 vaccine effectiveness in New York State. <em>N Engl J Med</em> 2022;386:116-127.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r12" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_13_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2117608&amp;key=10.1056%2FNEJMoa2116063&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34942067/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000724451300001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Covid-19+vaccine+effectiveness+in+New+York+State.&amp;publication_year=2022&amp;journal=N+Engl+J+Med&amp;pages=116-127&amp;doi=10.1056%2FNEJMoa2116063&amp;pmid=34942067" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r12" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r12-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] from 60% to 94% against hospitalization, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r14" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] 13% to 78% against SARS-CoV-2 infection, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">13.</div><div id="r13" class="citations"><div class="citation"><div class="citation-content">Institute Infectious Disease Epidemiology and Surveillance, AGES, Austrian Agency for Health and Food Safety. Estimates of COVID-19 vaccine effectiveness against SARS-CoV-2 infection following a nationwide vaccination campaign: a population-based cohort study. 2021 (<a href="https://wissenaktuell.ages.at/impfeffektivitaet-in-bezug-auf-sars-cov-2-infektion-der-in-oesterreich-eingesetzten-covid19-impfstoffe/">https://wissenaktuell.ages.at/impfeffektivitaet-in-bezug-auf-sars-cov-2-infektion-der-in-oesterreich-eingesetzten-covid19-impfstoffe/</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r14"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Estimates+of+COVID-19+vaccine+effectiveness+against+SARS-CoV-2+infection+following+a+nationwide+vaccination+campaign%3A+a+population-based+cohort+study.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">14.</div><div id="r14" class="citations"><div class="citation"><div class="citation-content">Corchado-Garcia J, Zemmour D, Hughes T, et al. Analysis of the effectiveness of the Ad26.COV2.S adenoviral vector vaccine for preventing COVID-19. <em>JAMA Netw Open</em> 2021;4(11):e2132540-e2132540.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r14"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/jamanetworkopen.2021.32540" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34726743/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000714704800008" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Analysis+of+the+effectiveness+of+the+Ad26.COV2.S+adenoviral+vector+vaccine+for+preventing+COVID-19.&amp;publication_year=2021&amp;journal=JAMA+Netw+Open&amp;pages=e2132540-e2132540&amp;doi=10.1001%2Fjamanetworkopen.2021.32540&amp;pmid=34726743" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">15.</div><div id="r15" class="citations"><div class="citation"><div class="citation-content">Kojima N, Shrestha NK, Klausner JD. A systematic review of the protective effect of prior SARS-CoV-2 infection on repeat infection. <em>Eval Health Prof</em> 2021;44:327-332.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r17"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1177/01632787211047932" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34592838/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000705504500001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=A+systematic+review+of+the+protective+effect+of+prior+SARS-CoV-2+infection+on+repeat+infection.&amp;publication_year=2021&amp;journal=Eval+Health+Prof&amp;pages=327-332&amp;doi=10.1177%2F01632787211047932&amp;pmid=34592838" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">16.</div><div id="r16" class="citations"><div class="citation"><div class="citation-content">Crotty S. Hybrid immunity. <em>Science</em> 2021;372:1392-1393 (<a href="https://www.science.org/doi/10.1126/science.abj2258" target="_blank">https://www.science.org/doi/10.1126/science.abj2258</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r17"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.abj2258" target="_blank">Crossref</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000665860000026" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Hybrid+immunity.&amp;publication_year=2021&amp;journal=Science&amp;pages=1392-1393&amp;doi=10.1126%2Fscience.abj2258" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">17.</div><div id="r17" class="citations"><div class="citation"><div class="citation-content">Keeton R, Richardson SI, Moyo-Gwete T, et al. Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner. <em>Cell Host Microbe</em> 2021;29:1611-1619.e5.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r17"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.chom.2021.10.003" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34688376/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000718619900006" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Prior+infection+with+SARS-CoV-2+boosts+and+broadens+Ad26.COV2.S+immunogenicity+in+a+variant-dependent+manner.&amp;publication_year=2021&amp;journal=Cell+Host+Microbe&amp;pages=1611-1619.e5&amp;doi=10.1016%2Fj.chom.2021.10.003&amp;pmid=34688376" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">18.</div><div id="r18" class="citations"><div class="citation"><div class="citation-content">Fact sheet for recipients and caregivers: emergency use authorization (EUA) of the Janssen COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19) in individuals 18 years of age and older. Horsham, PA: Janssen Biotech, 2021 (<a href="https://www.janssenlabels.com/emergency-use-authorization/Janssen+COVID-19+Vaccine-Recipient-fact-sheet.pdf">https://www.janssenlabels.com/emergency-use-authorization/Janssen+COVID-19+Vaccine-Recipient-fact-sheet.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r18" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Fact+sheet+for+recipients+and+caregivers%3A+emergency+use+authorization+%28EUA%29+of+the+Janssen+COVID-19+vaccine+to+prevent+coronavirus+disease+2019+%28COVID-19%29+in+individuals+18+years+of+age+and+older&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r18" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r18-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] the fact sheet associated with the label. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r19" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] that were identified after marketing began, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">19.</div><div id="r19" class="citations"><div class="citation"><div class="citation-content">Shay DK, Gee J, Su JR, et al. Safety monitoring of the Janssen (Johnson &amp; Johnson) COVID-19 vaccine â United States, MarchâApril 2021. <em>MMWR Morb Mortal Wkly Rep</em> 2021;70:680-684.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r19"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.15585/mmwr.mm7018e2" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33956784/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000647643800004" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+monitoring+of+the+Janssen+%28Johnson+%26+Johnson%29+COVID-19+vaccine+%E2%80%94+United+States%2C+March%E2%80%93April+2021.&amp;publication_year=2021&amp;journal=MMWR+Morb+Mortal+Wkly+Rep&amp;pages=680-684&amp;doi=10.15585%2Fmmwr.mm7018e2&amp;pmid=33956784" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">20.</div><div id="r20" class="citations"><div class="citation"><div class="citation-content">See I, Su JR, Lale A, et al. US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021. <em>JAMA</em> 2021;325:2448-2456.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r22"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/jama.2021.7517" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33929487/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000645632000002" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=US+case+reports+of+cerebral+venous+sinus+thrombosis+with+thrombocytopenia+after+Ad26.COV2.S+vaccination%2C+March+2+to+April+21%2C+2021.&amp;publication_year=2021&amp;journal=JAMA&amp;pages=2448-2456&amp;doi=10.1001%2Fjama.2021.7517&amp;pmid=33929487" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">21.</div><div id="r21" class="citations"><div class="citation"><div class="citation-content">Rizk JG, Gupta A, Sardar P, et al. Clinical characteristics and pharmacological management of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with cerebral venous sinus thrombosis: a review. <em>JAMA Cardiol</em> 2021;6:1451-1460.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r22"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/jamacardio.2021.3444" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34374713/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000684941200001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Clinical+characteristics+and+pharmacological+management+of+COVID-19+vaccine-induced+immune+thrombotic+thrombocytopenia+with+cerebral+venous+sinus+thrombosis%3A+a+review.&amp;publication_year=2021&amp;journal=JAMA+Cardiol&amp;pages=1451-1460&amp;doi=10.1001%2Fjamacardio.2021.3444&amp;pmid=34374713" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">22.</div><div id="r22" class="citations"><div class="citation"><div class="citation-content">Rosenblum HG, Hadler SC, Moulia D, et al. Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson &amp; Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna): update from the Advisory Committee on Immunization Practices â United States, July 2021. <em>MMWR Morb Mortal Wkly Rep</em> 2021;70:1094-1099.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r22"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.15585/mmwr.mm7032e4" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34383735/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000685284200006" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Use+of+COVID-19+vaccines+after+reports+of+adverse+events+among+adult+recipients+of+Janssen+%28Johnson+%26+Johnson%29+and+mRNA+COVID-19+vaccines+%28Pfizer-BioNTech+and+Moderna%29%3A+update+from+the+Advisory+Committee+on+Immunization+Practices+%E2%80%94+United+States%2C+July+2021.&amp;publication_year=2021&amp;journal=MMWR+Morb+Mortal+Wkly+Rep&amp;pages=1094-1099&amp;doi=10.15585%2Fmmwr.mm7032e4&amp;pmid=34383735" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">23.</div><div id="r23" class="citations"><div class="citation"><div class="citation-content">Thomas SJ, Moreira ED Jr, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. <em>N Engl J Med</em> 2021;385:1761-1773.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r24"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_24_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2117608&amp;key=10.1056%2FNEJMoa2110345&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34525277/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000696036700001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+the+BNT162b2+mRNA+Covid-19+vaccine+through+6+months.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1761-1773&amp;doi=10.1056%2FNEJMoa2110345&amp;pmid=34525277" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">24.</div><div id="r24" class="citations"><div class="citation"><div class="citation-content">El Sahly HM, Baden LR, Essink B, et al. Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase. <em>N Engl J Med</em> 2021;385:1774-1785.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r24"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_25_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2117608&amp;key=10.1056%2FNEJMoa2113017&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34551225/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000697804800001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+the+mRNA-1273+SARS-CoV-2+vaccine+at+completion+of+blinded+phase.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1774-1785&amp;doi=10.1056%2FNEJMoa2113017&amp;pmid=34551225" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">25.</div><div id="r25" class="citations"><div class="citation"><div class="citation-content">Centers for Disease Control and Prevention. Omicron variant: what you need to know. 2021 (<a href="https://www.cdc.gov/coronavirus/2019-ncov/variants/omicron-variant.html">https://www.cdc.gov/coronavirus/2019-ncov/variants/omicron-variant.html</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r25"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Omicron+variant%3A+what+you+need+to+know.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">26.</div><div id="r26" class="citations"><div class="citation"><div class="citation-content">Gray GE, Collie S, Garrett N, et al. Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26.COV2 during an Omicron COVID19 wave: preliminary results of the Sisonke 2 study. December 29, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.12.28.21268436v1" target="_blank">https://www.medrxiv.org/content/10.1101/2021.12.28.21268436v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r26"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Vaccine+effectiveness+against+hospital+admission+in+South+African+health+care+workers+who+received+a+homologous+booster+of+Ad26.COV2+during+an+Omicron+COVID19+wave%3A+preliminary+results+of+the+Sisonke+2+study.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div></div><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--secondary" aria-expanded="false" aria-controls="collapsible-text"><span>Show all references</span></button></div></section></div></section></div><div class="core-collateral"><div id="core-collateral-info" role="tabpanel" data-core-tabs="core-collateral-info" tabindex="-1" aria-labelledby="pane-core-collateral-info"><header><h2 id="pane-core-collateral-info"><i class="icon-info" aria-hidden="true"></i>Information &amp; Authors</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-information" role="tab" id="tab-information-label" aria-selected="true" class="active">Information</button><button aria-controls="tab-contributors" role="tab" id="tab-contributors-label" tabindex="-1" aria-selected="false">Authors</button></div><section id="tab-information" aria-labelledby="tab-information-label" role="tabpanel" tabindex="0"><h3>Information</h3><section class="core-self-citation"><h4>Published In</h4><div class="core-journal-presentation"><div class="core-journal-description"><div property="isPartOf" typeof="Periodical"><span property="name">New England Journal of Medicine</span></div><div class="core-enumeration"><a href="/toc/nejm/386/9"><span property="isPartOf" typeof="PublicationVolume">Volume <span property="volumeNumber">386</span></span> â¢ <span property="isPartOf" typeof="PublicationIssue">Number <span property="issueNumber">9</span></span> â¢ <span property="datePublished">March 3, 2022</span></a></div><div class="core-pagination"><span class="heading">Pages</span>: <span class="content"><span property="pageStart">847</span>-<span property="pageEnd">860</span></span></div></div></div></section><section class="core-copyright"><h4>Copyright</h4><div role="paragraph">Copyright Â© 2022 Massachusetts Medical Society. All rights reserved.</div><div>For personal use only. Any commercial reuse of NEJM Group content requires <a href="mailto:permissions@nejm.org">permission</a>.</div></section><section class="core-history"><h4>History</h4><div><b class="core-label">Published online</b>: February 9, 2022</div><div><b class="core-label">Published in issue</b>: March 3, 2022</div></section><section data-location="recirc_topics_article" class="core-classifications"><h4>Topics</h4><div class="keywords"><ol><li><a href="/browse/topic/coronavirus" alt="View article keyword Coronavirus" data-interactiontype="article_recirculation_click">Coronavirus</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li><li><a href="/browse/topic/vaccines" alt="View article keyword Vaccines" data-interactiontype="article_recirculation_click">Vaccines</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li></ol></div></section></section><section id="tab-contributors" aria-labelledby="tab-contributors-label" role="tabpanel" tabindex="-1"><h3>Authors</h3><section class="core-authors"><h4>Authors</h4><div role="paragraph"><span property="author" typeof="Person"><span property="givenName">Jerald</span> <span property="familyName">Sadoff</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Glenda</span> <span property="familyName">Gray</span>, <span property="honorificSuffix">M.B., B.Ch.</span> <a class="orcid-id" href="https://orcid.org/0000-0003-4649-1477" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0003-4649-1477</a></span>, <span property="author" typeof="Person"><span property="givenName">An</span> <span property="familyName">Vandebosch</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Vicky</span> <span property="familyName">CÃ¡rdenas</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Georgi</span> <span property="familyName">Shukarev</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Beatriz</span> <span property="familyName">Grinsztejn</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Paul A.</span> <span property="familyName">Goepfert</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Carla</span> <span property="familyName">Truyers</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Ilse</span> <span property="familyName">Van Dromme</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Bart</span> <span property="familyName">Spiessens</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Johan</span> <span property="familyName">Vingerhoets</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Jerome</span> <span property="familyName">Custers</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Gert</span> <span property="familyName">Scheper</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Merlin L.</span> <span property="familyName">Robb</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">John</span> <span property="familyName">Treanor</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Martin F.</span> <span property="familyName">Ryser</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Dan H.</span> <span property="familyName">Barouch</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Edith</span> <span property="familyName">Swann</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Mary A.</span> <span property="familyName">Marovich</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Kathleen M.</span> <span property="familyName">Neuzil</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Lawrence</span> <span property="familyName">Corey</span>, <span property="honorificSuffix">M.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0002-2179-2436" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0002-2179-2436</a></span>, <span property="author" typeof="Person"><span property="givenName">Jeffrey</span> <span property="familyName">Stoddard</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Karin</span> <span property="familyName">Hardt</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Javier</span> <span property="familyName">Ruiz-GuiÃ±azÃº</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Mathieu</span> <span property="familyName">Le Gars</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Hanneke</span> <span property="familyName">Schuitemaker</span>, <span property="honorificSuffix">Ph.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0001-8563-2266" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0001-8563-2266</a></span>, <span property="author" typeof="Person"><span property="givenName">Johan</span> <span property="familyName">Van Hoof</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Frank</span> <span property="familyName">Struyf</span>, <span property="honorificSuffix">M.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0001-9988-0260" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0001-9988-0260</a></span>, and <span property="author" typeof="Person"><span property="givenName">Macaya</span> <span property="familyName">Douoguih</span>, <span property="honorificSuffix">M.D.</span></span>, for <span property="author" typeof="Person">the ENSEMBLE Study Group<sup><a href="#fn1" role="doc-noteref">*</a></sup></span></div></section><section class="core-affiliations"><h4>Affiliations</h4><div property="affiliation" typeof="Organization"><span property="name">From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, G. Shukarev, J.C., G. Scheper, M.L.G., H.S., J.V.H., M.D.); the South African Research Council, Cape Town, South Africa (G.G.); Janssen Research and Development, Beerse, Belgium (A.V., C.T., I.V.D., B.S., J.V., M.F.R., K.H., J.R.-G., F.S.); Janssen Research and Development, Spring House, PA (V.C.); Evandro Chagas National Institute of Infectious DiseasesâFiocruz, Rio de Janeiro (B.G.); the University of Alabama at Birmingham, Birmingham (P.A.G.); Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the National Institute of Allergy and Infectious Diseases, Rockville (E.S., M.A.M.), and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (K.M.N.) â all in Maryland; the Biomedical Advanced Research and Development Authority, Washington, DC (J.T.); the Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston (D.H.B.); the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C.); and Janssen Research and Development, Raritan, NJ (J. Stoddard).</span></div></section><section class="core-authors-notes"><h4>Notes</h4><div role="doc-footnote">Dr. Douoguih can be contacted at <a href="mailto:mdouogui@its.jnj.com">mdouogui@its.jnj.com</a> or at Janssen Vaccines and Prevention, Newtonweg 1, CP 2333 Leiden, the Netherlands.</div><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="fn1" role="paragraph">The members of the ENSEMBLE Study Group are listed in the <a href="#ap2">Supplementary Appendix</a>, available at NEJM.org.</div></div></section></section></div><div id="core-collateral-metrics" role="tabpanel" data-core-tabs="core-collateral-metrics" tabindex="-1" aria-labelledby="pane-core-collateral-metrics"><header><h2 id="pane-core-collateral-metrics"><i class="icon-timeline" aria-hidden="true"></i>Metrics &amp; Citations</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-metrics-inner" role="tab" id="tab-metrics-inner-label" aria-selected="true" class="active" data-interactiontype="article_tab" data-tabname="metricsWindow">Metrics</button><button aria-controls="tab-citations" role="tab" id="tab-citations-label" tabindex="-1" aria-selected="false" data-interactiontype="article_tab" data-tabname="metricsWindow">Citations<span class="citations-count">168</span></button></div><section id="tab-metrics-inner" aria-labelledby="tab-metrics-inner-label" role="tabpanel" tabindex="0"><h3>Metrics</h3><section>









    
    
        <div data-widget-def="UX3HTMLWidget" data-widget-id="95ea9f58-ec0e-4db2-b2ab-280fc876af53" data-location="article_metrics_article">
        



        
            <h4 class="">
                Altmetrics
            </h4>
        
        <div data-badge-details="right" data-badge-type="large-donut" data-doi="10.1056/NEJMoa2117608" data-hide-no-mentions="true" data-link-target="_blank" class="altmetric-embed" data-uuid="c21bf094-d4b8-cdaa-303f-fe47de364e51"><div style="overflow:hidden;">
    <div class="altmetric-normal-legend">
        <a target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=122787297" style="display:inline-block;">
                <img alt="Article has an altmetric score of 303" src="https://badges.altmetric.com/?size=320&amp;score=303&amp;types=mbrttwfu" width="180" height="180" style="border:0; margin:0; max-width: none;">
        </a>
        <p class="altmetric-see-more-details" style="padding-top: 10px; text-align: center;"><a target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=122787297">See more details</a></p>
    </div>
    <div id="_altmetric_popover_el_c21bf094-d4b8-cdaa-303f-fe47de364e51" class="altmetric-embed right" style="margin:0; padding:0; display:inline-block; float:left; position:relative;">
        <div class="altmetric_container">
            <div class="altmetric-embed altmetric-popover-inner right">
                <div style="padding:0; margin: 0;" class="altmetric-embed altmetric-popover-content">
                        <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=122787297&amp;tab=news">
          Picked up by <b>19</b> news outlets
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #ffd140;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=122787297&amp;tab=blogs">
          Blogged by <b>5</b>
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=122787297&amp;tab=twitter">
          Posted by <b>197</b> X users
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #2445bd;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=122787297&amp;tab=facebook">
          On <b>2</b> Facebook pages
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #958899;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=122787297&amp;tab=wikipedia">
          Referenced in <b>1</b> Wikipedia pages
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #D5E8F0;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=122787297&amp;tab=reddit">
          Reddited by <b>1</b>
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #70B1FF;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=122787297&amp;tab=bluesky">
          Referenced by <b>1</b> Bluesky users
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>258</b> readers on Mendeley
          </div>
    </div>

                </div>
            </div>
        </div>
    </div>
</div></div>
<script async="" type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" nonce="94d6c2dc21f201c0-SJC"></script>

        </div>
    

</section></section><section id="tab-citations" aria-labelledby="tab-citations-label" role="tabpanel" tabindex="-1"><h3>Citations</h3><section>



        
            <h4 class="">
                Export citation
            </h4>
        
        <div class="citation-download cd-sec">
<p class="citation-download_msg">Select the format you want to export the citation of this publication.</p>
<form action="/action/downloadCitation" name="frmCitmgr" method="post" target="_self" class="citation-download_form"><input type="hidden" name="doi" value="10.1056/NEJMoa2117608"> <input type="hidden" name="downloadFileName" value="csp_386_"> <input type="hidden" name="include" value="abs">
<div class="dropdown dropdown-selectable dropdown-selectable--form-control"><input type="hidden" name="format" value=""> <label class="form-label">Format*</label> <button id="slct_format" type="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" class="btn dropdown-toggle d-flex align-items-center justify-content-between">Please Select </button>
<div aria-labelledby="slct_format" role="listbox" class="dropdown-menu"><a href="#" data-value="ris" class="dropdown-item">RIS (ProCite, Reference Manager)</a><a href="#" data-value="endnote" class="dropdown-item">EndNote</a><a href="#" data-value="bibtex" class="dropdown-item">BibTex</a><a href="#" data-value="medlars" class="dropdown-item">Medlars</a><a href="#" data-value="refworks" class="dropdown-item">RefWorks</a></div>
<div class="invalid-feedback">Please select an item in the list</div>
</div>
<div class="citation-download_checkbox"><label class="checkbox--primary"><input type="checkbox" name="direct" value="true"><span class="checkbox--primary-icons"><span class="checkbox--primary-unchecked"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#toggles-checboxUnchecked"></use></svg></span></span><span class="checkbox--primary-checked"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#toggles-checboxChecked"></use></svg></span></span></span><span class="checkbox--primary-label"><span class="checkbox--primary-label-text">Direct Import</span></span></label></div>
<div class="citation-download_btn"><button type="submit" name="submit" value="Download" class="ng-btn_default ng-btn_iconLeft" data-interactiontype="article_tools_citation_download" data-multimedia-type="Citation"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#citations"></use></svg></span><span class="ng-btn_text">Export citation</span></button></div>
</form></div>
</section><section>









    
    
        <div data-widget-def="UX3CitedByWidget" data-widget-id="efb4df9a-8e1a-47f9-bfb7-271959277a9f" data-location="citedby_article">
        



        
            <h4 class="">
                Cited by
            </h4>
        
        <section id="cited-by" class="cited-by"><div class="cited-by__wrapper"><div id="cited-by__content" class="cited-by__content"><ol data-source="/pb/widgets/citedBy?page=1&amp;widgetId=efb4df9a-8e1a-47f9-bfb7-271959277a9f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Anejm%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3Adoi%5C%3A10.1056%2FNEJMoa2117608%3Bwgroup%3Astring%3AMMS+NextGen+Website+Group%3Bissue%3Aissue%3Adoi%5C%3A10.1056%2Fnejm_2022.386.issue-9%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bwebsite%3Awebsite%3Amms-site%3Bjournal%3Ajournal%3Anejms" data-lazyload="false" data-total="168" class="cited-by__list list-unstyled"><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Chiranjib Chakraborty, </li><li class="list-inline-item cited-by__entry__author">Yi-Hao Lo, </li><li class="list-inline-item cited-by__entry__author">Manojit Bhattacharya, </li><li class="list-inline-item cited-by__entry__author">Arpita Das, </li><li class="list-inline-item cited-by__entry__author">Zhi-Hong Wen, </li></ul><span class="cited-by__entry__title">Looking beyond the origin of SARS-CoV-2: Significant strategic aspects during the five-year journey of COVID-19 vaccine development, </span><span class="cited-by__entry__series-title">Molecular Therapy Nucleic Acids, </span><span class="cited-by__entry__volume"><strong>36</strong>, </span><span class="cited-by__entry__issue">2, </span><span class="cited-by__entry__page-range">(102527), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.omtn.2025.102527" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.omtn.2025.102527</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.omtn.2025.102527" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Leah I. B. Andrews, </li><li class="list-inline-item cited-by__entry__author">M. Elizabeth Halloran, </li><li class="list-inline-item cited-by__entry__author">Kathleen M. Neuzil, </li><li class="list-inline-item cited-by__entry__author">Lars van der Laan, </li><li class="list-inline-item cited-by__entry__author">Yunda Huang, </li><li class="list-inline-item cited-by__entry__author">Jessica Andriesen, </li><li class="list-inline-item cited-by__entry__author">Mayur Patel, </li><li class="list-inline-item cited-by__entry__author">Leigh H. Fisher, </li><li class="list-inline-item cited-by__entry__author">Holly Janes, </li><li class="list-inline-item cited-by__entry__author">Nadine Rouphael, </li><li class="list-inline-item cited-by__entry__author">Stephen R. Walsh, </li><li class="list-inline-item cited-by__entry__author">Deborah A. Theodore, </li><li class="list-inline-item cited-by__entry__author">Hong-Van Tieu, </li><li class="list-inline-item cited-by__entry__author">Magdalena Sobieszczyk, </li><li class="list-inline-item cited-by__entry__author">Hana M. El Sahly, </li><li class="list-inline-item cited-by__entry__author">Lindsey R. Baden, </li><li class="list-inline-item cited-by__entry__author">Ann R. Falsey, </li><li class="list-inline-item cited-by__entry__author">Thomas B. Campbell, </li><li class="list-inline-item cited-by__entry__author">Colleen F. Kelley, </li><li class="list-inline-item cited-by__entry__author">Catherine Mary Healy, </li><li class="list-inline-item cited-by__entry__author">Lilly Immergluck, </li><li class="list-inline-item cited-by__entry__author">Benjamin Luft, </li><li class="list-inline-item cited-by__entry__author">Ian Hirsch, </li><li class="list-inline-item cited-by__entry__author">Guy de Bruyn, </li><li class="list-inline-item cited-by__entry__author">Carla Truyers, </li><li class="list-inline-item cited-by__entry__author">Frances Priddy, </li><li class="list-inline-item cited-by__entry__author">Kelsey M. Sumner, </li><li class="list-inline-item cited-by__entry__author">Brendan Flannery, </li><li class="list-inline-item cited-by__entry__author">Dean Follmann, </li><li class="list-inline-item cited-by__entry__author">Peter B. Gilbert, </li><li class="list-inline-item cited-by__entry__author">Vanessa Abad, </li><li class="list-inline-item cited-by__entry__author">Karina Abalos, </li><li class="list-inline-item cited-by__entry__author">Getahun Abate, </li><li class="list-inline-item cited-by__entry__author">Anum Abbas, </li><li class="list-inline-item cited-by__entry__author">Jose Accini, </li><li class="list-inline-item cited-by__entry__author">Ronald Ackerman, </li><li class="list-inline-item cited-by__entry__author">Jamie Ackerman, </li><li class="list-inline-item cited-by__entry__author">Jeremy Ackermann, </li><li class="list-inline-item cited-by__entry__author">Atoya Adams, </li><li class="list-inline-item cited-by__entry__author">Michael R. Adams, </li><li class="list-inline-item cited-by__entry__author">Mark S. Adams, </li><li class="list-inline-item cited-by__entry__author">Michael Adams, </li><li class="list-inline-item cited-by__entry__author">Jeffrey M. Adelglass, </li><li class="list-inline-item cited-by__entry__author">Sarah Afework, </li><li class="list-inline-item cited-by__entry__author">Nina Ahmad, </li><li class="list-inline-item cited-by__entry__author">Christine Akamine, </li><li class="list-inline-item cited-by__entry__author">Julie A. Ake, </li><li class="list-inline-item cited-by__entry__author">Gary Albert, </li><li class="list-inline-item cited-by__entry__author">Maria L. Alcaide, </li><li class="list-inline-item cited-by__entry__author">Nathan Alderson, </li><li class="list-inline-item cited-by__entry__author">Lily Aleman, </li><li class="list-inline-item cited-by__entry__author">JosÃ© O. AlemÃ¡n, </li><li class="list-inline-item cited-by__entry__author">Mohamed S. Al-Ibrahim, </li><li class="list-inline-item cited-by__entry__author">Mohammed Allaw, </li><li class="list-inline-item cited-by__entry__author">Leland N. Allen, </li><li class="list-inline-item cited-by__entry__author">Mary Allen, </li><li class="list-inline-item cited-by__entry__author">Naveena Aloysia, </li><li class="list-inline-item cited-by__entry__author">Hilario Alvarado, </li><li class="list-inline-item cited-by__entry__author">Winniberg Stephany Alvarez LeÃ³n, </li><li class="list-inline-item cited-by__entry__author">Carmen Amador, </li><li class="list-inline-item cited-by__entry__author">John Humphrey Amuasi, </li><li class="list-inline-item cited-by__entry__author">James Andersen, </li><li class="list-inline-item cited-by__entry__author">Evan J. Anderson, </li><li class="list-inline-item cited-by__entry__author">Corey G. Anderson, </li><li class="list-inline-item cited-by__entry__author">Victoria R. Anderson, </li><li class="list-inline-item cited-by__entry__author">David R. Andes, </li><li class="list-inline-item cited-by__entry__author">Michele P. Andrasik, </li><li class="list-inline-item cited-by__entry__author">Stephanie Andree, </li><li class="list-inline-item cited-by__entry__author">Jeb Andrews, </li><li class="list-inline-item cited-by__entry__author">Jessica G. Andriesen, </li><li class="list-inline-item cited-by__entry__author">Victoria Andriulis, </li><li class="list-inline-item cited-by__entry__author">GermÃ¡n ÃÃ±ez, </li><li class="list-inline-item cited-by__entry__author">Maria Angeles&nbsp;Ceregido, </li><li class="list-inline-item cited-by__entry__author">Nana Akosua Ansah, </li><li class="list-inline-item cited-by__entry__author">Jessica L. Ansel, </li><li class="list-inline-item cited-by__entry__author">Codi M. Anthony, </li><li class="list-inline-item cited-by__entry__author">Johannes Antony, </li><li class="list-inline-item cited-by__entry__author">Mohammed Antwi, </li><li class="list-inline-item cited-by__entry__author">Roberto C. Arduino, </li><li class="list-inline-item cited-by__entry__author">Florida Aristy, </li><li class="list-inline-item cited-by__entry__author">Valerie K. Arnold, </li><li class="list-inline-item cited-by__entry__author">Alicia Arrazcaeta, </li><li class="list-inline-item cited-by__entry__author">Hugo Macareno Arroyo, </li><li class="list-inline-item cited-by__entry__author">Kwaku Poku Asante, </li><li class="list-inline-item cited-by__entry__author">Robert L. Atmar, </li><li class="list-inline-item cited-by__entry__author">Allison August, </li><li class="list-inline-item cited-by__entry__author">Ayoade Avworo, </li><li class="list-inline-item cited-by__entry__author">Christina Bacher, </li><li class="list-inline-item cited-by__entry__author">MartÃ­n BÃ¤cker, </li><li class="list-inline-item cited-by__entry__author">Lindsay R. Baden, </li><li class="list-inline-item cited-by__entry__author">Diana Badillo, </li><li class="list-inline-item cited-by__entry__author">Emma Bainbridge, </li><li class="list-inline-item cited-by__entry__author">Michele Baka, </li><li class="list-inline-item cited-by__entry__author">Sherrie Baker, </li><li class="list-inline-item cited-by__entry__author">Bindu Balani, </li><li class="list-inline-item cited-by__entry__author">Brandy Ball, </li><li class="list-inline-item cited-by__entry__author">Mira Baron, </li><li class="list-inline-item cited-by__entry__author">Dan H. Barouch, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Barranco-Santana, </li><li class="list-inline-item cited-by__entry__author">Alejandro QuintÃ­n Barrat HernÃ¡ndez, </li><li class="list-inline-item cited-by__entry__author">Darlene Bartilucci, </li><li class="list-inline-item cited-by__entry__author">Jennifer Bashour, </li><li class="list-inline-item cited-by__entry__author">Teresa A. Batteiger, </li><li class="list-inline-item cited-by__entry__author">Clarisse Baudelaire, </li><li class="list-inline-item cited-by__entry__author">George H. Bauer, </li><li class="list-inline-item cited-by__entry__author">Jose A. Bazan, </li><li class="list-inline-item cited-by__entry__author">Maria G. Becerra, </li><li class="list-inline-item cited-by__entry__author">Cynthia Becher Strout, </li><li class="list-inline-item cited-by__entry__author">Teresa Becker, </li><li class="list-inline-item cited-by__entry__author">David Beckmann, </li><li class="list-inline-item cited-by__entry__author">Roger J. Bedimo, </li><li class="list-inline-item cited-by__entry__author">Linda R. Belhorn, </li><li class="list-inline-item cited-by__entry__author">Genevieve Beninati, </li><li class="list-inline-item cited-by__entry__author">Jorge A. Benitez, </li><li class="list-inline-item cited-by__entry__author">David Benkeser, </li><li class="list-inline-item cited-by__entry__author">Annette R. Bennett, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Bennett, </li><li class="list-inline-item cited-by__entry__author">Tatiana Beresnev, </li><li class="list-inline-item cited-by__entry__author">Aude Berge, </li><li class="list-inline-item cited-by__entry__author">Megan Berman, </li><li class="list-inline-item cited-by__entry__author">Maria I. Bermudez, </li><li class="list-inline-item cited-by__entry__author">Marcia Bernard, </li><li class="list-inline-item cited-by__entry__author">David I. Bernstein, </li><li class="list-inline-item cited-by__entry__author">Jennifer Berry, </li><li class="list-inline-item cited-by__entry__author">Andrea Berry, </li><li class="list-inline-item cited-by__entry__author">Vladimir Berthaud, </li><li class="list-inline-item cited-by__entry__author">Hanna Beyko, </li><li class="list-inline-item cited-by__entry__author">Kristin Bialobok, </li><li class="list-inline-item cited-by__entry__author">Joanne L. Billings, </li><li class="list-inline-item cited-by__entry__author">Oleksandra Bilotkach, </li><li class="list-inline-item cited-by__entry__author">Zachary Bittner, </li><li class="list-inline-item cited-by__entry__author">Jeanne Blevins, </li><li class="list-inline-item cited-by__entry__author">Jill Blumenthal, </li><li class="list-inline-item cited-by__entry__author">Rebecca Boas, </li><li class="list-inline-item cited-by__entry__author">Joseph Bocchini, </li><li class="list-inline-item cited-by__entry__author">Tyler D. Bold, </li><li class="list-inline-item cited-by__entry__author">Matthew I. Bonaparte, </li><li class="list-inline-item cited-by__entry__author">Alison Bondell, </li><li class="list-inline-item cited-by__entry__author">Paul Bondy, </li><li class="list-inline-item cited-by__entry__author">Alberto Cadena Bonfanti, </li><li class="list-inline-item cited-by__entry__author">Judith Borger, </li><li class="list-inline-item cited-by__entry__author">Scott Borgetti, </li><li class="list-inline-item cited-by__entry__author">Joseph Boscia, </li><li class="list-inline-item cited-by__entry__author">Dean M. Boswell, </li><li class="list-inline-item cited-by__entry__author">Tana Bourgeois, </li><li class="list-inline-item cited-by__entry__author">Maggie Bowers, </li><li class="list-inline-item cited-by__entry__author">Paul S Bradley, </li><li class="list-inline-item cited-by__entry__author">Judith Brady, </li><li class="list-inline-item cited-by__entry__author">Riemke Brakema, </li><li class="list-inline-item cited-by__entry__author">Andres Bran, </li><li class="list-inline-item cited-by__entry__author">Angela R. Branche, </li><li class="list-inline-item cited-by__entry__author">Boerries Brandenburg, </li><li class="list-inline-item cited-by__entry__author">Donald M. Brandon, </li><li class="list-inline-item cited-by__entry__author">Eric Bravo, </li><li class="list-inline-item cited-by__entry__author">Thomas Breuer, </li><li class="list-inline-item cited-by__entry__author">Margaret Brewinski Isaacs, </li><li class="list-inline-item cited-by__entry__author">Liz Briesemeister, </li><li class="list-inline-item cited-by__entry__author">Toby Briskin, </li><li class="list-inline-item cited-by__entry__author">Gail Broder, </li><li class="list-inline-item cited-by__entry__author">Adam B. Brosz, </li><li class="list-inline-item cited-by__entry__author">David Browder, </li><li class="list-inline-item cited-by__entry__author">Lesley Browder, </li><li class="list-inline-item cited-by__entry__author">Jeremy Brown, </li><li class="list-inline-item cited-by__entry__author">Cynthia Brown, </li><li class="list-inline-item cited-by__entry__author">Robert Brownlee, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Bruce, </li><li class="list-inline-item cited-by__entry__author">Susan Buchbinder, </li><li class="list-inline-item cited-by__entry__author">Cynthia Bueno, </li><li class="list-inline-item cited-by__entry__author">Elisabeth Bukusi, </li><li class="list-inline-item cited-by__entry__author">Delia Bullock, </li><li class="list-inline-item cited-by__entry__author">Catherine A. Bunce, </li><li class="list-inline-item cited-by__entry__author">Cortney Burch, </li><li class="list-inline-item cited-by__entry__author">Michelle L. Burgett, </li><li class="list-inline-item cited-by__entry__author">Abram Burgher, </li><li class="list-inline-item cited-by__entry__author">Larry Bush, </li><li class="list-inline-item cited-by__entry__author">Michael B. Butcher, </li><li class="list-inline-item cited-by__entry__author">Robert J. Buynak, </li><li class="list-inline-item cited-by__entry__author">LaShondra Cade, </li><li class="list-inline-item cited-by__entry__author">Rafael Calderon, </li><li class="list-inline-item cited-by__entry__author">Richard Calderone, </li><li class="list-inline-item cited-by__entry__author">Amy Caldwell, </li><li class="list-inline-item cited-by__entry__author">Cornell Calinescu, </li><li class="list-inline-item cited-by__entry__author">Robert S. Call, </li><li class="list-inline-item cited-by__entry__author">Jim Callis, </li><li class="list-inline-item cited-by__entry__author">Laura Julia Camacho Choza, </li><li class="list-inline-item cited-by__entry__author">Andres Camacho-Gonzalez, </li><li class="list-inline-item cited-by__entry__author">Thomas B. Campbell, </li><li class="list-inline-item cited-by__entry__author">Wesley Campbell, </li><li class="list-inline-item cited-by__entry__author">Michael Cancilla, </li><li class="list-inline-item cited-by__entry__author">Kevin D. Cannon, </li><li class="list-inline-item cited-by__entry__author">Karina Cano MartÃ­nez, </li><li class="list-inline-item cited-by__entry__author">Richard Canter, </li><li class="list-inline-item cited-by__entry__author">Valeria D. Cantos, </li><li class="list-inline-item cited-by__entry__author">Vicky CÃ¡rdenas, </li><li class="list-inline-item cited-by__entry__author">Martha Carmen Medina, </li><li class="list-inline-item cited-by__entry__author">Ellie Carmody, </li><li class="list-inline-item cited-by__entry__author">Christopher Carpenter, </li><li class="list-inline-item cited-by__entry__author">Melissa Carr, </li><li class="list-inline-item cited-by__entry__author">Monica B. Carrascal, </li><li class="list-inline-item cited-by__entry__author">Jaime Augusto Carrillo, </li><li class="list-inline-item cited-by__entry__author">Steven E. Carsons, </li><li class="list-inline-item cited-by__entry__author">Marianela Carvajal, </li><li class="list-inline-item cited-by__entry__author">Denise Casey, </li><li class="list-inline-item cited-by__entry__author">Jorge Caso, </li><li class="list-inline-item cited-by__entry__author">Flora Castellino, </li><li class="list-inline-item cited-by__entry__author">Marvin Castellon, </li><li class="list-inline-item cited-by__entry__author">Jose Castillo Mancilla, </li><li class="list-inline-item cited-by__entry__author">Mario Castro, </li><li class="list-inline-item cited-by__entry__author">Hannah Catan, </li><li class="list-inline-item cited-by__entry__author">Nancy Cauwenberghs, </li><li class="list-inline-item cited-by__entry__author">Winston Cavert, </li><li class="list-inline-item cited-by__entry__author">MÃ©dÃ©ric Celle, </li><li class="list-inline-item cited-by__entry__author">Jorge A. ChacÃ³n, </li><li class="list-inline-item cited-by__entry__author">Mesha M. Chadwick, </li><li class="list-inline-item cited-by__entry__author">Amy Chamberlain, </li><li class="list-inline-item cited-by__entry__author">Austin Chan, </li><li class="list-inline-item cited-by__entry__author">Jennifer Chang, </li><li class="list-inline-item cited-by__entry__author">Danaya Chansinghakul, </li><li class="list-inline-item cited-by__entry__author">Mouna G. Chebib, </li><li class="list-inline-item cited-by__entry__author">Corey M. Chen, </li><li class="list-inline-item cited-by__entry__author">Aiying Chen, </li><li class="list-inline-item cited-by__entry__author">Margaret Cheng, </li><li class="list-inline-item cited-by__entry__author">Roman M. Chicz, </li><li class="list-inline-item cited-by__entry__author">Iksung Cho, </li><li class="list-inline-item cited-by__entry__author">Karin Choquette, </li><li class="list-inline-item cited-by__entry__author">R. Michelle Chouteau, </li><li class="list-inline-item cited-by__entry__author">Brian D. W. Chow, </li><li class="list-inline-item cited-by__entry__author">Lisa Chrisley, </li><li class="list-inline-item cited-by__entry__author">Shane G. Christensen, </li><li class="list-inline-item cited-by__entry__author">Laurence Chu, </li><li class="list-inline-item cited-by__entry__author">Hanh Chu, </li><li class="list-inline-item cited-by__entry__author">Waseem Chughtai, </li><li class="list-inline-item cited-by__entry__author">Michael Chung, </li><li class="list-inline-item cited-by__entry__author">Annie Ciambruschini, </li><li class="list-inline-item cited-by__entry__author">Cristina Cicogna, </li><li class="list-inline-item cited-by__entry__author">Alexander Clark, </li><li class="list-inline-item cited-by__entry__author">Jesse L. Clark, </li><li class="list-inline-item cited-by__entry__author">Phillip Claybrook, </li><li class="list-inline-item cited-by__entry__author">Andrea Clement, </li><li class="list-inline-item cited-by__entry__author">Lauren Clement, </li><li class="list-inline-item cited-by__entry__author">Steve Clemons, </li><li class="list-inline-item cited-by__entry__author">Heather Clouting, </li><li class="list-inline-item cited-by__entry__author">Lisa Cohen, </li><li class="list-inline-item cited-by__entry__author">Stuart H. Cohen, </li><li class="list-inline-item cited-by__entry__author">Jacob Coleman, </li><li class="list-inline-item cited-by__entry__author">Joseph P. Connor, </li><li class="list-inline-item cited-by__entry__author">James H. Conway, </li><li class="list-inline-item cited-by__entry__author">Erin Cooksey, </li><li class="list-inline-item cited-by__entry__author">Robert W. Coombs, </li><li class="list-inline-item cited-by__entry__author">Maureen Cooney, </li><li class="list-inline-item cited-by__entry__author">Deanna Cooper, </li><li class="list-inline-item cited-by__entry__author">Paul Coplan, </li><li class="list-inline-item cited-by__entry__author">Lawrence Corey, </li><li class="list-inline-item cited-by__entry__author">Raymond Cornelison, </li><li class="list-inline-item cited-by__entry__author">Barbara Corral, </li><li class="list-inline-item cited-by__entry__author">Jordan Coslet, </li><li class="list-inline-item cited-by__entry__author">Erin Coston, </li><li class="list-inline-item cited-by__entry__author">Michael J. Cotugno, </li><li class="list-inline-item cited-by__entry__author">Florence Coux, </li><li class="list-inline-item cited-by__entry__author">Jessica Cowden, </li><li class="list-inline-item cited-by__entry__author">Paul Cramer, </li><li class="list-inline-item cited-by__entry__author">Clarence B. Creech, </li><li class="list-inline-item cited-by__entry__author">Charnell Cromer, </li><li class="list-inline-item cited-by__entry__author">Marshall A. Cross, </li><li class="list-inline-item cited-by__entry__author">Aurelio Cruz-Valdez, </li><li class="list-inline-item cited-by__entry__author">Marcel Curlin, </li><li class="list-inline-item cited-by__entry__author">LaKondria Curry, </li><li class="list-inline-item cited-by__entry__author">Jerome Custers, </li><li class="list-inline-item cited-by__entry__author">Erika A. Cutz, </li><li class="list-inline-item cited-by__entry__author">Eric S. Daar, </li><li class="list-inline-item cited-by__entry__author">Michelle DallaPiazza, </li><li class="list-inline-item cited-by__entry__author">Dima Dandachi, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Danford, </li><li class="list-inline-item cited-by__entry__author">Lyly Dang, </li><li class="list-inline-item cited-by__entry__author">Stephen Daniels, </li><li class="list-inline-item cited-by__entry__author">Chandan Das, </li><li class="list-inline-item cited-by__entry__author">Santa Kumar Das, </li><li class="list-inline-item cited-by__entry__author">Matthew Davies, </li><li class="list-inline-item cited-by__entry__author">Yvonne Davis, </li><li class="list-inline-item cited-by__entry__author">Joseph D. Davis, </li><li class="list-inline-item cited-by__entry__author">William S. Davis, </li><li class="list-inline-item cited-by__entry__author">William B. Davis, </li><li class="list-inline-item cited-by__entry__author">Matthew G. Davis, </li><li class="list-inline-item cited-by__entry__author">Rajesh K. Davit, </li><li class="list-inline-item cited-by__entry__author">Gustavo H. Dayan, </li><li class="list-inline-item cited-by__entry__author">Anne Marit de Groot, </li><li class="list-inline-item cited-by__entry__author">Luis I. De La Cruz, </li><li class="list-inline-item cited-by__entry__author">Claudia De La Matta Rodriguez, </li><li class="list-inline-item cited-by__entry__author">Ian De Proost, </li><li class="list-inline-item cited-by__entry__author">Christopher Dedon, </li><li class="list-inline-item cited-by__entry__author">Jon F. Dedon, </li><li class="list-inline-item cited-by__entry__author">Teresa Deese, </li><li class="list-inline-item cited-by__entry__author">Emily Degan, </li><li class="list-inline-item cited-by__entry__author">Elliot DeHaan, </li><li class="list-inline-item cited-by__entry__author">Edwin DeJesus, </li><li class="list-inline-item cited-by__entry__author">Carlos del Rio, </li><li class="list-inline-item cited-by__entry__author">Michael Delgado, </li><li class="list-inline-item cited-by__entry__author">Mike Delgado, </li><li class="list-inline-item cited-by__entry__author">Ernesto Delgado, </li><li class="list-inline-item cited-by__entry__author">David Dellaero, </li><li class="list-inline-item cited-by__entry__author">Weiping Deng, </li><li class="list-inline-item cited-by__entry__author">Douglas S. Denham, </li><li class="list-inline-item cited-by__entry__author">Chinar Desai, </li><li class="list-inline-item cited-by__entry__author">Parul Desai, </li><li class="list-inline-item cited-by__entry__author">Michael Desjardins, </li><li class="list-inline-item cited-by__entry__author">Karen Deutsch, </li><li class="list-inline-item cited-by__entry__author">Michael E. Dever, </li><li class="list-inline-item cited-by__entry__author">Naomi Devine, </li><li class="list-inline-item cited-by__entry__author">Louis Devlin, </li><li class="list-inline-item cited-by__entry__author">Carlos A. Diazgranados, </li><li class="list-inline-item cited-by__entry__author">Secia DÃ­az-Miralrio, </li><li class="list-inline-item cited-by__entry__author">Michelle Dickey, </li><li class="list-inline-item cited-by__entry__author">David J. Diemert, </li><li class="list-inline-item cited-by__entry__author">Craig Dietz, </li><li class="list-inline-item cited-by__entry__author">Susanne Doblecki-Lewis, </li><li class="list-inline-item cited-by__entry__author">Dmytro Dobrianskyi, </li><li class="list-inline-item cited-by__entry__author">Jennifer L Dong, </li><li class="list-inline-item cited-by__entry__author">Tambra Dora, </li><li class="list-inline-item cited-by__entry__author">Brenda Dorcely, </li><li class="list-inline-item cited-by__entry__author">Macaya Douoguih, </li><li class="list-inline-item cited-by__entry__author">Matthew W. Doust, </li><li class="list-inline-item cited-by__entry__author">Frances Downing, </li><li class="list-inline-item cited-by__entry__author">Michael P. Dube, </li><li class="list-inline-item cited-by__entry__author">Filip Dubovsky, </li><li class="list-inline-item cited-by__entry__author">Pete Ducheneaux, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Dugas, </li><li class="list-inline-item cited-by__entry__author">Aeiress Duhart, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Duke, </li><li class="list-inline-item cited-by__entry__author">Debora Dunbar, </li><li class="list-inline-item cited-by__entry__author">Haoua Dunbar, </li><li class="list-inline-item cited-by__entry__author">Daniel M. Duncanson, </li><li class="list-inline-item cited-by__entry__author">Lisa M. Dunkle, </li><li class="list-inline-item cited-by__entry__author">Hillary Dunlevy, </li><li class="list-inline-item cited-by__entry__author">Anna Durbin, </li><li class="list-inline-item cited-by__entry__author">Amy Dye, </li><li class="list-inline-item cited-by__entry__author">Carmel B. Dyer, </li><li class="list-inline-item cited-by__entry__author">Sarah Dzigiel, </li><li class="list-inline-item cited-by__entry__author">Mary Easley, </li><li class="list-inline-item cited-by__entry__author">Niles Eaton, </li><li class="list-inline-item cited-by__entry__author">Valentine M. Ebuh, </li><li class="list-inline-item cited-by__entry__author">Georgette Ebuh, </li><li class="list-inline-item cited-by__entry__author">Lynn Eckert, </li><li class="list-inline-item cited-by__entry__author">Benjamin Eckhardt, </li><li class="list-inline-item cited-by__entry__author">Frank S. Eder, </li><li class="list-inline-item cited-by__entry__author">Srilatha Edupuganti, </li><li class="list-inline-item cited-by__entry__author">Leslie A. Edwards, </li><li class="list-inline-item cited-by__entry__author">Mark Eickhoff, </li><li class="list-inline-item cited-by__entry__author">Hana M. El Sahly, </li><li class="list-inline-item cited-by__entry__author">Edward Ellerbeck, </li><li class="list-inline-item cited-by__entry__author">Grant Ellsworth, </li><li class="list-inline-item cited-by__entry__author">Elwaleed Elnagar, </li><li class="list-inline-item cited-by__entry__author">Victoria Engler, </li><li class="list-inline-item cited-by__entry__author">Kendra Enright, </li><li class="list-inline-item cited-by__entry__author">David J. Ensz, </li><li class="list-inline-item cited-by__entry__author">Sally Eppenbach, </li><li class="list-inline-item cited-by__entry__author">Sandra Erickson, </li><li class="list-inline-item cited-by__entry__author">Joseph Eron, </li><li class="list-inline-item cited-by__entry__author">Joseph J. Eron, </li><li class="list-inline-item cited-by__entry__author">Tiffany Esinhart, </li><li class="list-inline-item cited-by__entry__author">Claudia Espinosa, </li><li class="list-inline-item cited-by__entry__author">Luis Espinoza, </li><li class="list-inline-item cited-by__entry__author">Brandon J. Essink, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Everette, </li><li class="list-inline-item cited-by__entry__author">Evan C. Ewers, </li><li class="list-inline-item cited-by__entry__author">Beverly Ewing, </li><li class="list-inline-item cited-by__entry__author">Amy Falk, </li><li class="list-inline-item cited-by__entry__author">Ann R. Falsey, </li><li class="list-inline-item cited-by__entry__author">Norberto Fas, </li><li class="list-inline-item cited-by__entry__author">Michael Fay, </li><li class="list-inline-item cited-by__entry__author">Szheckera Fearon, </li><li class="list-inline-item cited-by__entry__author">Brittany Feijoo, </li><li class="list-inline-item cited-by__entry__author">Gregory J. Feldman, </li><li class="list-inline-item cited-by__entry__author">Uriel R. Felsen, </li><li class="list-inline-item cited-by__entry__author">Hein Fennema, </li><li class="list-inline-item cited-by__entry__author">Carl J. Fichtenbaum, </li><li class="list-inline-item cited-by__entry__author">Tom Fiel, </li><li class="list-inline-item cited-by__entry__author">Carlos A. Fierro, </li><li class="list-inline-item cited-by__entry__author">Kenneth Finkelstein, </li><li class="list-inline-item cited-by__entry__author">Jon Finley, </li><li class="list-inline-item cited-by__entry__author">Suzanne Fiorillo, </li><li class="list-inline-item cited-by__entry__author">David Fitz-Patrick, </li><li class="list-inline-item cited-by__entry__author">Diana F. Florescu, </li><li class="list-inline-item cited-by__entry__author">Patrick Flume, </li><li class="list-inline-item cited-by__entry__author">Charles M. Fogarty, </li><li class="list-inline-item cited-by__entry__author">Jennifer Foley, </li><li class="list-inline-item cited-by__entry__author">Dean Follmann, </li><li class="list-inline-item cited-by__entry__author">Pink Folmar, </li><li class="list-inline-item cited-by__entry__author">Lyndsea Folsom, </li><li class="list-inline-item cited-by__entry__author">Youyi Fong, </li><li class="list-inline-item cited-by__entry__author">Stacy Ford, </li><li class="list-inline-item cited-by__entry__author">Lina M. Forero, </li><li class="list-inline-item cited-by__entry__author">Les B. Forgosh, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Formentini, </li><li class="list-inline-item cited-by__entry__author">Rhodna Fouts, </li><li class="list-inline-item cited-by__entry__author">Carina Frago, </li><li class="list-inline-item cited-by__entry__author">Veronica G. Fragoso, </li><li class="list-inline-item cited-by__entry__author">Doris Franco-Vitteri, </li><li class="list-inline-item cited-by__entry__author">Ian Frank, </li><li class="list-inline-item cited-by__entry__author">George H. Freeman, </li><li class="list-inline-item cited-by__entry__author">Lena R. Freese, </li><li class="list-inline-item cited-by__entry__author">Robert W. Frenck, </li><li class="list-inline-item cited-by__entry__author">Karen Freudemann, </li><li class="list-inline-item cited-by__entry__author">Sharon E. Frey, </li><li class="list-inline-item cited-by__entry__author">David L. Fried, </li><li class="list-inline-item cited-by__entry__author">Luke Friesen, </li><li class="list-inline-item cited-by__entry__author">James Fry, </li><li class="list-inline-item cited-by__entry__author">Bo Fu, </li><li class="list-inline-item cited-by__entry__author">Hiroyuki Fukase, </li><li class="list-inline-item cited-by__entry__author">Dawn Furey, </li><li class="list-inline-item cited-by__entry__author">Christopher Galloway, </li><li class="list-inline-item cited-by__entry__author">Sarah Galloway, </li><li class="list-inline-item cited-by__entry__author">Edgar Garcia, </li><li class="list-inline-item cited-by__entry__author">Jenina Garcia, </li><li class="list-inline-item cited-by__entry__author">Iris GarcÃ­a, </li><li class="list-inline-item cited-by__entry__author">Sebastian Garcia Escallon, </li><li class="list-inline-item cited-by__entry__author">Veronica Garcia-Fragoso, </li><li class="list-inline-item cited-by__entry__author">Agnes Garinga, </li><li class="list-inline-item cited-by__entry__author">Janet Garvey, </li><li class="list-inline-item cited-by__entry__author">Cynthia L. Gay, </li><li class="list-inline-item cited-by__entry__author">Bruce C. Gebhardt, </li><li class="list-inline-item cited-by__entry__author">Grant Geiger, </li><li class="list-inline-item cited-by__entry__author">Huub G. Gelderblom, </li><li class="list-inline-item cited-by__entry__author">Georgettea Geuss, </li><li class="list-inline-item cited-by__entry__author">Elham Ghadishah, </li><li class="list-inline-item cited-by__entry__author">Elie Gharib, </li><li class="list-inline-item cited-by__entry__author">Suzanne Gharib, </li><li class="list-inline-item cited-by__entry__author">Richard L. Gibson, </li><li class="list-inline-item cited-by__entry__author">Peter B. Gilbert, </li><li class="list-inline-item cited-by__entry__author">Alfredo Gilberto Guerreros Benavides, </li><li class="list-inline-item cited-by__entry__author">Teletha Gipson, </li><li class="list-inline-item cited-by__entry__author">Eneyda Giuvanela Llerena Zegarra, </li><li class="list-inline-item cited-by__entry__author">Gregory M. Glenn, </li><li class="list-inline-item cited-by__entry__author">Richard M. Glover, </li><li class="list-inline-item cited-by__entry__author">Erin A. Goecker, </li><li class="list-inline-item cited-by__entry__author">Paul A. Goepfert, </li><li class="list-inline-item cited-by__entry__author">James N. Goldenberg, </li><li class="list-inline-item cited-by__entry__author">Blanca Gomez, </li><li class="list-inline-item cited-by__entry__author">Martha Cecilia GÃ³mora Madrid, </li><li class="list-inline-item cited-by__entry__author">Jose Gonzales-Zamora, </li><li class="list-inline-item cited-by__entry__author">Celia Gonzalez, </li><li class="list-inline-item cited-by__entry__author">Lazaro Gonzalez, </li><li class="list-inline-item cited-by__entry__author">Viviana Gonzalez, </li><li class="list-inline-item cited-by__entry__author">Claudia Gonzalez, </li><li class="list-inline-item cited-by__entry__author">Luis H. GonzÃ¡lez, </li><li class="list-inline-item cited-by__entry__author">Denisse Alejandra GonzÃ¡lez Estrada, </li><li class="list-inline-item cited-by__entry__author">Antonio Gonzalez-Lopez, </li><li class="list-inline-item cited-by__entry__author">Sarah Gordon, </li><li class="list-inline-item cited-by__entry__author">Bryan Gordon, </li><li class="list-inline-item cited-by__entry__author">Richard Gorman, </li><li class="list-inline-item cited-by__entry__author">Gregory M. Gottschlich, </li><li class="list-inline-item cited-by__entry__author">Melissa Gottschlich, </li><li class="list-inline-item cited-by__entry__author">Shanda Gower, </li><li class="list-inline-item cited-by__entry__author">Daniel S. Graciaa, </li><li class="list-inline-item cited-by__entry__author">Barney S. Graham, </li><li class="list-inline-item cited-by__entry__author">Irene Graham, </li><li class="list-inline-item cited-by__entry__author">Maria Angelica Granados, </li><li class="list-inline-item cited-by__entry__author">Amber Grant, </li><li class="list-inline-item cited-by__entry__author">Brett Gray, </li><li class="list-inline-item cited-by__entry__author">Glenda Gray, </li><li class="list-inline-item cited-by__entry__author">Roni Gray, </li><li class="list-inline-item cited-by__entry__author">Sinikka L. Green, </li><li class="list-inline-item cited-by__entry__author">Allison Green, </li><li class="list-inline-item cited-by__entry__author">Justin A. Green, </li><li class="list-inline-item cited-by__entry__author">Rusty Greene, </li><li class="list-inline-item cited-by__entry__author">Caroline Greene, </li><li class="list-inline-item cited-by__entry__author">Cathy Greiwe, </li><li class="list-inline-item cited-by__entry__author">Alex Greninger, </li><li class="list-inline-item cited-by__entry__author">Carl P. Griffin, </li><li class="list-inline-item cited-by__entry__author">Marie-Helene Grillet, </li><li class="list-inline-item cited-by__entry__author">Joseph Grillo, </li><li class="list-inline-item cited-by__entry__author">Beatriz Grinsztejn, </li><li class="list-inline-item cited-by__entry__author">Robert M. Grossberg, </li><li class="list-inline-item cited-by__entry__author">Nicole Grunenberg, </li><li class="list-inline-item cited-by__entry__author">Bernard Grunstra, </li><li class="list-inline-item cited-by__entry__author">Juan V. Guanira-Carranza, </li><li class="list-inline-item cited-by__entry__author">Sonia Guerrero, </li><li class="list-inline-item cited-by__entry__author">Lea Guillery, </li><li class="list-inline-item cited-by__entry__author">Clint C. Guillory, </li><li class="list-inline-item cited-by__entry__author">Caitlin J. Guiney, </li><li class="list-inline-item cited-by__entry__author">Catherine Q. Gular, </li><li class="list-inline-item cited-by__entry__author">Shauna H. Gunaratne, </li><li class="list-inline-item cited-by__entry__author">Sanjay Gurunathan, </li><li class="list-inline-item cited-by__entry__author">Milton Haber, </li><li class="list-inline-item cited-by__entry__author">Greg Hachigian, </li><li class="list-inline-item cited-by__entry__author">Amina Z. Haggag, </li><li class="list-inline-item cited-by__entry__author">William Hahn, </li><li class="list-inline-item cited-by__entry__author">Evelyn Hall, </li><li class="list-inline-item cited-by__entry__author">Jessicalee Hall, </li><li class="list-inline-item cited-by__entry__author">David Halpert, </li><li class="list-inline-item cited-by__entry__author">Holli Hamilton, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Hammershaimb, </li><li class="list-inline-item cited-by__entry__author">Shu Han, </li><li class="list-inline-item cited-by__entry__author">Laurie J. Han-Conrad, </li><li class="list-inline-item cited-by__entry__author">Kate Harden, </li><li class="list-inline-item cited-by__entry__author">Karin Hardt, </li><li class="list-inline-item cited-by__entry__author">Esther L. Harmon, </li><li class="list-inline-item cited-by__entry__author">Wayne L. Harper, </li><li class="list-inline-item cited-by__entry__author">Charles Harper, </li><li class="list-inline-item cited-by__entry__author">Nicole Harrell, </li><li class="list-inline-item cited-by__entry__author">Hannah Harrington, </li><li class="list-inline-item cited-by__entry__author">Tavane Harrison, </li><li class="list-inline-item cited-by__entry__author">Kristina Harrison, </li><li class="list-inline-item cited-by__entry__author">Shana Harshell, </li><li class="list-inline-item cited-by__entry__author">William R. Hartman, </li><li class="list-inline-item cited-by__entry__author">Robyn Hartvickson, </li><li class="list-inline-item cited-by__entry__author">Michael Hassman, </li><li class="list-inline-item cited-by__entry__author">Timothy J. Hatlen, </li><li class="list-inline-item cited-by__entry__author">Kirsten Hauge, </li><li class="list-inline-item cited-by__entry__author">Lynne A. Haughey, </li><li class="list-inline-item cited-by__entry__author">Michelle Haynes, </li><li class="list-inline-item cited-by__entry__author">Gary Headden, </li><li class="list-inline-item cited-by__entry__author">C. Mary Healy, </li><li class="list-inline-item cited-by__entry__author">Parke Hedges, </li><li class="list-inline-item cited-by__entry__author">Dirk Heerwegh, </li><li class="list-inline-item cited-by__entry__author">Theresa Hegmann, </li><li class="list-inline-item cited-by__entry__author">Jessica Heimonen, </li><li class="list-inline-item cited-by__entry__author">Destiny S. Heinzig-Cartwright, </li><li class="list-inline-item cited-by__entry__author">Sheryl L. Henderson, </li><li class="list-inline-item cited-by__entry__author">Jeffrey A. Henderson, </li><li class="list-inline-item cited-by__entry__author">Renea Henderson, </li><li class="list-inline-item cited-by__entry__author">Jenny Hendriks, </li><li class="list-inline-item cited-by__entry__author">Gayle D. Hennekes, </li><li class="list-inline-item cited-by__entry__author">Matthew Hepburn, </li><li class="list-inline-item cited-by__entry__author">Ramin Herati, </li><li class="list-inline-item cited-by__entry__author">Erica Herc, </li><li class="list-inline-item cited-by__entry__author">Will Hernandez, </li><li class="list-inline-item cited-by__entry__author">Laura Hernandez Guarin, </li><li class="list-inline-item cited-by__entry__author">Maria Hernandez Moran, </li><li class="list-inline-item cited-by__entry__author">Robin Hilder, </li><li class="list-inline-item cited-by__entry__author">John M. Hill, </li><li class="list-inline-item cited-by__entry__author">Janet Hill, </li><li class="list-inline-item cited-by__entry__author">Ian Hirsch, </li><li class="list-inline-item cited-by__entry__author">Ken Ho, </li><li class="list-inline-item cited-by__entry__author">Alejandro Hoberman, </li><li class="list-inline-item cited-by__entry__author">Daniel Hoft, </li><li class="list-inline-item cited-by__entry__author">Leila Hojat, </li><li class="list-inline-item cited-by__entry__author">Troy Holdeman, </li><li class="list-inline-item cited-by__entry__author">Ripley R. Hollister, </li><li class="list-inline-item cited-by__entry__author">Lisa Holloway, </li><li class="list-inline-item cited-by__entry__author">Gregory Holt, </li><li class="list-inline-item cited-by__entry__author">Matthew Hong, </li><li class="list-inline-item cited-by__entry__author">Stephan Hong, </li><li class="list-inline-item cited-by__entry__author">Rosamond Hong, </li><li class="list-inline-item cited-by__entry__author">Amanda Horn, </li><li class="list-inline-item cited-by__entry__author">Manisha Horton, </li><li class="list-inline-item cited-by__entry__author">Gary Horwith, </li><li class="list-inline-item cited-by__entry__author">Sybil G. Hosek, </li><li class="list-inline-item cited-by__entry__author">Cyrus Hoseyni, </li><li class="list-inline-item cited-by__entry__author">Patty Howenstine, </li><li class="list-inline-item cited-by__entry__author">Yunda Huang, </li><li class="list-inline-item cited-by__entry__author">Ying Huang, </li><li class="list-inline-item cited-by__entry__author">Kathy Hudzina, </li><li class="list-inline-item cited-by__entry__author">Cory J. Huffine, </li><li class="list-inline-item cited-by__entry__author">Esther S. Huffine, </li><li class="list-inline-item cited-by__entry__author">Christine Hull, </li><li class="list-inline-item cited-by__entry__author">Julie Hunt, </li><li class="list-inline-item cited-by__entry__author">John Hural, </li><li class="list-inline-item cited-by__entry__author">James W. Hurst, </li><li class="list-inline-item cited-by__entry__author">Shamika Huskey, </li><li class="list-inline-item cited-by__entry__author">Mary Hussain, </li><li class="list-inline-item cited-by__entry__author">Julie Hussey, </li><li class="list-inline-item cited-by__entry__author">Morgan Hussey, </li><li class="list-inline-item cited-by__entry__author">Mark Hutchens, </li><li class="list-inline-item cited-by__entry__author">Tanya Hutchins, </li><li class="list-inline-item cited-by__entry__author">Julia Hutter, </li><li class="list-inline-item cited-by__entry__author">Vincent Huynh, </li><li class="list-inline-item cited-by__entry__author">Jessica Ibarra, </li><li class="list-inline-item cited-by__entry__author">Lilly Immergluck, </li><li class="list-inline-item cited-by__entry__author">Dilek Ince, </li><li class="list-inline-item cited-by__entry__author">Sarah M. Ingalsbe-Geno, </li><li class="list-inline-item cited-by__entry__author">Asha Inniss, </li><li class="list-inline-item cited-by__entry__author">Farah Irani, </li><li class="list-inline-item cited-by__entry__author">Mashrur Islam Majumder, </li><li class="list-inline-item cited-by__entry__author">Ryan Israelsen, </li><li class="list-inline-item cited-by__entry__author">Leslie Iverson, </li><li class="list-inline-item cited-by__entry__author">Genevieve Iwuala, </li><li class="list-inline-item cited-by__entry__author">Lisa A. Jackson, </li><li class="list-inline-item cited-by__entry__author">Peta-Gay Jackson-Booth, </li><li class="list-inline-item cited-by__entry__author">Michael Jacobs, </li><li class="list-inline-item cited-by__entry__author">Colleen Jacobsen, </li><li class="list-inline-item cited-by__entry__author">Jeffrey M. Jacobson, </li><li class="list-inline-item cited-by__entry__author">Jeffry Jacqmein, </li><li class="list-inline-item cited-by__entry__author">Kate Jaegle, </li><li class="list-inline-item cited-by__entry__author">Shireen H. Jaffer, </li><li class="list-inline-item cited-by__entry__author">Maryam Jahromi, </li><li class="list-inline-item cited-by__entry__author">Manish Jain, </li><li class="list-inline-item cited-by__entry__author">Frank James, </li><li class="list-inline-item cited-by__entry__author">Holly Janes, </li><li class="list-inline-item cited-by__entry__author">Melanie Jay, </li><li class="list-inline-item cited-by__entry__author">Robert Jeanfreau, </li><li class="list-inline-item cited-by__entry__author">Susan Jeanfreau, </li><li class="list-inline-item cited-by__entry__author">William Jennings, </li><li class="list-inline-item cited-by__entry__author">Natasa Jenson, </li><li class="list-inline-item cited-by__entry__author">Keith R. Jerome, </li><li class="list-inline-item cited-by__entry__author">Jennifer A. Johnson, </li><li class="list-inline-item cited-by__entry__author">John Johnson, </li><li class="list-inline-item cited-by__entry__author">Danyel Johnson, </li><li class="list-inline-item cited-by__entry__author">Diane H. Johnson, </li><li class="list-inline-item cited-by__entry__author">Maria Johnson, </li><li class="list-inline-item cited-by__entry__author">Lisa Johnson, </li><li class="list-inline-item cited-by__entry__author">Erica Johnson, </li><li class="list-inline-item cited-by__entry__author">Kristen Johnson, </li><li class="list-inline-item cited-by__entry__author">Jennie Johnson, </li><li class="list-inline-item cited-by__entry__author">Carrie Johnston, </li><li class="list-inline-item cited-by__entry__author">William H. Jones, </li><li class="list-inline-item cited-by__entry__author">Kathleen S. Jones, </li><li class="list-inline-item cited-by__entry__author">Edward C. Jones-LÃ³pez, </li><li class="list-inline-item cited-by__entry__author">Bailey Jordan, </li><li class="list-inline-item cited-by__entry__author">Michal Juraska, </li><li class="list-inline-item cited-by__entry__author">Jarek Juraszek, </li><li class="list-inline-item cited-by__entry__author">Jessica E. Justman, </li><li class="list-inline-item cited-by__entry__author">Seyram Kaali, </li><li class="list-inline-item cited-by__entry__author">Scott Kahney, </li><li class="list-inline-item cited-by__entry__author">Spyros A. Kalams, </li><li class="list-inline-item cited-by__entry__author">Satoshi Kamidani, </li><li class="list-inline-item cited-by__entry__author">Sheetal Kandiah, </li><li class="list-inline-item cited-by__entry__author">Pamela Kane, </li><li class="list-inline-item cited-by__entry__author">Piush Kanodia, </li><li class="list-inline-item cited-by__entry__author">Shashi Kapadia, </li><li class="list-inline-item cited-by__entry__author">Lois Katz, </li><li class="list-inline-item cited-by__entry__author">Melinda Katz, </li><li class="list-inline-item cited-by__entry__author">Carol Kauffman, </li><li class="list-inline-item cited-by__entry__author">Daniel Kaul, </li><li class="list-inline-item cited-by__entry__author">Margaret Kautz, </li><li class="list-inline-item cited-by__entry__author">Westly Keating, </li><li class="list-inline-item cited-by__entry__author">Jia Jin&nbsp; Kee, </li><li class="list-inline-item cited-by__entry__author">Michael C. Keefer, </li><li class="list-inline-item cited-by__entry__author">Wendy A. Keitel, </li><li class="list-inline-item cited-by__entry__author">Colleen F. Kelley, </li><li class="list-inline-item cited-by__entry__author">Amy Kelley, </li><li class="list-inline-item cited-by__entry__author">Kary Kelly, </li><li class="list-inline-item cited-by__entry__author">Elizabeth J. Kelly, </li><li class="list-inline-item cited-by__entry__author">Sandra Kelman, </li><li class="list-inline-item cited-by__entry__author">Gerald Kelty, </li><li class="list-inline-item cited-by__entry__author">Ashley Kennedy, </li><li class="list-inline-item cited-by__entry__author">Christina Kennelly, </li><li class="list-inline-item cited-by__entry__author">Maryam Keshtkar-Jahromi, </li><li class="list-inline-item cited-by__entry__author">Jill Kessler, </li><li class="list-inline-item cited-by__entry__author">Nzeera Ketter, </li><li class="list-inline-item cited-by__entry__author">Najat Khan, </li><li class="list-inline-item cited-by__entry__author">Nitin Khandelwal, </li><li class="list-inline-item cited-by__entry__author">Shishir K. Khetan, </li><li class="list-inline-item cited-by__entry__author">Saadia Khizer, </li><li class="list-inline-item cited-by__entry__author">Hannah Kibuuka, </li><li class="list-inline-item cited-by__entry__author">Kristen Kiersey, </li><li class="list-inline-item cited-by__entry__author">Paul Kilgore, </li><li class="list-inline-item cited-by__entry__author">Anthony Kim, </li><li class="list-inline-item cited-by__entry__author">Kami Kim, </li><li class="list-inline-item cited-by__entry__author">Murray A. Kimmel, </li><li class="list-inline-item cited-by__entry__author">Michelle King, </li><li class="list-inline-item cited-by__entry__author">Jeffrey K. Kingsley, </li><li class="list-inline-item cited-by__entry__author">William Kirby, </li><li class="list-inline-item cited-by__entry__author">John A. Kirby, </li><li class="list-inline-item cited-by__entry__author">Beth D. Kirkpatrick, </li><li class="list-inline-item cited-by__entry__author">Judith L. Kirstein, </li><li class="list-inline-item cited-by__entry__author">Cissy Kityo Mutuluuza, </li><li class="list-inline-item cited-by__entry__author">Noah Kiwanuka, </li><li class="list-inline-item cited-by__entry__author">Francis Kiweewa, </li><li class="list-inline-item cited-by__entry__author">John S. Kizer, </li><li class="list-inline-item cited-by__entry__author">Terry D. Klein, </li><li class="list-inline-item cited-by__entry__author">Thomas C. Klein, </li><li class="list-inline-item cited-by__entry__author">Tracy R. Klein, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Klein, </li><li class="list-inline-item cited-by__entry__author">Susan Kline, </li><li class="list-inline-item cited-by__entry__author">David Kline, </li><li class="list-inline-item cited-by__entry__author">Jennifer Knishinsky, </li><li class="list-inline-item cited-by__entry__author">Jennifer Knowles, </li><li class="list-inline-item cited-by__entry__author">Laura Kogelman, </li><li class="list-inline-item cited-by__entry__author">Sharon Kohrs, </li><li class="list-inline-item cited-by__entry__author">Susan L. Koletar, </li><li class="list-inline-item cited-by__entry__author">James Kopp, </li><li class="list-inline-item cited-by__entry__author">Michael J. Koren, </li><li class="list-inline-item cited-by__entry__author">Chalit Kosolsak, </li><li class="list-inline-item cited-by__entry__author">Karen L. Kotloff, </li><li class="list-inline-item cited-by__entry__author">Angelica Kottkamp, </li><li class="list-inline-item cited-by__entry__author">Marguerite Koutsoukos, </li><li class="list-inline-item cited-by__entry__author">Jayasree Krishnankutty, </li><li class="list-inline-item cited-by__entry__author">Mara Kryvicky, </li><li class="list-inline-item cited-by__entry__author">James G. Kublin, </li><li class="list-inline-item cited-by__entry__author">Kristine J. Kucera, </li><li class="list-inline-item cited-by__entry__author">Darshna Kukian, </li><li class="list-inline-item cited-by__entry__author">Marcy Kulic, </li><li class="list-inline-item cited-by__entry__author">Rebecca J. Kurnat, </li><li class="list-inline-item cited-by__entry__author">Kelly Kush, </li><li class="list-inline-item cited-by__entry__author">Jitendra Singh Kushwaha, </li><li class="list-inline-item cited-by__entry__author">Mark E. Kutner, </li><li class="list-inline-item cited-by__entry__author">Ben Ladner, </li><li class="list-inline-item cited-by__entry__author">Cathy Laflan, </li><li class="list-inline-item cited-by__entry__author">Maryrose Laguio-Vila, </li><li class="list-inline-item cited-by__entry__author">Sherry Lamberth, </li><li class="list-inline-item cited-by__entry__author">Raphael J. Landovitz, </li><li class="list-inline-item cited-by__entry__author">Dakotah C. Lane, </li><li class="list-inline-item cited-by__entry__author">Thelma Laot, </li><li class="list-inline-item cited-by__entry__author">Anyela Lara, </li><li class="list-inline-item cited-by__entry__author">Matthew Laurens, </li><li class="list-inline-item cited-by__entry__author">Andrew Lauria, </li><li class="list-inline-item cited-by__entry__author">Daniel T. Lawler, </li><li class="list-inline-item cited-by__entry__author">Nga Le, </li><li class="list-inline-item cited-by__entry__author">Mathieu Le Gars, </li><li class="list-inline-item cited-by__entry__author">Vickie Leathers, </li><li class="list-inline-item cited-by__entry__author">Brett Leav, </li><li class="list-inline-item cited-by__entry__author">Logan Ledbetter, </li><li class="list-inline-item cited-by__entry__author">Julie E. Ledgerwood, </li><li class="list-inline-item cited-by__entry__author">Kia Lee, </li><li class="list-inline-item cited-by__entry__author">Jessica L. Lee, </li><li class="list-inline-item cited-by__entry__author">Marina Lee, </li><li class="list-inline-item cited-by__entry__author">Angela Lee, </li><li class="list-inline-item cited-by__entry__author">Mark Leibowitz, </li><li class="list-inline-item cited-by__entry__author">Natalia Leistner, </li><li class="list-inline-item cited-by__entry__author">Mark Lerman, </li><li class="list-inline-item cited-by__entry__author">Michael L. Levin, </li><li class="list-inline-item cited-by__entry__author">Brendan Levy, </li><li class="list-inline-item cited-by__entry__author">Phillip Levy, </li><li class="list-inline-item cited-by__entry__author">Wendell Lewis, </li><li class="list-inline-item cited-by__entry__author">Michael Lewis, </li><li class="list-inline-item cited-by__entry__author">Derek Lewis, </li><li class="list-inline-item cited-by__entry__author">Wendell Lewis, </li><li class="list-inline-item cited-by__entry__author">Maggie Lewis, </li><li class="list-inline-item cited-by__entry__author">Paola Lichtenberger, </li><li class="list-inline-item cited-by__entry__author">Amanda Lilienthal, </li><li class="list-inline-item cited-by__entry__author">Kathleen Linder, </li><li class="list-inline-item cited-by__entry__author">Carol Ann Linebarger, </li><li class="list-inline-item cited-by__entry__author">Kendra Lisec, </li><li class="list-inline-item cited-by__entry__author">Ryan Little, </li><li class="list-inline-item cited-by__entry__author">Susan J. Little, </li><li class="list-inline-item cited-by__entry__author">Albert Liu, </li><li class="list-inline-item cited-by__entry__author">Anna S. Lok, </li><li class="list-inline-item cited-by__entry__author">Evelyn Lomasney, </li><li class="list-inline-item cited-by__entry__author">James Longe, </li><li class="list-inline-item cited-by__entry__author">Carlos Lopez, </li><li class="list-inline-item cited-by__entry__author">Eduardo Lopez-Medina, </li><li class="list-inline-item cited-by__entry__author">Julia Lord, </li><li class="list-inline-item cited-by__entry__author">James Lovell, </li><li class="list-inline-item cited-by__entry__author">Ronald Lubelchek, </li><li class="list-inline-item cited-by__entry__author">John Lucaj, </li><li class="list-inline-item cited-by__entry__author">Njira Lucia Lugogo, </li><li class="list-inline-item cited-by__entry__author">Gary Luckasen, </li><li class="list-inline-item cited-by__entry__author">Gregg H. Lucksinger, </li><li class="list-inline-item cited-by__entry__author">Annie Luetkemeyer, </li><li class="list-inline-item cited-by__entry__author">Benjamin J. Luft, </li><li class="list-inline-item cited-by__entry__author">Rafael Lupercio, </li><li class="list-inline-item cited-by__entry__author">Alisha Lutat, </li><li class="list-inline-item cited-by__entry__author">Jill Maaske, </li><li class="list-inline-item cited-by__entry__author">Rosa MacBryde, </li><li class="list-inline-item cited-by__entry__author">Nolan Mackey, </li><li class="list-inline-item cited-by__entry__author">Rebecca P. Madan, </li><li class="list-inline-item cited-by__entry__author">Janine Maenza, </li><li class="list-inline-item cited-by__entry__author">Siham Mahgoub, </li><li class="list-inline-item cited-by__entry__author">Mamodikoe Makhene, </li><li class="list-inline-item cited-by__entry__author">Hussain Malbari, </li><li class="list-inline-item cited-by__entry__author">Elissa Malkin, </li><li class="list-inline-item cited-by__entry__author">Carlos Malvestutto, </li><li class="list-inline-item cited-by__entry__author">Stephanie Mamod, </li><li class="list-inline-item cited-by__entry__author">Millie Manalo, </li><li class="list-inline-item cited-by__entry__author">Jose C. Mancilla, </li><li class="list-inline-item cited-by__entry__author">Kishorchandra Mandaliya, </li><li class="list-inline-item cited-by__entry__author">Somnath Mangarule, </li><li class="list-inline-item cited-by__entry__author">Padma N. Mangu, </li><li class="list-inline-item cited-by__entry__author">Mary Beth Manning, </li><li class="list-inline-item cited-by__entry__author">Rickey D. Manning, </li><li class="list-inline-item cited-by__entry__author">Deb Manzo, </li><li class="list-inline-item cited-by__entry__author">Horacio Marafioti, </li><li class="list-inline-item cited-by__entry__author">Kristin Marks, </li><li class="list-inline-item cited-by__entry__author">Mary A. Marovich, </li><li class="list-inline-item cited-by__entry__author">Adrienna Marquez, </li><li class="list-inline-item cited-by__entry__author">Richard P. Marshall, </li><li class="list-inline-item cited-by__entry__author">Judith Martin, </li><li class="list-inline-item cited-by__entry__author">Troy Martin, </li><li class="list-inline-item cited-by__entry__author">Becky Martinez, </li><li class="list-inline-item cited-by__entry__author">Reuben Martinez, </li><li class="list-inline-item cited-by__entry__author">Javier MartÃ­nez, </li><li class="list-inline-item cited-by__entry__author">Silvano Omar MartÃ­nez PÃ©rez, </li><li class="list-inline-item cited-by__entry__author">Catherine Mary Healy, </li><li class="list-inline-item cited-by__entry__author">John Mascola, </li><li class="list-inline-item cited-by__entry__author">Robin Mason, </li><li class="list-inline-item cited-by__entry__author">Roger Masotti, </li><li class="list-inline-item cited-by__entry__author">Paul G. Matherne, </li><li class="list-inline-item cited-by__entry__author">Christopher Matich, </li><li class="list-inline-item cited-by__entry__author">Monica Mauri, </li><li class="list-inline-item cited-by__entry__author">Ryan C. Maves, </li><li class="list-inline-item cited-by__entry__author">Michelle Maxwell, </li><li class="list-inline-item cited-by__entry__author">Celia Maxwell, </li><li class="list-inline-item cited-by__entry__author">Kenneth H. Mayer, </li><li class="list-inline-item cited-by__entry__author">Monica A. McArthur, </li><li class="list-inline-item cited-by__entry__author">Jennifer McCarter, </li><li class="list-inline-item cited-by__entry__author">Michael J. McCartney, </li><li class="list-inline-item cited-by__entry__author">R. Scott McClelland, </li><li class="list-inline-item cited-by__entry__author">Bruce McClenathan, </li><li class="list-inline-item cited-by__entry__author">Rachael McClennen, </li><li class="list-inline-item cited-by__entry__author">Andrew McConnell, </li><li class="list-inline-item cited-by__entry__author">Margaret E. McCort, </li><li class="list-inline-item cited-by__entry__author">M. Juliana McElrath, </li><li class="list-inline-item cited-by__entry__author">Charlene McEvoy, </li><li class="list-inline-item cited-by__entry__author">Alice McGarry, </li><li class="list-inline-item cited-by__entry__author">John W. McGettigan, </li><li class="list-inline-item cited-by__entry__author">Jonlyn McGettigan, </li><li class="list-inline-item cited-by__entry__author">Lora J. McGill, </li><li class="list-inline-item cited-by__entry__author">Eric McGrath, </li><li class="list-inline-item cited-by__entry__author">Mark M. McKenzie, </li><li class="list-inline-item cited-by__entry__author">Cecilia McKeown-Bragas, </li><li class="list-inline-item cited-by__entry__author">Irene McKnight, </li><li class="list-inline-item cited-by__entry__author">Morgan McLaughlin, </li><li class="list-inline-item cited-by__entry__author">Meredith McNairy, </li><li class="list-inline-item cited-by__entry__author">Kelly McQuarrie, </li><li class="list-inline-item cited-by__entry__author">Andrew McWilliams, </li><li class="list-inline-item cited-by__entry__author">Jodi Meck, </li><li class="list-inline-item cited-by__entry__author">Surisday Mederos, </li><li class="list-inline-item cited-by__entry__author">Amy Medina, </li><li class="list-inline-item cited-by__entry__author">Carmen Medina, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Meier, </li><li class="list-inline-item cited-by__entry__author">Thomas Mellman, </li><li class="list-inline-item cited-by__entry__author">Jessica M. Mena, </li><li class="list-inline-item cited-by__entry__author">Lisa Menard, </li><li class="list-inline-item cited-by__entry__author">Kathleen Menasche, </li><li class="list-inline-item cited-by__entry__author">Janet Mendez, </li><li class="list-inline-item cited-by__entry__author">Jorge F. MÃ©ndez GalvÃ¡n, </li><li class="list-inline-item cited-by__entry__author">Rafael Mendoza, </li><li class="list-inline-item cited-by__entry__author">Erika Mendoza, </li><li class="list-inline-item cited-by__entry__author">Sandra Mendoza, </li><li class="list-inline-item cited-by__entry__author">Rajan Merchant, </li><li class="list-inline-item cited-by__entry__author">Fernando L. Merino, </li><li class="list-inline-item cited-by__entry__author">David Metzger, </li><li class="list-inline-item cited-by__entry__author">Jay Meyer, </li><li class="list-inline-item cited-by__entry__author">Robert Meyer, </li><li class="list-inline-item cited-by__entry__author">Eric A. Meyerowitz, </li><li class="list-inline-item cited-by__entry__author">Nelson L. Michael, </li><li class="list-inline-item cited-by__entry__author">Randle Middleton, </li><li class="list-inline-item cited-by__entry__author">Maria Mileno, </li><li class="list-inline-item cited-by__entry__author">Matthew Miles, </li><li class="list-inline-item cited-by__entry__author">Chelsea Miles, </li><li class="list-inline-item cited-by__entry__author">Eric Miller, </li><li class="list-inline-item cited-by__entry__author">Jacqueline Miller, </li><li class="list-inline-item cited-by__entry__author">Vicki E. Miller, </li><li class="list-inline-item cited-by__entry__author">Meagan Miller, </li><li class="list-inline-item cited-by__entry__author">Paulina Miller, </li><li class="list-inline-item cited-by__entry__author">Jason Milligan, </li><li class="list-inline-item cited-by__entry__author">Ann M. Milliken, </li><li class="list-inline-item cited-by__entry__author">Jill Miracle, </li><li class="list-inline-item cited-by__entry__author">Vincent Mirkil, </li><li class="list-inline-item cited-by__entry__author">Mehdi Mirsaeidi, </li><li class="list-inline-item cited-by__entry__author">Carol L. Mitchell, </li><li class="list-inline-item cited-by__entry__author">Kazuyuki Mizuyama, </li><li class="list-inline-item cited-by__entry__author">Gowdhami Mohan, </li><li class="list-inline-item cited-by__entry__author">Satyajit Mohapatra, </li><li class="list-inline-item cited-by__entry__author">Sharzhaad Molina Guizar, </li><li class="list-inline-item cited-by__entry__author">Florence Momplaisir, </li><li class="list-inline-item cited-by__entry__author">Cynthia L. Monaco, </li><li class="list-inline-item cited-by__entry__author">Cynthia Montano-Pereira, </li><li class="list-inline-item cited-by__entry__author">Natasha Montoya, </li><li class="list-inline-item cited-by__entry__author">Candice Montros, </li><li class="list-inline-item cited-by__entry__author">Amaran Moodley, </li><li class="list-inline-item cited-by__entry__author">Fernanda Morales, </li><li class="list-inline-item cited-by__entry__author">Caitlin Moran, </li><li class="list-inline-item cited-by__entry__author">Catherine Moreau, </li><li class="list-inline-item cited-by__entry__author">Stephen Morris, </li><li class="list-inline-item cited-by__entry__author">Victoria Mosteller, </li><li class="list-inline-item cited-by__entry__author">Stefanie Mott, </li><li class="list-inline-item cited-by__entry__author">Connie Moya, </li><li class="list-inline-item cited-by__entry__author">Terri Moye, </li><li class="list-inline-item cited-by__entry__author">Kimberly Mueller, </li><li class="list-inline-item cited-by__entry__author">Nancy Mueller, </li><li class="list-inline-item cited-by__entry__author">Jacqueline Muenzner, </li><li class="list-inline-item cited-by__entry__author">Nelly Mugo, </li><li class="list-inline-item cited-by__entry__author">Sauda Muhammad, </li><li class="list-inline-item cited-by__entry__author">Kathleen M. Mullane, </li><li class="list-inline-item cited-by__entry__author">Mark J. Mulligan, </li><li class="list-inline-item cited-by__entry__author">Gysella Muniz, </li><li class="list-inline-item cited-by__entry__author">Sigridh MuÃ±oz-GÃ³mez, </li><li class="list-inline-item cited-by__entry__author">Sonal Munsiff, </li><li class="list-inline-item cited-by__entry__author">Deborah Murray, </li><li class="list-inline-item cited-by__entry__author">Monica Murray, </li><li class="list-inline-item cited-by__entry__author">Linda Murray, </li><li class="list-inline-item cited-by__entry__author">David B. Musante, </li><li class="list-inline-item cited-by__entry__author">Sharon Nachman, </li><li class="list-inline-item cited-by__entry__author">Shinya Nagamatsu, </li><li class="list-inline-item cited-by__entry__author">Sherif Naguib, </li><li class="list-inline-item cited-by__entry__author">Jerome G. Naifeh, </li><li class="list-inline-item cited-by__entry__author">S. Hasan Naqvi, </li><li class="list-inline-item cited-by__entry__author">Marshall Nash, </li><li class="list-inline-item cited-by__entry__author">Julio Nasim, </li><li class="list-inline-item cited-by__entry__author">Martha Nason, </li><li class="list-inline-item cited-by__entry__author">Videlis Nduba, </li><li class="list-inline-item cited-by__entry__author">Paul Nee, </li><li class="list-inline-item cited-by__entry__author">Rosa Negron, </li><li class="list-inline-item cited-by__entry__author">Marguerite Neill, </li><li class="list-inline-item cited-by__entry__author">Joy Nelson, </li><li class="list-inline-item cited-by__entry__author">Taylor Nelson, </li><li class="list-inline-item cited-by__entry__author">Tiffany Nemecek, </li><li class="list-inline-item cited-by__entry__author">Lori Nesbitt, </li><li class="list-inline-item cited-by__entry__author">Sonja Neumeister, </li><li class="list-inline-item cited-by__entry__author">Kathleen Neuzil, </li><li class="list-inline-item cited-by__entry__author">Hannah Nevarez, </li><li class="list-inline-item cited-by__entry__author">Joseph L. Newberg, </li><li class="list-inline-item cited-by__entry__author">Lauren Newhouse, </li><li class="list-inline-item cited-by__entry__author">Patrick Newingham, </li><li class="list-inline-item cited-by__entry__author">Fred E. Newton, </li><li class="list-inline-item cited-by__entry__author">Lucy Ng-Price, </li><li class="list-inline-item cited-by__entry__author">Kimberly Nieves, </li><li class="list-inline-item cited-by__entry__author">Chimeremma Nnadi, </li><li class="list-inline-item cited-by__entry__author">Kimberly Nofz, </li><li class="list-inline-item cited-by__entry__author">Nicole L. Nollen, </li><li class="list-inline-item cited-by__entry__author">Asif Noor, </li><li class="list-inline-item cited-by__entry__author">Fernando Noriega, </li><li class="list-inline-item cited-by__entry__author">Richard M. Novak, </li><li class="list-inline-item cited-by__entry__author">Patricia Nahirya Ntege, </li><li class="list-inline-item cited-by__entry__author">Paul J. Nugent, </li><li class="list-inline-item cited-by__entry__author">Claudio NuÃ±ez Lagos, </li><li class="list-inline-item cited-by__entry__author">Cheryl Nuss, </li><li class="list-inline-item cited-by__entry__author">Chelsie Nutsch, </li><li class="list-inline-item cited-by__entry__author">Amesika Nyaku, </li><li class="list-inline-item cited-by__entry__author">Allison O'Brien, </li><li class="list-inline-item cited-by__entry__author">Enrique OcaÃ±a, </li><li class="list-inline-item cited-by__entry__author">Amanda Occhino, </li><li class="list-inline-item cited-by__entry__author">Kimberly Offergeld, </li><li class="list-inline-item cited-by__entry__author">Brenda Okech, </li><li class="list-inline-item cited-by__entry__author">Tracy Okonya, </li><li class="list-inline-item cited-by__entry__author">Jason F. Okulicz, </li><li class="list-inline-item cited-by__entry__author">Oyebisi Olanrewaju, </li><li class="list-inline-item cited-by__entry__author">Shelby Olds, </li><li class="list-inline-item cited-by__entry__author">Marcia O'Leary, </li><li class="list-inline-item cited-by__entry__author">Patrick A. Oliver, </li><li class="list-inline-item cited-by__entry__author">Odette Olivieri, </li><li class="list-inline-item cited-by__entry__author">Jocelyn Zuleica Olmos Vega, </li><li class="list-inline-item cited-by__entry__author">Sarah Omodele, </li><li class="list-inline-item cited-by__entry__author">Allie Oplinger, </li><li class="list-inline-item cited-by__entry__author">Emily Oppenheim, </li><li class="list-inline-item cited-by__entry__author">Yaa D. Oppong, </li><li class="list-inline-item cited-by__entry__author">Jessica Ortega, </li><li class="list-inline-item cited-by__entry__author">Sandra Janeth Ortega DomÃ­nguez, </li><li class="list-inline-item cited-by__entry__author">Maricruz E. OrtegÃ³n, </li><li class="list-inline-item cited-by__entry__author">Masaru Oshita, </li><li class="list-inline-item cited-by__entry__author">Erica Osmundsen, </li><li class="list-inline-item cited-by__entry__author">Jaleh Ostovar, </li><li class="list-inline-item cited-by__entry__author">Quito Osuna&nbsp;Carr, </li><li class="list-inline-item cited-by__entry__author">Maria Otero, </li><li class="list-inline-item cited-by__entry__author">Janet Otto, </li><li class="list-inline-item cited-by__entry__author">Samuel Gurrion Ouma, </li><li class="list-inline-item cited-by__entry__author">Jeffrey S. Overcash, </li><li class="list-inline-item cited-by__entry__author">Temitope Oyedele, </li><li class="list-inline-item cited-by__entry__author">Janet Oyieko, </li><li class="list-inline-item cited-by__entry__author">Janeth Pacheco-Flores, </li><li class="list-inline-item cited-by__entry__author">Carmen A. Paez, </li><li class="list-inline-item cited-by__entry__author">Barbara A. Pahud, </li><li class="list-inline-item cited-by__entry__author">Ruth Paiano, </li><li class="list-inline-item cited-by__entry__author">Rolando Pajon, </li><li class="list-inline-item cited-by__entry__author">Yogesh K. Paliwal, </li><li class="list-inline-item cited-by__entry__author">Amit Paliwal, </li><li class="list-inline-item cited-by__entry__author">Steven Palmer, </li><li class="list-inline-item cited-by__entry__author">David Pampe, </li><li class="list-inline-item cited-by__entry__author">Menelas N. Pangalos, </li><li class="list-inline-item cited-by__entry__author">Lalitha Parameswaran, </li><li class="list-inline-item cited-by__entry__author">Erwin Pardo, </li><li class="list-inline-item cited-by__entry__author">Mercedes Paredes, </li><li class="list-inline-item cited-by__entry__author">Purvi Parikh, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Parker, </li><li class="list-inline-item cited-by__entry__author">Susan Parker, </li><li class="list-inline-item cited-by__entry__author">Kevin Parks, </li><li class="list-inline-item cited-by__entry__author">Reza Parungao, </li><li class="list-inline-item cited-by__entry__author">Alpa Patel, </li><li class="list-inline-item cited-by__entry__author">Priti Patel, </li><li class="list-inline-item cited-by__entry__author">Thomas Patterson, </li><li class="list-inline-item cited-by__entry__author">Jan Patterson, </li><li class="list-inline-item cited-by__entry__author">Walter Patton, </li><li class="list-inline-item cited-by__entry__author">Leena Paul, </li><li class="list-inline-item cited-by__entry__author">Corrina Pavetto, </li><li class="list-inline-item cited-by__entry__author">Juana R. Pavie, </li><li class="list-inline-item cited-by__entry__author">James Peacock, </li><li class="list-inline-item cited-by__entry__author">Michele Peake-Andrasik, </li><li class="list-inline-item cited-by__entry__author">Laura Pearlman, </li><li class="list-inline-item cited-by__entry__author">Alyssa-Kay Peay, </li><li class="list-inline-item cited-by__entry__author">David Pekala, </li><li class="list-inline-item cited-by__entry__author">Alison Pellecchia, </li><li class="list-inline-item cited-by__entry__author">Issac Pena-Renteria, </li><li class="list-inline-item cited-by__entry__author">Penny Peng, </li><li class="list-inline-item cited-by__entry__author">Noris Peraita, </li><li class="list-inline-item cited-by__entry__author">Henry Peralta, </li><li class="list-inline-item cited-by__entry__author">Donna Percy, </li><li class="list-inline-item cited-by__entry__author">Isabel Pereira, </li><li class="list-inline-item cited-by__entry__author">Ashley Perez, </li><li class="list-inline-item cited-by__entry__author">James T. Peterson, </li><li class="list-inline-item cited-by__entry__author">Jennifer Petts, </li><li class="list-inline-item cited-by__entry__author">Taryn Petty, </li><li class="list-inline-item cited-by__entry__author">Mai Pham, </li><li class="list-inline-item cited-by__entry__author">Sharine Phan, </li><li class="list-inline-item cited-by__entry__author">Amanda Philyaw, </li><li class="list-inline-item cited-by__entry__author">Sikhongi Phungwayo, </li><li class="list-inline-item cited-by__entry__author">Judy Pi, </li><li class="list-inline-item cited-by__entry__author">Shelby Pickle, </li><li class="list-inline-item cited-by__entry__author">Paul Pickrell, </li><li class="list-inline-item cited-by__entry__author">Terry Piedra, </li><li class="list-inline-item cited-by__entry__author">Kristen K. Pierce, </li><li class="list-inline-item cited-by__entry__author">Daniela Pineda MÃ©ndez, </li><li class="list-inline-item cited-by__entry__author">Ruth S. Pinilla, </li><li class="list-inline-item cited-by__entry__author">Simmy Pinto, </li><li class="list-inline-item cited-by__entry__author">Rebecca Pitotti, </li><li class="list-inline-item cited-by__entry__author">David Pitrak, </li><li class="list-inline-item cited-by__entry__author">April Pixler, </li><li class="list-inline-item cited-by__entry__author">Stanford Plavin, </li><li class="list-inline-item cited-by__entry__author">Laura Polakowski, </li><li class="list-inline-item cited-by__entry__author">Terry L. Poling, </li><li class="list-inline-item cited-by__entry__author">Philip Ponce, </li><li class="list-inline-item cited-by__entry__author">Laura Porterfield, </li><li class="list-inline-item cited-by__entry__author">Svitlana Postol, </li><li class="list-inline-item cited-by__entry__author">Amy Potts, </li><li class="list-inline-item cited-by__entry__author">Richard Powell, </li><li class="list-inline-item cited-by__entry__author">Margaret Powers-Fletcher, </li><li class="list-inline-item cited-by__entry__author">E. Javier Pretell Alva, </li><li class="list-inline-item cited-by__entry__author">Patty Price-Abbott, </li><li class="list-inline-item cited-by__entry__author">Veronica Procasky, </li><li class="list-inline-item cited-by__entry__author">John Pullman, </li><li class="list-inline-item cited-by__entry__author">Lawrence J. Purpura, </li><li class="list-inline-item cited-by__entry__author">Marie-Laure Py, </li><li class="list-inline-item cited-by__entry__author">Evelyn Quevedo, </li><li class="list-inline-item cited-by__entry__author">Kim Quillin, </li><li class="list-inline-item cited-by__entry__author">Donald Quinn, </li><li class="list-inline-item cited-by__entry__author">Jalima Quintero, </li><li class="list-inline-item cited-by__entry__author">Vanessa Raabe, </li><li class="list-inline-item cited-by__entry__author">Frederick Raiser, </li><li class="list-inline-item cited-by__entry__author">Sabina Raja, </li><li class="list-inline-item cited-by__entry__author">Vivek Rajasekhar, </li><li class="list-inline-item cited-by__entry__author">Danielle Raley, </li><li class="list-inline-item cited-by__entry__author">Mayur Ramesh, </li><li class="list-inline-item cited-by__entry__author">Natalie Ramirez, </li><li class="list-inline-item cited-by__entry__author">Shelly Ramirez, </li><li class="list-inline-item cited-by__entry__author">Wanda Ramon, </li><li class="list-inline-item cited-by__entry__author">James Ramsey, </li><li class="list-inline-item cited-by__entry__author">Bruce G. Rankin, </li><li class="list-inline-item cited-by__entry__author">Heather Rattenbury-Shaw, </li><li class="list-inline-item cited-by__entry__author">Paulina Rebolledo, </li><li class="list-inline-item cited-by__entry__author">Sergio E. Recuenco, </li><li class="list-inline-item cited-by__entry__author">Chinthaparthi Prabhakar Reddy, </li><li class="list-inline-item cited-by__entry__author">Patty Reed, </li><li class="list-inline-item cited-by__entry__author">Maria M. Regalado, </li><li class="list-inline-item cited-by__entry__author">Malina Regalado, </li><li class="list-inline-item cited-by__entry__author">MarÃ­a JosÃ© Reyes Fentanes, </li><li class="list-inline-item cited-by__entry__author">Humberto Reynales, </li><li class="list-inline-item cited-by__entry__author">Michele D. Reynolds, </li><li class="list-inline-item cited-by__entry__author">Trina L. Reynolds, </li><li class="list-inline-item cited-by__entry__author">Michelle Reynolds, </li><li class="list-inline-item cited-by__entry__author">Margaret Rhee, </li><li class="list-inline-item cited-by__entry__author">Tamara Richards, </li><li class="list-inline-item cited-by__entry__author">Sha-Wanda Richmond, </li><li class="list-inline-item cited-by__entry__author">Sharon A. Riddler, </li><li class="list-inline-item cited-by__entry__author">Robert A. Riesenberg, </li><li class="list-inline-item cited-by__entry__author">Dolores Rijos, </li><li class="list-inline-item cited-by__entry__author">Joshua Rindt, </li><li class="list-inline-item cited-by__entry__author">Enrique Rivas, </li><li class="list-inline-item cited-by__entry__author">Juan J. Rivera, </li><li class="list-inline-item cited-by__entry__author">MarÃ­a I. Rivera, </li><li class="list-inline-item cited-by__entry__author">Juana Rivera, </li><li class="list-inline-item cited-by__entry__author">Gina Rivero, </li><li class="list-inline-item cited-by__entry__author">Rafael Rivero, </li><li class="list-inline-item cited-by__entry__author">Zainab Rizvi, </li><li class="list-inline-item cited-by__entry__author">Barbara Rizzardi, </li><li class="list-inline-item cited-by__entry__author">Denise Roadman, </li><li class="list-inline-item cited-by__entry__author">Merlin L. Robb, </li><li class="list-inline-item cited-by__entry__author">Afsoon Roberts, </li><li class="list-inline-item cited-by__entry__author">Toni Robinson, </li><li class="list-inline-item cited-by__entry__author">Dawn Robison, </li><li class="list-inline-item cited-by__entry__author">Elizabeth E. Robison, </li><li class="list-inline-item cited-by__entry__author">Shannon Rodman, </li><li class="list-inline-item cited-by__entry__author">Jessica Rodriguez, </li><li class="list-inline-item cited-by__entry__author">Carina A. Rodriguez, </li><li class="list-inline-item cited-by__entry__author">Edith Rodriguez, </li><li class="list-inline-item cited-by__entry__author">Rachel Rokser, </li><li class="list-inline-item cited-by__entry__author">Charlotte-Paige Rolle, </li><li class="list-inline-item cited-by__entry__author">Stephanie Rolsma, </li><li class="list-inline-item cited-by__entry__author">Peter Ronco, </li><li class="list-inline-item cited-by__entry__author">Melody Ronk, </li><li class="list-inline-item cited-by__entry__author">Adam Rosen, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Rosen, </li><li class="list-inline-item cited-by__entry__author">David Rosenberg, </li><li class="list-inline-item cited-by__entry__author">A. Lina Rosengren, </li><li class="list-inline-item cited-by__entry__author">Christiana A. Rostad, </li><li class="list-inline-item cited-by__entry__author">Joan Rothenberg, </li><li class="list-inline-item cited-by__entry__author">Rambod Rouhbakhsh, </li><li class="list-inline-item cited-by__entry__author">Nadine Rouphael, </li><li class="list-inline-item cited-by__entry__author">Crystal Rowell, </li><li class="list-inline-item cited-by__entry__author">Pavitra Roychoudhury, </li><li class="list-inline-item cited-by__entry__author">Rola G. Rucker, </li><li class="list-inline-item cited-by__entry__author">Monica Ruiz, </li><li class="list-inline-item cited-by__entry__author">Vida Veronica Ruiz Herrera, </li><li class="list-inline-item cited-by__entry__author">Javier Ruiz-GuiÃ±azÃº, </li><li class="list-inline-item cited-by__entry__author">Guillermo M. Ruiz-Palacios, </li><li class="list-inline-item cited-by__entry__author">Karen Ruperto, </li><li class="list-inline-item cited-by__entry__author">Richard Rupp, </li><li class="list-inline-item cited-by__entry__author">Sarah E. Rutstein, </li><li class="list-inline-item cited-by__entry__author">Natasha Rybak, </li><li class="list-inline-item cited-by__entry__author">Martin F. Ryser, </li><li class="list-inline-item cited-by__entry__author">Jerald Sadoff, </li><li class="list-inline-item cited-by__entry__author">Michelle Saemann, </li><li class="list-inline-item cited-by__entry__author">Beth E. Safirstein, </li><li class="list-inline-item cited-by__entry__author">Nafisa Saleem, </li><li class="list-inline-item cited-by__entry__author">Jamshid Saleh, </li><li class="list-inline-item cited-by__entry__author">Mansoor Saleh, </li><li class="list-inline-item cited-by__entry__author">Kacie Sales, </li><li class="list-inline-item cited-by__entry__author">Amy Salzl, </li><li class="list-inline-item cited-by__entry__author">Denise Sample, </li><li class="list-inline-item cited-by__entry__author">Robert Samuels, </li><li class="list-inline-item cited-by__entry__author">Rosario Sanchez, </li><li class="list-inline-item cited-by__entry__author">Martha Sanchez, </li><li class="list-inline-item cited-by__entry__author">Erica Sanchez, </li><li class="list-inline-item cited-by__entry__author">Pedro SÃ¡nchez, </li><li class="list-inline-item cited-by__entry__author">Laura Ruy Sanchez Guerrero, </li><li class="list-inline-item cited-by__entry__author">Nelia Sanchez-Crespo, </li><li class="list-inline-item cited-by__entry__author">John Sanders, </li><li class="list-inline-item cited-by__entry__author">Lisa J. Sanders, </li><li class="list-inline-item cited-by__entry__author">Rica Santiago, </li><li class="list-inline-item cited-by__entry__author">Fredric Santiago, </li><li class="list-inline-item cited-by__entry__author">MarÃ­a E. Santolaya, </li><li class="list-inline-item cited-by__entry__author">Nessryne Sater, </li><li class="list-inline-item cited-by__entry__author">Stephen Savarino, </li><li class="list-inline-item cited-by__entry__author">Fredrick Sawe, </li><li class="list-inline-item cited-by__entry__author">Carolyn Scatamacchia, </li><li class="list-inline-item cited-by__entry__author">Timothy W. Schacker, </li><li class="list-inline-item cited-by__entry__author">Gert Scheper, </li><li class="list-inline-item cited-by__entry__author">Linda M. Schipani, </li><li class="list-inline-item cited-by__entry__author">Christy Schmeck, </li><li class="list-inline-item cited-by__entry__author">Robert Schmidt, </li><li class="list-inline-item cited-by__entry__author">William Schnitz, </li><li class="list-inline-item cited-by__entry__author">Florian SchÃ¶del, </li><li class="list-inline-item cited-by__entry__author">Debra B. Schroeck, </li><li class="list-inline-item cited-by__entry__author">Lode Schuerman, </li><li class="list-inline-item cited-by__entry__author">Hanneke Schuitemaker, </li><li class="list-inline-item cited-by__entry__author">Howard I. Schwartz, </li><li class="list-inline-item cited-by__entry__author">Adam Schwartz, </li><li class="list-inline-item cited-by__entry__author">Howard Schwartz, </li><li class="list-inline-item cited-by__entry__author">Jennifer Schwartz, </li><li class="list-inline-item cited-by__entry__author">Tiffany Schwasinger-Schmidt, </li><li class="list-inline-item cited-by__entry__author">Michael Sciaudone, </li><li class="list-inline-item cited-by__entry__author">Hyman Scott, </li><li class="list-inline-item cited-by__entry__author">Tameika Scott, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Secord, </li><li class="list-inline-item cited-by__entry__author">Nathan Segall, </li><li class="list-inline-item cited-by__entry__author">William Seger, </li><li class="list-inline-item cited-by__entry__author">Shannen Seversen, </li><li class="list-inline-item cited-by__entry__author">Beverly E. Sha, </li><li class="list-inline-item cited-by__entry__author">Mitul Shah, </li><li class="list-inline-item cited-by__entry__author">Jinen Shah, </li><li class="list-inline-item cited-by__entry__author">Samira Shairi, </li><li class="list-inline-item cited-by__entry__author">Shivanjali Shankaran, </li><li class="list-inline-item cited-by__entry__author">Amie Shannon, </li><li class="list-inline-item cited-by__entry__author">Adrienne E. Shapiro, </li><li class="list-inline-item cited-by__entry__author">Stephan C. Sharp, </li><li class="list-inline-item cited-by__entry__author">Marian E. Shaw, </li><li class="list-inline-item cited-by__entry__author">Rozeli Shelly, </li><li class="list-inline-item cited-by__entry__author">Sandra Shelton, </li><li class="list-inline-item cited-by__entry__author">Lawrence Sher, </li><li class="list-inline-item cited-by__entry__author">Amy Sherman, </li><li class="list-inline-item cited-by__entry__author">Neil P. Sheth, </li><li class="list-inline-item cited-by__entry__author">Steven Shinn, </li><li class="list-inline-item cited-by__entry__author">Tammi L. Shlotzhauer, </li><li class="list-inline-item cited-by__entry__author">Kathryn Shoemaker, </li><li class="list-inline-item cited-by__entry__author">Timothy Shope, </li><li class="list-inline-item cited-by__entry__author">Bo Shopsin, </li><li class="list-inline-item cited-by__entry__author">Steven Shoptaw, </li><li class="list-inline-item cited-by__entry__author">Rajeev Shrestha, </li><li class="list-inline-item cited-by__entry__author">Georgi Shukarev, </li><li class="list-inline-item cited-by__entry__author">Farhan Siddiqui, </li><li class="list-inline-item cited-by__entry__author">Marc Siegel, </li><li class="list-inline-item cited-by__entry__author">Silva Sieger, </li><li class="list-inline-item cited-by__entry__author">Dianca Sierra, </li><li class="list-inline-item cited-by__entry__author">Abraham Siika, </li><li class="list-inline-item cited-by__entry__author">William P. Silver, </li><li class="list-inline-item cited-by__entry__author">Todd Simmons, </li><li class="list-inline-item cited-by__entry__author">Gary Simon, </li><li class="list-inline-item cited-by__entry__author">Matthew D. Sims, </li><li class="list-inline-item cited-by__entry__author">Leonard Singer, </li><li class="list-inline-item cited-by__entry__author">Chandramani Singh, </li><li class="list-inline-item cited-by__entry__author">Veer Bahadur Singh, </li><li class="list-inline-item cited-by__entry__author">Justin Singletary, </li><li class="list-inline-item cited-by__entry__author">Nuchra Sirisuphmitr, </li><li class="list-inline-item cited-by__entry__author">Stephanie Skipper, </li><li class="list-inline-item cited-by__entry__author">Stacy Slechta, </li><li class="list-inline-item cited-by__entry__author">Teresa S. Sligh, </li><li class="list-inline-item cited-by__entry__author">William B. Smith, </li><li class="list-inline-item cited-by__entry__author">Mary Smith, </li><li class="list-inline-item cited-by__entry__author">Derek M. Smith, </li><li class="list-inline-item cited-by__entry__author">Michael J. Smith, </li><li class="list-inline-item cited-by__entry__author">Katherine Smith, </li><li class="list-inline-item cited-by__entry__author">Candace Smith, </li><li class="list-inline-item cited-by__entry__author">Kimberly Snell, </li><li class="list-inline-item cited-by__entry__author">M. Mahdee Sobhanie, </li><li class="list-inline-item cited-by__entry__author">Magdalena E. Sobieszczyk, </li><li class="list-inline-item cited-by__entry__author">Obiageli Sogbetun, </li><li class="list-inline-item cited-by__entry__author">Joel Solis, </li><li class="list-inline-item cited-by__entry__author">Cora Sonnier, </li><li class="list-inline-item cited-by__entry__author">Carrie Sopher, </li><li class="list-inline-item cited-by__entry__author">Adriana Sordo Duran, </li><li class="list-inline-item cited-by__entry__author">Brit Sovic, </li><li class="list-inline-item cited-by__entry__author">Stephen A. Spector, </li><li class="list-inline-item cited-by__entry__author">Steven Sperber, </li><li class="list-inline-item cited-by__entry__author">Bart Spiessens, </li><li class="list-inline-item cited-by__entry__author">Stephanie&nbsp; Sproule, </li><li class="list-inline-item cited-by__entry__author">Saranya Sridhar, </li><li class="list-inline-item cited-by__entry__author">Jonathan Staben, </li><li class="list-inline-item cited-by__entry__author">Jessica Stahl, </li><li class="list-inline-item cited-by__entry__author">Amber Stanford, </li><li class="list-inline-item cited-by__entry__author">Lisa Stangl, </li><li class="list-inline-item cited-by__entry__author">Ariana C. Stanton, </li><li class="list-inline-item cited-by__entry__author">Katherine Stapleton, </li><li class="list-inline-item cited-by__entry__author">Jack Stapleton, </li><li class="list-inline-item cited-by__entry__author">Thomas Starkey, </li><li class="list-inline-item cited-by__entry__author">Richard Starlin, </li><li class="list-inline-item cited-by__entry__author">Amy Starr, </li><li class="list-inline-item cited-by__entry__author">Ryan P. Starr, </li><li class="list-inline-item cited-by__entry__author">Kenneth Steil, </li><li class="list-inline-item cited-by__entry__author">Carolene Stephenson, </li><li class="list-inline-item cited-by__entry__author">Kathryn E. Stephenson, </li><li class="list-inline-item cited-by__entry__author">Stephanie Sterling, </li><li class="list-inline-item cited-by__entry__author">Lisa Stevens Rameaka, </li><li class="list-inline-item cited-by__entry__author">Brittany Stewart, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Stoddard, </li><li class="list-inline-item cited-by__entry__author">Robert Striker, </li><li class="list-inline-item cited-by__entry__author">Frank Struyf, </li><li class="list-inline-item cited-by__entry__author">Suzanna Studdard, </li><li class="list-inline-item cited-by__entry__author">Laura Stulken, </li><li class="list-inline-item cited-by__entry__author">Mildred Stull, </li><li class="list-inline-item cited-by__entry__author">Rodney E. Sturgeon, </li><li class="list-inline-item cited-by__entry__author">May-Yin Suen, </li><li class="list-inline-item cited-by__entry__author">Danny Sugimoto, </li><li class="list-inline-item cited-by__entry__author">Amit Suresh&nbsp;Bhate, </li><li class="list-inline-item cited-by__entry__author">Janice Suyehira, </li><li class="list-inline-item cited-by__entry__author">Kazuo Suzuki, </li><li class="list-inline-item cited-by__entry__author">Shobha Swaminathan, </li><li class="list-inline-item cited-by__entry__author">Suzanne Swan, </li><li class="list-inline-item cited-by__entry__author">Edith Swann, </li><li class="list-inline-item cited-by__entry__author">Austin Swanson, </li><li class="list-inline-item cited-by__entry__author">Christy Sweet, </li><li class="list-inline-item cited-by__entry__author">Elisa Swieboda, </li><li class="list-inline-item cited-by__entry__author">Scott N. Syndergaard, </li><li class="list-inline-item cited-by__entry__author">Karla Beatriz Tafur Bances, </li><li class="list-inline-item cited-by__entry__author">Therese Takas, </li><li class="list-inline-item cited-by__entry__author">Zudi-Mwak Takizala, </li><li class="list-inline-item cited-by__entry__author">Simbarashe G. Takuva, </li><li class="list-inline-item cited-by__entry__author">Kawsar R. Talaat, </li><li class="list-inline-item cited-by__entry__author">Dipesh Tamrakar, </li><li class="list-inline-item cited-by__entry__author">Chen S. Tan, </li><li class="list-inline-item cited-by__entry__author">Cayce Tangemen, </li><li class="list-inline-item cited-by__entry__author">Tamzin Tanner, </li><li class="list-inline-item cited-by__entry__author">Milagritos Tapia, </li><li class="list-inline-item cited-by__entry__author">Denis Tarakjian, </li><li class="list-inline-item cited-by__entry__author">Karen Tashima, </li><li class="list-inline-item cited-by__entry__author">David Tatelbaum, </li><li class="list-inline-item cited-by__entry__author">Fernanda Tavares Da-Silva, </li><li class="list-inline-item cited-by__entry__author">Edward M. Tavel, </li><li class="list-inline-item cited-by__entry__author">Kimberly L. Taylor, </li><li class="list-inline-item cited-by__entry__author">Brandie Taylor, </li><li class="list-inline-item cited-by__entry__author">Barbara S. Taylor, </li><li class="list-inline-item cited-by__entry__author">David Taylor, </li><li class="list-inline-item cited-by__entry__author">Sharita Tedder-Edwards, </li><li class="list-inline-item cited-by__entry__author">Meghan Teherani, </li><li class="list-inline-item cited-by__entry__author">Leslie Tharenos, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Thessing, </li><li class="list-inline-item cited-by__entry__author">Meagan Thomas, </li><li class="list-inline-item cited-by__entry__author">LaTeshia Thomas-Seaton, </li><li class="list-inline-item cited-by__entry__author">Amy Thompson, </li><li class="list-inline-item cited-by__entry__author">Karl M. Thompson, </li><li class="list-inline-item cited-by__entry__author">Teri Thompson-Seim, </li><li class="list-inline-item cited-by__entry__author">Isaac Thomsen, </li><li class="list-inline-item cited-by__entry__author">Hong V Tieu, </li><li class="list-inline-item cited-by__entry__author">Lucas Otieno Tina, </li><li class="list-inline-item cited-by__entry__author">Ramy J. Toma, </li><li class="list-inline-item cited-by__entry__author">Joanne E. Tomassini, </li><li class="list-inline-item cited-by__entry__author">Christian Tomaszewski, </li><li class="list-inline-item cited-by__entry__author">Lee Tomatsu, </li><li class="list-inline-item cited-by__entry__author">Ryan Tomlinson, </li><li class="list-inline-item cited-by__entry__author">Xiaomi Tong, </li><li class="list-inline-item cited-by__entry__author">Tina Tong, </li><li class="list-inline-item cited-by__entry__author">Juan P. Torres, </li><li class="list-inline-item cited-by__entry__author">Julian A. Torres, </li><li class="list-inline-item cited-by__entry__author">Dalia Tovar, </li><li class="list-inline-item cited-by__entry__author">Carolyn Tran, </li><li class="list-inline-item cited-by__entry__author">John J. Treanor, </li><li class="list-inline-item cited-by__entry__author">Carla Truyers, </li><li class="list-inline-item cited-by__entry__author">Sade Tukuru, </li><li class="list-inline-item cited-by__entry__author">Christine B. Turley, </li><li class="list-inline-item cited-by__entry__author">Mark A. Turner, </li><li class="list-inline-item cited-by__entry__author">Stefanie Tyson, </li><li class="list-inline-item cited-by__entry__author">Akiyoshi Uchiyama, </li><li class="list-inline-item cited-by__entry__author">Robert J. Ulrich, </li><li class="list-inline-item cited-by__entry__author">Lisa S. Usdan, </li><li class="list-inline-item cited-by__entry__author">Gregory C. Utz, </li><li class="list-inline-item cited-by__entry__author">Timothy P. Vachris, </li><li class="list-inline-item cited-by__entry__author">Bruno Valenti, </li><li class="list-inline-item cited-by__entry__author">Insiya Valika, </li><li class="list-inline-item cited-by__entry__author">Mimi Van Der Leden, </li><li class="list-inline-item cited-by__entry__author">Ilse Van Dromme, </li><li class="list-inline-item cited-by__entry__author">Wesley Van Ever, </li><li class="list-inline-item cited-by__entry__author">Johan Van Hoof, </li><li class="list-inline-item cited-by__entry__author">Griet Van Roey, </li><li class="list-inline-item cited-by__entry__author">An Vandebosch, </li><li class="list-inline-item cited-by__entry__author">Sergio L. Vargas, </li><li class="list-inline-item cited-by__entry__author">Tilly Varughese, </li><li class="list-inline-item cited-by__entry__author">Eduardo Gabriel VÃ¡zquez SaldaÃ±a, </li><li class="list-inline-item cited-by__entry__author">Norma Vega, </li><li class="list-inline-item cited-by__entry__author">Karen Sofia Vega Orozco, </li><li class="list-inline-item cited-by__entry__author">Diana Vegas, </li><li class="list-inline-item cited-by__entry__author">Hector Velasquez, </li><li class="list-inline-item cited-by__entry__author">Michele Vertucci, </li><li class="list-inline-item cited-by__entry__author">Veronica Viar, </li><li class="list-inline-item cited-by__entry__author">Roberto A. Viau Colindres, </li><li class="list-inline-item cited-by__entry__author">Nicholas A. Viens, </li><li class="list-inline-item cited-by__entry__author">Tonya Villafana, </li><li class="list-inline-item cited-by__entry__author">Sandra M. VillagÃ³mez MartÃ­nez, </li><li class="list-inline-item cited-by__entry__author">Marysol Villegas, </li><li class="list-inline-item cited-by__entry__author">Johan Vingerhoets, </li><li class="list-inline-item cited-by__entry__author">Mary Vogler, </li><li class="list-inline-item cited-by__entry__author">Mandy Vowell, </li><li class="list-inline-item cited-by__entry__author">Keith W. Vrbicky, </li><li class="list-inline-item cited-by__entry__author">Deo Wabwire, </li><li class="list-inline-item cited-by__entry__author">Larkin T. Wadsworth, </li><li class="list-inline-item cited-by__entry__author">Tami Wahlin, </li><li class="list-inline-item cited-by__entry__author">Anne Wajja, </li><li class="list-inline-item cited-by__entry__author">Paul H. Wakefield, </li><li class="list-inline-item cited-by__entry__author">Anna Wald, </li><li class="list-inline-item cited-by__entry__author">Shannon Walker, </li><li class="list-inline-item cited-by__entry__author">James Walker, </li><li class="list-inline-item cited-by__entry__author">Stephen R. Walsh, </li><li class="list-inline-item cited-by__entry__author">Edward E. Walsh, </li><li class="list-inline-item cited-by__entry__author">Mary C. Walsh, </li><li class="list-inline-item cited-by__entry__author">Emmanuel B. Walter, </li><li class="list-inline-item cited-by__entry__author">Ayanna Walters, </li><li class="list-inline-item cited-by__entry__author">Tina Wang, </li><li class="list-inline-item cited-by__entry__author">Ashley Warden, </li><li class="list-inline-item cited-by__entry__author">T. Anh Wartel, </li><li class="list-inline-item cited-by__entry__author">Michael Waters, </li><li class="list-inline-item cited-by__entry__author">Breanz Watkins, </li><li class="list-inline-item cited-by__entry__author">Angella Webb, </li><li class="list-inline-item cited-by__entry__author">Hala Webster, </li><li class="list-inline-item cited-by__entry__author">Jessica L. Weidler, </li><li class="list-inline-item cited-by__entry__author">Thomas Weiss, </li><li class="list-inline-item cited-by__entry__author">Margaret Wells, </li><li class="list-inline-item cited-by__entry__author">Andrea Wendrow, </li><li class="list-inline-item cited-by__entry__author">Melody Werne, </li><li class="list-inline-item cited-by__entry__author">Whitney West, </li><li class="list-inline-item cited-by__entry__author">Jordan L. Whatley, </li><li class="list-inline-item cited-by__entry__author">Jennifer A. Whitaker, </li><li class="list-inline-item cited-by__entry__author">Julie White, </li><li class="list-inline-item cited-by__entry__author">Jewel J. White, </li><li class="list-inline-item cited-by__entry__author">Toni White, </li><li class="list-inline-item cited-by__entry__author">Priyantha N. Wijewardane, </li><li class="list-inline-item cited-by__entry__author">Timothy Wilkin, </li><li class="list-inline-item cited-by__entry__author">Bethanie Wilkinson, </li><li class="list-inline-item cited-by__entry__author">Samantha Williams, </li><li class="list-inline-item cited-by__entry__author">Barton G. Williams, </li><li class="list-inline-item cited-by__entry__author">Hayes Williams, </li><li class="list-inline-item cited-by__entry__author">Greg Wilson, </li><li class="list-inline-item cited-by__entry__author">Christine Wilson, </li><li class="list-inline-item cited-by__entry__author">Natasha Wilson, </li><li class="list-inline-item cited-by__entry__author">Clint Wilson, </li><li class="list-inline-item cited-by__entry__author">Jennifer Winbigler, </li><li class="list-inline-item cited-by__entry__author">Peter J. Winkle, </li><li class="list-inline-item cited-by__entry__author">Patricia L. Winokur, </li><li class="list-inline-item cited-by__entry__author">John Witbeck, </li><li class="list-inline-item cited-by__entry__author">David Wohl, </li><li class="list-inline-item cited-by__entry__author">Wayne Woo, </li><li class="list-inline-item cited-by__entry__author">Leana Woodside, </li><li class="list-inline-item cited-by__entry__author">Glenn Wortman, </li><li class="list-inline-item cited-by__entry__author">Yi H. Wu, </li><li class="list-inline-item cited-by__entry__author">Paul E. Wylie, </li><li class="list-inline-item cited-by__entry__author">Kinara S. Yang, </li><li class="list-inline-item cited-by__entry__author">Fan Yang, </li><li class="list-inline-item cited-by__entry__author">Anelgine C. Yoon, </li><li class="list-inline-item cited-by__entry__author">Jill York, </li><li class="list-inline-item cited-by__entry__author">Cheryl Young, </li><li class="list-inline-item cited-by__entry__author">Juan Luis Yrivarren Giorza, </li><li class="list-inline-item cited-by__entry__author">Joseph Yusin, </li><li class="list-inline-item cited-by__entry__author">Luz Zapata, </li><li class="list-inline-item cited-by__entry__author">Zindy YazmÃ­n ZÃ¡rate Hinojosa, </li><li class="list-inline-item cited-by__entry__author">Rebecca Zash, </li><li class="list-inline-item cited-by__entry__author">Elodie Zaworski, </li><li class="list-inline-item cited-by__entry__author">Arthur L. Zemanek, </li><li class="list-inline-item cited-by__entry__author">Kate Zenlea, </li><li class="list-inline-item cited-by__entry__author">Karla Zepeda, </li><li class="list-inline-item cited-by__entry__author">Marcus J. Zervos, </li><li class="list-inline-item cited-by__entry__author">Nan Zhai, </li><li class="list-inline-item cited-by__entry__author">Kevin Zhang, </li><li class="list-inline-item cited-by__entry__author">Nianxian Zhang, </li><li class="list-inline-item cited-by__entry__author">Honghong Zhou, </li><li class="list-inline-item cited-by__entry__author">James Zhou, </li><li class="list-inline-item cited-by__entry__author">Andrea Zimmer, </li><li class="list-inline-item cited-by__entry__author">Barry S. Zingman, </li><li class="list-inline-item cited-by__entry__author">Carmen D. Zorrilla, </li></ul><span class="cited-by__entry__title">Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data, </span><span class="cited-by__entry__series-title">JAMA Network Open, </span><span class="cited-by__entry__volume"><strong>8</strong>, </span><span class="cited-by__entry__issue">5, </span><span class="cited-by__entry__page-range">(e2512763), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1001/jamanetworkopen.2025.12763" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1001/jamanetworkopen.2025.12763</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1001/jamanetworkopen.2025.12763" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Tobias Monschein, </li><li class="list-inline-item cited-by__entry__author">Tobias Zrzavy, </li><li class="list-inline-item cited-by__entry__author">Paulus S. Rommer, </li><li class="list-inline-item cited-by__entry__author">Sven G. Meuth, </li><li class="list-inline-item cited-by__entry__author">Andrew Chan, </li><li class="list-inline-item cited-by__entry__author">Thomas Berger, </li><li class="list-inline-item cited-by__entry__author">Hans-Peter Hartung, </li></ul><span class="cited-by__entry__title">SARS-CoV-2 Vaccines and Multiple Sclerosis, </span><span class="cited-by__entry__series-title">Neurology Neuroimmunology &amp; Neuroinflammation, </span><span class="cited-by__entry__volume"><strong>12</strong>, </span><span class="cited-by__entry__issue">3, </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1212/NXI.0000000000200393" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1212/NXI.0000000000200393</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1212/NXI.0000000000200393" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Meagan E Deming, </li><li class="list-inline-item cited-by__entry__author">Elizabeth R Brown, </li><li class="list-inline-item cited-by__entry__author">Monica A McArthur, </li><li class="list-inline-item cited-by__entry__author">Stephanie J Schrag, </li><li class="list-inline-item cited-by__entry__author">Melissa Arvay, </li><li class="list-inline-item cited-by__entry__author">Mike Humphrys, </li><li class="list-inline-item cited-by__entry__author">Jacques Ravel, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Adelglass, </li><li class="list-inline-item cited-by__entry__author">Brandon Essink, </li><li class="list-inline-item cited-by__entry__author">David B Musante, </li><li class="list-inline-item cited-by__entry__author">Rebecca Maguire, </li><li class="list-inline-item cited-by__entry__author">Richard Gorman, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Formentini, </li><li class="list-inline-item cited-by__entry__author">Robin Mason, </li><li class="list-inline-item cited-by__entry__author">Merlin L Robb, </li><li class="list-inline-item cited-by__entry__author">Kathleen M Neuzil, </li><li class="list-inline-item cited-by__entry__author">Rekha R Rapaka, </li><li class="list-inline-item cited-by__entry__author">Peter Wolff, </li><li class="list-inline-item cited-by__entry__author">Karen L Kotloff, </li><li class="list-inline-item cited-by__entry__author">Meagan E. Deming, </li><li class="list-inline-item cited-by__entry__author">Elizabeth R. Brown, </li><li class="list-inline-item cited-by__entry__author">Monica A. McArthur, </li><li class="list-inline-item cited-by__entry__author">Stephanie J. Schrag, </li><li class="list-inline-item cited-by__entry__author">Melissa Arvay, </li><li class="list-inline-item cited-by__entry__author">Mike Humphrys, </li><li class="list-inline-item cited-by__entry__author">Jacques Ravel, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Adelglass, </li><li class="list-inline-item cited-by__entry__author">Brandon Essink, </li><li class="list-inline-item cited-by__entry__author">David Musante, </li><li class="list-inline-item cited-by__entry__author">Rebecca Maguire, </li><li class="list-inline-item cited-by__entry__author">Richard Gorman, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Formentini, </li><li class="list-inline-item cited-by__entry__author">Robin Mason, </li><li class="list-inline-item cited-by__entry__author">Merlin L. Robb, </li><li class="list-inline-item cited-by__entry__author">Kathleen M. Neuzil, </li><li class="list-inline-item cited-by__entry__author">Rekha Repaka, </li><li class="list-inline-item cited-by__entry__author">Peter Wolff, </li><li class="list-inline-item cited-by__entry__author">Karen L. Kotloff, </li><li class="list-inline-item cited-by__entry__author">Ronald Ackerman, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Barranco-Santana, </li><li class="list-inline-item cited-by__entry__author">Laurence Chu, </li><li class="list-inline-item cited-by__entry__author">Stuart H. Cohen, </li><li class="list-inline-item cited-by__entry__author">Wendy Daly, </li><li class="list-inline-item cited-by__entry__author">Kenneth Etokhana, </li><li class="list-inline-item cited-by__entry__author">Cynthia Gay, </li><li class="list-inline-item cited-by__entry__author">Greg Hachigian, </li><li class="list-inline-item cited-by__entry__author">Robert Jeanfreau, </li><li class="list-inline-item cited-by__entry__author">Vicki E. Miller, </li><li class="list-inline-item cited-by__entry__author">William Seger, </li><li class="list-inline-item cited-by__entry__author">Joanna Sexter, </li><li class="list-inline-item cited-by__entry__author">Marian E. Shaw, </li><li class="list-inline-item cited-by__entry__author">Kenneth Steil, </li><li class="list-inline-item cited-by__entry__author">Christine B. Turley, </li><li class="list-inline-item cited-by__entry__author">Michael Waters, </li></ul><span class="cited-by__entry__title">Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo-controlled trial, </span><span class="cited-by__entry__series-title">The Lancet Microbe, </span><span class="cited-by__entry__volume"><strong>6</strong>, </span><span class="cited-by__entry__issue">4, </span><span class="cited-by__entry__page-range">(100984), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.lanmic.2024.100984" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.lanmic.2024.100984</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.lanmic.2024.100984" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Shuwen Luo, </li><li class="list-inline-item cited-by__entry__author">Lihong Yin, </li><li class="list-inline-item cited-by__entry__author">Xiaohui Liu, </li><li class="list-inline-item cited-by__entry__author">Xuemei Wang, </li></ul><span class="cited-by__entry__title">Advances in Virus Biorecognition and Detection Techniques for the Surveillance and Prevention of Infectious Diseases, </span><span class="cited-by__entry__series-title">Biosensors, </span><span class="cited-by__entry__volume"><strong>15</strong>, </span><span class="cited-by__entry__issue">3, </span><span class="cited-by__entry__page-range">(198), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.3390/bios15030198" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.3390/bios15030198</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.3390/bios15030198" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Lingling Hong, </li><li class="list-inline-item cited-by__entry__author">Jiashun Li, </li><li class="list-inline-item cited-by__entry__author">Weikai Zeng, </li><li class="list-inline-item cited-by__entry__author">Yuhua Li, </li><li class="list-inline-item cited-by__entry__author">Changfa Yu, </li><li class="list-inline-item cited-by__entry__author">Shutao Zhao, </li><li class="list-inline-item cited-by__entry__author">Ling Chen, </li><li class="list-inline-item cited-by__entry__author">Ying Feng, </li></ul><span class="cited-by__entry__title">
              The seroprevalence of adenoviruses since 2000
              1
               , </span><span class="cited-by__entry__series-title">Emerging Microbes &amp; Infections, </span><span class="cited-by__entry__volume"><strong>14</strong>, </span><span class="cited-by__entry__issue">1, </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1080/22221751.2025.2475831" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1080/22221751.2025.2475831</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1080/22221751.2025.2475831" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Adam J. Schieferecke, </li><li class="list-inline-item cited-by__entry__author">Nadia Kuxhausen Ralph, </li><li class="list-inline-item cited-by__entry__author">David V. Schaffer, </li></ul><span class="cited-by__entry__title">The Application of DNA Viruses to Biotechnology, </span><span class="cited-by__entry__series-title">Viruses, </span><span class="cited-by__entry__volume"><strong>17</strong>, </span><span class="cited-by__entry__issue">3, </span><span class="cited-by__entry__page-range">(414), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.3390/v17030414" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.3390/v17030414</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.3390/v17030414" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Fei Heng, </li><li class="list-inline-item cited-by__entry__author">Yanqing Sun, </li><li class="list-inline-item cited-by__entry__author">Li Li, </li><li class="list-inline-item cited-by__entry__author">Peter B. Gilbert, </li></ul><span class="cited-by__entry__title">Estimation and Hypothesis Testing of StrainâSpecific Vaccine Efficacy With Missing Strain Types With Application to a COVIDâ19 Vaccine Trial, </span><span class="cited-by__entry__series-title">Statistics in Medicine, </span><span class="cited-by__entry__volume"><strong>44</strong>, </span><span class="cited-by__entry__issue">6, </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1002/sim.10345" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1002/sim.10345</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1002/sim.10345" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Ankita Saha, </li><li class="list-inline-item cited-by__entry__author">Shweta Choudhary, </li><li class="list-inline-item cited-by__entry__author">Priyanshu Walia, </li><li class="list-inline-item cited-by__entry__author">Pravindra Kumar, </li><li class="list-inline-item cited-by__entry__author">Shailly Tomar, </li></ul><span class="cited-by__entry__title">Transformative approaches in SARS-CoV-2 management: Vaccines, therapeutics and future direction, </span><span class="cited-by__entry__series-title">Virology, </span><span class="cited-by__entry__volume"><strong>604</strong>, </span><span class="cited-by__entry__page-range">(110394), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.virol.2025.110394" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.virol.2025.110394</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.virol.2025.110394" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Ismail Cem Yilmaz, </li><li class="list-inline-item cited-by__entry__author">Emre Mert Ipekoglu, </li><li class="list-inline-item cited-by__entry__author">Berfu Saraydar Golcuklu, </li><li class="list-inline-item cited-by__entry__author">Tugce Bildik, </li><li class="list-inline-item cited-by__entry__author">AslÄ± Gulce Bartan Aksoy, </li><li class="list-inline-item cited-by__entry__author">Irem Evcili, </li><li class="list-inline-item cited-by__entry__author">Nilsu Turay, </li><li class="list-inline-item cited-by__entry__author">Naz Surucu, </li><li class="list-inline-item cited-by__entry__author">Artun Bulbul, </li><li class="list-inline-item cited-by__entry__author">Nese Guvencli, </li><li class="list-inline-item cited-by__entry__author">Muzaffer Yildirim, </li><li class="list-inline-item cited-by__entry__author">Tugce Canavar Yildirim, </li><li class="list-inline-item cited-by__entry__author">Yagmur Aydin Atalay, </li><li class="list-inline-item cited-by__entry__author">Irem Abras, </li><li class="list-inline-item cited-by__entry__author">Yasemin Ceylan, </li><li class="list-inline-item cited-by__entry__author">Yasemin Ozsurekci, </li><li class="list-inline-item cited-by__entry__author">Elif Tukenmez Tigen, </li><li class="list-inline-item cited-by__entry__author">Volkan Korten, </li><li class="list-inline-item cited-by__entry__author">Mayda Gursel, </li><li class="list-inline-item cited-by__entry__author">Ihsan Gursel, </li></ul><span class="cited-by__entry__title">A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccine, </span><span class="cited-by__entry__series-title">Vaccine, </span><span class="cited-by__entry__volume"><strong>49</strong>, </span><span class="cited-by__entry__page-range">(126787), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.vaccine.2025.126787" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.vaccine.2025.126787</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.vaccine.2025.126787" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry--see-more"><a href="javascript:void(0)" data-source="/pb/widgets/citedBy?page=1&amp;widgetId=efb4df9a-8e1a-47f9-bfb7-271959277a9f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Anejm%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3Adoi%5C%3A10.1056%2FNEJMoa2117608%3Bwgroup%3Astring%3AMMS+NextGen+Website+Group%3Bissue%3Aissue%3Adoi%5C%3A10.1056%2Fnejm_2022.386.issue-9%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bwebsite%3Awebsite%3Amms-site%3Bjournal%3Ajournal%3Anejms" class="cited-by__see-more">See more</a></li></ol></div><div class="cited-by__spinner justify-content-center align-items-center d-none"><div role="status" class="spinner-border text-gray"><span class="sr-only">Loading...</span></div></div></div></section>

        </div>
    

</section></section></div><div id="core-collateral-fulltext-options" role="tabpanel" data-core-tabs="core-collateral-fulltext-options" tabindex="-1" aria-labelledby="pane-core-collateral-fulltext-options"><header><h2 id="pane-core-collateral-fulltext-options"><i class="icon-eye" aria-hidden="true"></i>View Options</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div class="section--wrapper"><h3>View options</h3><section class="format--pdf"><h4> <abbr title="Portable Document Format">PDF</abbr></h4><a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa2117608" class="btn btn--pdf" aria-label="View PDF" data-behavior="trackDownloadEvent" data-doi="10.1056/NEJMoa2117608" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2117608.pdf"><i aria-hidden="true" class="icon-pdf"></i><span>View PDF</span></a></section></div><!-- Its needed to duplicate this for PB check Collateral.js as well--></div><div id="core-collateral-media" role="tabpanel" data-core-tabs="core-collateral-media" tabindex="-1" aria-labelledby="pane-core-collateral-media"><header><h2 id="pane-core-collateral-media"><i class="icon-photo" aria-hidden="true"></i>Media</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-figures" role="tab" id="tab-figures-label" aria-selected="true" class="active">Figures</button><button aria-controls="tab-other" role="tab" id="tab-other-label" tabindex="-1" aria-selected="false" class="inactive" aria-disabled="true">Other</button></div><section id="tab-figures" aria-labelledby="tab-figures-label" role="tabpanel" tabindex="0"><h3>Figures</h3><div class="text-right"><a class="btn btn--inverse  open-in-viewer" href="#figures"><span>Open all in viewer</span><i class="icon-open_in_new" aria-hidden="true"></i></a></div><div id="core-f1"><figure class="graphic"><a class="open-in-viewer" href="#f1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f1.jpg"><img src="/cms/10.1056/NEJMoa2117608/asset/2a351918-67a8-4aaa-b189-a3113a0fef95/assets/images/large/nejmoa2117608_f1.jpg" height="2556" width="2640" aria-labelledby="f1" loading="lazy"></a><figcaption><div class="caption">Cases of Covid-19 According to SARS-CoV-2 Lineage (Full Analysis Population).</div><div class="notes"><div role="doc-footnote">The distribution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages among cases of coronavirus disease 2019 (Covid-19) is shown for each country in the trial over time during the double-blind phase of the trial. The reference sequence is defined as the SARS-CoV-2 Wuhan-Hu-1 sequence but with the D614G amino acid variation. At the time of the trial, sequences categorized as âotherâ were those with substitutions not resulting in another SARS-CoV-2 lineage or variant. âOther+E484Kâ refers to sequences with E484K but no other substitutions resulting in another SARS-CoV-2 lineage or variant. Next-generation sequencing was performed with the use of the Swift Biosciences SNAP Assay, version 2. Amino acid variants are defined as changes from the reference sequence. The last available visit date across countries was July 1 through 9, 2021, and the last available date of onset for a primary end-point case was June 26 (Argentina), March 24 (Brazil), April 22 (Chile), June 23 (Colombia), May 27 (Mexico), July 1 (Peru), July 5 (South Africa), and April 16 (United States). None of the cases were caused by the eta, kappa, theta, or C.36.3 variant. The alpha, beta, gamma, and delta variants were variants of concern according to World Health Organization definitions at the time of the analysis.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f1"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f1" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f1.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f2"><figure class="graphic"><a class="open-in-viewer" href="#f2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f2.jpg"><img src="/cms/10.1056/NEJMoa2117608/asset/265bbfd3-9d04-45e3-999e-edd40e9251fd/assets/images/large/nejmoa2117608_f2.jpg" height="2659" width="2640" aria-labelledby="f2" loading="lazy"></a><figcaption><div class="caption">Cumulative Incidence of Moderate to SevereâCritical Covid-19 and Vaccine Efficacy over Time (Per-Protocol Population).</div><div class="notes"><div role="doc-footnote">Panel A shows the KaplanâMeier cumulative incidence of molecularly confirmed moderate to severeâcritical Covid-19 with onset at least 1 day after administration of vaccine or placebo. Shading indicates the 95% confidence interval. Panel B shows vaccine efficacy against moderate to severeâcritical Covid-19 over time; dark gray shading indicates the 95% pointwise confidence interval, and light gray shading the 95% simultaneous confidence interval. The graph includes 95% of the events that occurred before day 189, with the hazard smoothed over 21 days. Participants were seronegative at baseline, as determined by reverse-transcriptaseâpolymerase-chain-reaction (RT-PCR) and serologic tests.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f2"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f2" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f2.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f3"><figure class="graphic"><a class="open-in-viewer" href="#f3" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f3.jpg"><img src="/cms/10.1056/NEJMoa2117608/asset/8dc13911-fa0b-4a22-9c69-fd33169ea821/assets/images/large/nejmoa2117608_f3.jpg" height="3148" width="2640" aria-labelledby="f3" loading="lazy"></a><figcaption><div class="caption">Vaccine Efficacy against Moderate to SevereâCritical Covid-19 According to SARS-CoV-2 Lineage (Per-Protocol Population).</div><div class="notes"><div role="doc-footnote">Shown is vaccine efficacy against moderate to severeâcritical Covid-19 with onset at least 14 days after administration (Panel A) and at least 28 days after administration (Panel B). SARS-CoV-2 in the category of âLineages other than the reference strainâ were all variants of concern or interest, with âotherâ sequences excluded. At the time of the trial, sequences categorized as âotherâ were those with substitutions not resulting in another SARS-CoV-2 lineage or variant. âOther+E484Kâ refers to sequences with E484K but no other substitutions resulting in another SARS-CoV-2 lineage or variant. Vaccine efficacy was not calculated if fewer than 6 cases were observed for an end point. Confidence intervals have not been adjusted for multiplicity and should not be used to infer statistical significance.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f3"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f3" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f3.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f4"><figure class="graphic"><a class="open-in-viewer" href="#f4" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f4.jpg"><img src="/cms/10.1056/NEJMoa2117608/asset/9ae468ee-5f05-4f1e-8a57-2947f1f3dc0b/assets/images/large/nejmoa2117608_f4.jpg" height="2737" width="2640" aria-labelledby="f4" loading="lazy"></a><figcaption><div class="caption">Cumulative Incidence of SevereâCritical Covid-19 and Vaccine Efficacy over Time (Per-Protocol Population).</div><div class="notes"><div role="doc-footnote">Panel A shows the KaplanâMeier cumulative incidence of molecularly confirmed severeâcritical Covid-19 with onset at least 1 day after administration of vaccine or placebo. Shading indicates the 95% confidence interval. Panel B shows vaccine efficacy against severeâcritical Covid-19 over time; dark gray shading indicates the 95% pointwise confidence interval, and light gray shading the 95% simultaneous confidence interval. The graph includes 95% of the events that occurred before day 189, with the hazard smoothed over 21 days. Participants were seronegative at baseline, as determined by RT-PCR and serologic tests.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f4"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f4" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f4.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div></section><section id="tab-other" aria-labelledby="tab-other-label" role="tabpanel" tabindex="-1"><h3>Other</h3></section></div><div id="core-collateral-tables" role="tabpanel" data-core-tabs="core-collateral-tables" tabindex="-1" aria-labelledby="pane-core-collateral-tables"><header><h2 id="pane-core-collateral-tables"><i class="icon-tables" aria-hidden="true"></i>Tables</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><!-- There is no content. --><div class="section--wrapper"><div class="text-right"><a class="btn btn--inverse  open-in-viewer" href="#tables"><span>Open all in viewer</span><i class="icon-open_in_new" aria-hidden="true"></i></a></div><div id="core-t1"><figure class="table"><a class="open-in-viewer" href="#t1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2117608_t1.jpg"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><img src="/cms/10.1056/NEJMoa2117608/asset/59220ea1-bb1a-4ce8-a3c7-c549dbbc3aec/assets/images/large/nejmoa2117608_t1.jpg" height="2505" width="2615" loading="lazy"></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">End Point</th><th class="txxx-borders" colspan="5"><span>â¥14 Days after Administration<a href="#core-t1fn2" role="doc-noteref">â </a></span></th><th class="txxr-borders" colspan="5"><span>â¥28 Days after Administration<a href="#core-t1fn3" role="doc-noteref">â¡</a></span></th></tr><tr class="head2" data-type="row head2"><td class="xxlx-borders">&nbsp;</td><th class="xxxx-borders" colspan="2"><span>Ad26.COV2.S<br>(N=19,400)</span></th><th class="xxxx-borders" colspan="2"><span>Placebo<br>(N=19,398)</span></th><th class="xxxx-borders">Vaccine Efficacy (95% CI)</th><th class="xxxx-borders" colspan="2"><span>Ad26.COV2.S<br>(N=19,113)</span></th><th class="xxxx-borders" colspan="2"><span>Placebo<br>(N=18,924)</span></th><th class="xxxr-borders">Vaccine Efficacy (95% CI)</th></tr><tr class="head3" data-type="row head3"><td class="xxlx-borders hanging02">&nbsp;</td><th class="xxxx-borders">no. of cases</th><th class="xxxx-borders">person-yr</th><th class="xxxx-borders">no. of cases</th><th class="xxxx-borders">person-yr</th><th class="xxxx-borders">%</th><th class="xxxx-borders">no. of cases</th><th class="xxxx-borders">person-yr</th><th class="xxxx-borders">no. of cases</th><th class="xxxx-borders">person-yr</th><th class="xxxr-borders">%</th></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Moderate to severeâcritical Covid-19<a href="#core-t1fn4" role="doc-noteref">Â§</a></td><td class="xxxx-borders shading">484</td><td class="xxxx-borders shading">6685.6</td><td class="xxxx-borders shading">1067</td><td class="xxxx-borders shading">6440.2</td><td class="xxxx-borders shading">56.3 (51.3 to 60.8)</td><td class="xxxx-borders shading">433</td><td class="xxxx-borders shading">6658.4</td><td class="xxxx-borders shading">883</td><td class="xxxx-borders shading">6400.4</td><td class="xxxr-borders shading">52.9 (47.1 to 58.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">18â59 yr</td><td class="xxxx-borders">381</td><td class="xxxx-borders">4682.1</td><td class="xxxx-borders">847</td><td class="xxxx-borders">4514.2</td><td class="xxxx-borders">56.6 (51.0 to 61.7)</td><td class="xxxx-borders">340</td><td class="xxxx-borders">4663.8</td><td class="xxxx-borders">716</td><td class="xxxx-borders">4486.7</td><td class="xxxr-borders">54.3 (48.0 to 60.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">â¥60 yr</td><td class="xxxx-borders shading">103</td><td class="xxxx-borders shading">2003.5</td><td class="xxxx-borders shading">220</td><td class="xxxx-borders shading">1926.0</td><td class="xxxx-borders shading">55.0 (42.9 to 64.7)</td><td class="xxxx-borders shading">93</td><td class="xxxx-borders shading">1994.6</td><td class="xxxx-borders shading">167</td><td class="xxxx-borders shading">1913.7</td><td class="xxxr-borders shading">46.6 (30.7 to 59.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Symptomatic Covid-19 of any severity<a href="#core-t1fn5" role="doc-noteref">Â¶</a></td><td class="xxxx-borders">495</td><td class="xxxx-borders">6683.8</td><td class="xxxx-borders">1082</td><td class="xxxx-borders">6437.4</td><td class="xxxx-borders">55.9 (51.0 to 60.5)</td><td class="xxxx-borders">443</td><td class="xxxx-borders">6656.8</td><td class="xxxx-borders">895</td><td class="xxxx-borders">6398.3</td><td class="xxxr-borders">52.4 (46.6 to 57.6)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Mild<a href="#core-t1fn6" role="doc-noteref">â</a></td><td class="xxxx-borders shading">11</td><td class="xxxx-borders shading">6683.8</td><td class="xxxx-borders shading">15</td><td class="xxxx-borders shading">6437.4</td><td class="xxxx-borders shading">29.4 (â64.6 to 70.7)</td><td class="xxxx-borders shading">10</td><td class="xxxx-borders shading">6656.8</td><td class="xxxx-borders shading">12</td><td class="xxxx-borders shading">6398.3</td><td class="xxxr-borders shading">19.9 (â102.3 to 69.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Moderate<a href="#core-t1fn6" role="doc-noteref">â</a></td><td class="xxxx-borders">429</td><td class="xxxx-borders">6685.6</td><td class="xxxx-borders">862</td><td class="xxxx-borders">6440.2</td><td class="xxxx-borders">52.1 (46.1 to 57.4)</td><td class="xxxx-borders">388</td><td class="xxxx-borders">6658.4</td><td class="xxxx-borders">707</td><td class="xxxx-borders">6400.4</td><td class="xxxr-borders">47.2 (40.2 to 53.5)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Severeâcritical<a href="#core-t1fn5" role="doc-noteref">Â¶</a></td><td class="xxxx-borders shading">56</td><td class="xxxx-borders shading">6774.6</td><td class="xxxx-borders shading">205</td><td class="xxxx-borders shading">6625.2</td><td class="xxxx-borders shading">73.3 (63.9 to 80.5)</td><td class="xxxx-borders shading">46</td><td class="xxxx-borders shading">6733.8</td><td class="xxxx-borders shading">176</td><td class="xxxx-borders shading">6542.1</td><td class="xxxr-borders shading">74.6 (64.7 to 82.1)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Any SARS-CoV-2 infection<a href="#core-t1fn5" role="doc-noteref">Â¶</a><a href="#core-t1fn7" role="doc-noteref">**</a><a href="#core-t1fn8" role="doc-noteref">â â </a></td><td class="xxxx-borders">â</td><td class="xxxx-borders">â</td><td class="xxxx-borders">â</td><td class="xxxx-borders">â</td><td class="xxxx-borders">â</td><td class="xxxx-borders">1038</td><td class="xxxx-borders">6560.8</td><td class="xxxx-borders">1699</td><td class="xxxx-borders">6257.5</td><td class="xxxr-borders">41.7 (36.3 to 46.7)<a href="#core-t1fn9" role="doc-noteref">â¡â¡</a></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Asymptomatic SARS-CoV-2 infection<a href="#core-t1fn5" role="doc-noteref">Â¶</a><a href="#core-t1fn8" role="doc-noteref">â â </a></td><td class="xxxx-borders shading">â</td><td class="xxxx-borders shading">â</td><td class="xxxx-borders shading">â</td><td class="xxxx-borders shading">â</td><td class="xxxx-borders shading">â</td><td class="xxxx-borders shading">498</td><td class="xxxx-borders shading">6581.0</td><td class="xxxx-borders shading">669</td><td class="xxxx-borders shading">6289.3</td><td class="xxxr-borders shading">28.9 (20.0 to 36.8)<a href="#core-t1fn9" role="doc-noteref">â¡â¡</a></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Covid-19 leading to medical intervention<a href="#core-t1fn5" role="doc-noteref">Â¶</a><a href="#core-t1fn10" role="doc-noteref">Â§Â§</a></td><td class="xxxx-borders">18</td><td class="xxxx-borders">6783.9</td><td class="xxxx-borders">74</td><td class="xxxx-borders">6656.7</td><td class="xxxx-borders">76.1 (56.9 to 87.7)<a href="#core-t1fn6" role="doc-noteref">Â¶</a></td><td class="xxxx-borders">16</td><td class="xxxx-borders">6739.8</td><td class="xxxx-borders">64</td><td class="xxxx-borders">6567.1</td><td class="xxxr-borders">75.6 (54.3 to 88.0)<a href="#core-t1fn9" role="doc-noteref">â¡â¡</a></td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Death from any cause<a href="#core-t1fn11" role="doc-noteref">Â¶Â¶</a></td><td class="xxxx-borders shading">19</td><td class="xxxx-borders shading">6787.0</td><td class="xxxx-borders shading">45</td><td class="xxxx-borders shading">6669.3</td><td class="xxxx-borders shading">58.5 (27.6 to 77.1)</td><td class="xxxx-borders shading">19</td><td class="xxxx-borders shading">6742.4</td><td class="xxxx-borders shading">37</td><td class="xxxx-borders shading">6577.3</td><td class="xxxr-borders shading">49.9 (10.6 to 72.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Covid-19ârelated death<a href="#core-t1fn11" role="doc-noteref">Â¶Â¶</a></td><td class="xxxx-borders">3</td><td class="xxxx-borders">6786.9</td><td class="xxxx-borders">19</td><td class="xxxx-borders">6668.4</td><td class="xxxx-borders">84.5 (47.3 to 97.1)</td><td class="xxxx-borders">3</td><td class="xxxx-borders">6742.2</td><td class="xxxx-borders">17</td><td class="xxxx-borders">6576.4</td><td class="xxxr-borders">82.8 (40.5 to 96.8)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging02 shading" data-xml-align="left">Covid-19 according to FDA harmonized definition<a href="#core-t1fn6" role="doc-noteref">â</a><a href="#core-t1fn12" role="doc-noteref">ââ</a></td><td class="xbxx-borders shading">492</td><td class="xbxx-borders shading">6684.7</td><td class="xbxx-borders shading">1067</td><td class="xbxx-borders shading">6440.5</td><td class="xbxx-borders shading">55.6 (50.5 to 60.2)</td><td class="xbxx-borders shading">441</td><td class="xbxx-borders shading">6657.3</td><td class="xbxx-borders shading">884</td><td class="xbxx-borders shading">6399.6</td><td class="xbxr-borders shading">52.0 (46.2 to 57.3)</td></tr></tbody></table></div><figcaption><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="core-t1fn1" role="paragraph" data-to-manipulate="true">All coronavirus disease 2019 (Covid-19) cases were centrally confirmed unless stated otherwise and occurred in participants who had been seronegative at baseline, had negative results on reverse-transcriptaseâpolymerase-chain-reaction (RT-PCR) testing before 14 or 28 days after administration of vaccine or placebo, and were considered to be at risk for Covid-19. The follow-up time for each participant was defined as the time from administration until onset of a Covid-19 episode or the end of the double-blind period (July 9, 2021). Mild Covid-19 cases were defined by a positive RT-PCR test result and at least one of the following signs or symptoms: fever (body temperature, â¥38.0Â°C), sore throat, malaise, headache, myalgia, gastrointestinal symptoms, cough, chest congestion, runny nose, wheezing, skin rash, eye irritation or discharge, chills, loss of taste or smell, red or bruised-looking feet or toes, and shaking chills or rigors. Moderate Covid-19 cases were defined by a positive RT-PCR test result and two or more of the following symptoms: fever (body temperature, â¥38.0Â°C), heart rate of at least 90 beats per minute, shaking chills or rigors, sore throat, cough, malaise, headache, myalgia, gastrointestinal symptoms, loss of taste or smell, and red or bruised-looking feet or toes; or one or more of the following symptoms: respiratory rate of at least 20 breaths per minute, abnormal oxygen saturation (but &gt;93% while breathing room air at sea level), clinical or radiologic evidence of pneumonia, radiologic evidence of deep-vein thrombosis, and shortness of breath or difficulty breathing. Severeâcritical Covid-19 cases were defined by a positive RT-PCR test result and one or more of the following features: signs of severe systemic illness (respiratory rate, â¥30 breaths per minute; heart rate, â¥125 beats per minute; oxygen saturation, â¤93% while breathing room air at sea level; or ratio of partial pressure of oxygen [in mm Hg] to fraction of inspired oxygen, &lt;300); respiratory failure (leading to receipt of high-flow oxygen, noninvasive ventilation, mechanical ventilation, or extracorporeal membrane oxygenation [ECMO]); shock; significant acute renal, hepatic, or neurologic dysfunction; admission to an intensive care unit; or death.</div></div><div role="doc-footnote" data-has="label"><div class="label">â </div><div id="core-t1fn2" role="paragraph" data-to-manipulate="true">The at-risk population excluded participants who were RT-PCRâpositive between day 1 and day 14.</div></div><div role="doc-footnote" data-has="label"><div class="label">â¡</div><div id="core-t1fn3" role="paragraph" data-to-manipulate="true">The at-risk population excluded participants who were RT-PCRâpositive between day 1 and day 28.</div></div><div role="doc-footnote" data-has="label"><div class="label">Â§</div><div id="core-t1fn4" role="paragraph" data-to-manipulate="true">The primary end points were the first occurrence of centrally RT-PCRâconfirmed moderate to severeâcritical Covid-19 with onset at least 14 days after administration and at least 28 days after administration. One participant had a moderate case of Covid-19 and later had a severe case; the adjudication committee considered these to be two separate infections.</div></div><div role="doc-footnote" data-has="label"><div class="label">Â¶</div><div id="core-t1fn5" role="paragraph" data-to-manipulate="true">This end point was a confirmatory secondary end point.</div></div><div role="doc-footnote" data-has="label"><div class="label">â</div><div id="core-t1fn6" role="paragraph" data-to-manipulate="true">This end point was a supportive secondary end point.</div></div><div role="doc-footnote" data-has="label"><div class="label">**</div><div id="core-t1fn7" role="paragraph" data-to-manipulate="true">This category includes undetected cases that were subsequently detected through a positive serologic result (according to the clinical severity adjudication committee), which did not count as either symptomatic cases (because they were RT-PCRânegative) or asymptomatic cases.</div></div><div role="doc-footnote" data-has="label"><div class="label">â â </div><div id="core-t1fn8" role="paragraph" data-to-manipulate="true">Data on this end point were not obtained for cases in which onset occurred after 14 days after administration.</div></div><div role="doc-footnote" data-has="label"><div class="label">â¡â¡</div><div id="core-t1fn9" role="paragraph" data-to-manipulate="true">The 95% confidence intervals for vaccine efficacy against any severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, asymptomatic infections, and Covid-19 leading to medical intervention were adjusted for multiplicity on the basis of prespecified procedures for familywise type I error control. All other confidence intervals have not been adjusted for multiplicity and should not be used to infer statistical significance.</div></div><div role="doc-footnote" data-has="label"><div class="label">Â§Â§</div><div id="core-t1fn10" role="paragraph" data-to-manipulate="true">Medical intervention included hospitalization as adjudicated by the clinical severity adjudication committee, admission to an intensive care unit, mechanical ventilation, and ECMO, linked to objective measures such as decreased oxygenation and findings on radiography or computed tomography.</div></div><div role="doc-footnote" data-has="label"><div class="label">Â¶Â¶</div><div id="core-t1fn11" role="paragraph" data-to-manipulate="true">This end point was an exploratory end point.</div></div><div role="doc-footnote" data-has="label"><div class="label">ââ</div><div id="core-t1fn12" role="paragraph" data-to-manipulate="true">At the time the protocol was written, the Food and Drug Administration (FDA) harmonized Covid-19 definition was a positive RT-PCR test result plus any of the following symptoms: fever or chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, and diarrhea.</div></div></div></figcaption></a><figcaption><div class="caption">Vaccine Efficacy against Covid-19 with Onset at Least 14 Days and at Least 28 Days after the Administration of Vaccine or Placebo (Per-Protocol at-Risk Population).<a href="#core-t1fn1" role="doc-noteref">*</a></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#t1"><i class="icon-return" aria-hidden="true"></i><span>Go to Table</span></a><a class="open-in-viewer" href="#t1" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2117608_t1.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div></div></div><div id="core-collateral-share" role="tabpanel" data-core-tabs="core-collateral-share" tabindex="-1" aria-labelledby="pane-core-collateral-share"><header><h2 id="pane-core-collateral-share"><i class="icon-share" aria-hidden="true"></i>Share</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><h3>Share</h3><div class="section--wrapper"><section><h4>CONTENT LINK</h4><div id="share-self"><p data-id="article-share-self-link" class="share-self__source">https://www.nejm.org/doi/full/10.1056/NEJMoa2117608</p><button data-id="article-share-access" aria-label="CONTENT LINK" class="share-self__action btn btn--inverse"><i aria-hidden="true" class="icon-copy-o"></i><span>Copy Link</span></button><div aria-live="polite" class="share-self__status"><p class="share-self__success"><i aria-hidden="true" class="icon-check_circle"></i><span>Copied!</span></p><p class="share-self__failed"><i aria-hidden="true" class="icon-x_btnclose"></i><span>Copying failed.</span></p></div></div></section><section data-location="share_tools_article"><h4>Share</h4><div class="share-buttons a2a a2a_kit" style="line-height: 16px;"><a href="/#facebook" aria-label="Share on Facebook" data-id="article-share-facebook" rel="nofollow noopener" role="link" target="_blank" title="Share on Facebook" class="btn btn--facebook a2a_button_facebook" data-interactiontype="social"><i aria-hidden="true" class="icon-facebook"></i><span>Facebook</span></a><a href="/#twitter" aria-label="Share on X (formerly Twitter)" data-id="article-share-twitter" rel="nofollow noopener" role="link" target="_blank" title="Share on X (formerly Twitter)" class="btn btn--twitter a2a_button_twitter" data-interactiontype="social"><i aria-hidden="true" class="icon-twitter"></i><span>X (formerly Twitter)</span></a><a href="/#linkedin" aria-label="Share on LinkedIn" data-id="article-share-linkedin" rel="nofollow noopener" role="link" target="_blank" title="Share on LinkedIn" class="btn btn--linkedin a2a_button_linkedin" data-interactiontype="social"><i aria-hidden="true" class="icon-linkedin"></i><span>LinkedIn</span></a><a href="/#email" aria-label="Share on email" data-id="article-share-email" rel="nofollow noopener" role="link" target="_blank" title="Share on email" class="btn btn--email a2a_button_email" data-interactiontype="content_email_click"><i aria-hidden="true" class="icon-mail"></i><span>email</span></a><a href="/#bluesky" aria-label="Share on Bluesky" data-id="article-share-bluesky" rel="nofollow noopener" role="link" target="_blank" title="Share on Bluesky" class="btn btn--bluesky a2a_button_bluesky" data-interactiontype="social"><i aria-hidden="true" class="icon-bluesky"></i><span>Bluesky</span></a></div></section></div></div><div data-location="references_article" id="core-collateral-references" role="tabpanel" aria-labelledby="pane-core-collateral-references" data-core-tabs="core-collateral-references" tabindex="-1"><header><h2 id="pane-core-collateral-references"><i aria-hidden="true" class="icon-references"></i>References</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><h3>References</h3><div role="list" class="section--wrapper"><div role="listitem" data-has="label"><div class="label">1.</div><div id="core-r1" class="citations"><div class="citation"><div class="citation-content">Bos R, Rutten L, van der Lubbe JEM, et al. Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses. <em>NPJ Vaccines</em> 2020;5:91-91.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r2"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41541-020-00243-x" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33083026/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000573260900001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Ad26+vector-based+COVID-19+vaccine+encoding+a+prefusion-stabilized+SARS-CoV-2+Spike+immunogen+induces+potent+humoral+and+cellular+immune+responses.&amp;publication_year=2020&amp;journal=NPJ+Vaccines&amp;pages=91-91&amp;doi=10.1038%2Fs41541-020-00243-x&amp;pmid=33083026" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">2.</div><div id="core-r2" class="citations"><div class="citation"><div class="citation-content">Sadoff J, Le Gars M, Shukarev G, et al. Interim results of a phase 1â2a trial of Ad26.COV2.S Covid-19 vaccine. <em>N Engl J Med</em> 2021;384:1824-1835.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r2"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_3_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2117608&amp;key=10.1056%2FNEJMoa2034201&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33440088/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000640382300001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Interim+results+of+a+phase+1%E2%80%932a+trial+of+Ad26.COV2.S+Covid-19+vaccine.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1824-1835&amp;doi=10.1056%2FNEJMoa2034201&amp;pmid=33440088" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">3.</div><div id="core-r3" class="citations"><div class="citation"><div class="citation-content">Sadoff J, Gray G, Vandebosch A, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. <em>N Engl J Med</em> 2021;384:2187-2201.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r3-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_4_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2117608&amp;key=10.1056%2FNEJMoa2101544&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33882225/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000642260000001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+single-dose+Ad26.COV2.S+vaccine+against+Covid-19.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=2187-2201&amp;doi=10.1056%2FNEJMoa2101544&amp;pmid=33882225" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r3-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r3-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] efficacy against severeâcritical disease. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r3-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] as compared with the primary analysis </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">4.</div><div id="core-r4" class="citations"><div class="citation"><div class="citation-content">Nauta J. <em>Statistics in clinical vaccine trials</em>. New York: Springer-Verlag, 2011.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r4"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/978-3-642-14691-6" target="_blank">Crossref</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Statistics+in+clinical+vaccine+trials&amp;publication_year=2011&amp;doi=10.1007%2F978-3-642-14691-6" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">5.</div><div id="core-r5" class="citations"><div class="citation"><div class="citation-content">Barouch DH, Stephenson KE, Sadoff J, et al. Durable humoral and cellular immune responses 8 months after Ad26.COV2.S vaccination. <em>N Engl J Med</em> 2021;385:951-953.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r5"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_6_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2117608&amp;key=10.1056%2FNEJMc2108829&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34260834/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000674415500001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Durable+humoral+and+cellular+immune+responses+8+months+after+Ad26.COV2.S+vaccination.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=951-953&amp;doi=10.1056%2FNEJMc2108829&amp;pmid=34260834" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">6.</div><div id="core-r6" class="citations"><div class="citation"><div class="citation-content">Alter G, Yu J, Liu J, et al. Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans. <em>Nature</em> 2021;596:268-272.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r6"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-021-03681-2" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34107529/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000668492400001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Immunogenicity+of+Ad26.COV2.S+vaccine+against+SARS-CoV-2+variants+in+humans.&amp;publication_year=2021&amp;journal=Nature&amp;pages=268-272&amp;doi=10.1038%2Fs41586-021-03681-2&amp;pmid=34107529" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">7.</div><div id="core-r7" class="citations"><div class="citation"><div class="citation-content">Grannis SJ, Rowley EA, Ong TC, et al. Interim estimates of COVID-19 vaccine effectiveness against COVID-19âassociated emergency department or urgent care clinic encounters and hospitalizations among adults during SARS-CoV-2 B.1.617.2 (Delta) variant predominance â nine states, JuneâAugust 2021. <em>MMWR Morb Mortal Wkly Rep</em> 2021;70:1291-1293.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r7-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.15585/mmwr.mm7037e2" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34529642/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000696621100005" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Interim+estimates+of+COVID-19+vaccine+effectiveness+against+COVID-19%E2%80%93associated+emergency+department+or+urgent+care+clinic+encounters+and+hospitalizations+among+adults+during+SARS-CoV-2+B.1.617.2+%28Delta%29+variant+predominance+%E2%80%94+nine+states%2C+June%E2%80%93August+2021.&amp;publication_year=2021&amp;journal=MMWR+Morb+Mortal+Wkly+Rep&amp;pages=1291-1293&amp;doi=10.15585%2Fmmwr.mm7037e2&amp;pmid=34529642" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r7-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] Real-world data from several studies </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] from 60% to 94% against hospitalization, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">8.</div><div id="core-r8" class="citations"><div class="citation"><div class="citation-content">Polinski JM, Weckstein AR, Batech M, et al. Effectiveness of the single-dose Ad26.COV2.S COVID vaccine. September 16, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.09.10.21263385v2" target="_blank">https://www.medrxiv.org/content/10.1101/2021.09.10.21263385v2</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r8-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+the+single-dose+Ad26.COV2.S+COVID+vaccine.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r8-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] Real-world data from several studies </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] from 60% to 94% against hospitalization, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r14" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] 13% to 78% against SARS-CoV-2 infection, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">9.</div><div id="core-r9" class="citations"><div class="citation"><div class="citation-content">Cohn BA, Cirillo PM, Murphy CC, Krigbaum NY, Wallace AW. SARS-CoV-2 vaccine protection and deaths among US veterans during 2021. <em>Science</em> 2022;375:331-336.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r9-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.abm0620" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34735261/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000745036100036" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+vaccine+protection+and+deaths+among+US+veterans+during+2021.&amp;publication_year=2022&amp;journal=Science&amp;pages=331-336&amp;doi=10.1126%2Fscience.abm0620&amp;pmid=34735261" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r9-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] Real-world data from several studies </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r14" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] 13% to 78% against SARS-CoV-2 infection, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] against death after SARS-CoV-2 infection </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">10.</div><div id="core-r10" class="citations"><div class="citation"><div class="citation-content">Bekker L-G, Garrett N, Goga A, et al. Effectiveness of the Ad26.Cov2.S vaccine in health care workers in South Africa. <em>SSRN</em>. November 17, 2021 (<a href="https://ssrn.com/abstract=3979291">https://ssrn.com/abstract=3979291</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r10-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+the+Ad26.Cov2.S+vaccine+in+health+care+workers+in+South+Africa&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r10-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] Real-world data from several studies </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r12-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] from 60% to 94% against hospitalization, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] against death after SARS-CoV-2 infection </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r10-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] participants living with HIV infection. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">11.</div><div id="core-r11" class="citations"><div class="citation"><div class="citation-content">de Gier B, Kooijman M, Kemmeren J, et al. COVID-19 vaccine effectiveness against hospitalizations and ICU admissions in the Netherlands, April-August 2021. September 17, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.09.15.21263613v1" target="_blank">https://www.medrxiv.org/content/10.1101/2021.09.15.21263613v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r12-1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=COVID-19+vaccine+effectiveness+against+hospitalizations+and+ICU+admissions+in+the+Netherlands%2C+April-August+2021.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">12.</div><div id="core-r12" class="citations"><div class="citation"><div class="citation-content">Rosenberg ES, Dorabawila V, Easton D, et al. Covid-19 vaccine effectiveness in New York State. <em>N Engl J Med</em> 2022;386:116-127.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r12-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_13_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2117608&amp;key=10.1056%2FNEJMoa2116063&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34942067/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000724451300001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Covid-19+vaccine+effectiveness+in+New+York+State.&amp;publication_year=2022&amp;journal=N+Engl+J+Med&amp;pages=116-127&amp;doi=10.1056%2FNEJMoa2116063&amp;pmid=34942067" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r12-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r12-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] from 60% to 94% against hospitalization, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r14" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] 13% to 78% against SARS-CoV-2 infection, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">13.</div><div id="core-r13" class="citations"><div class="citation"><div class="citation-content">Institute Infectious Disease Epidemiology and Surveillance, AGES, Austrian Agency for Health and Food Safety. Estimates of COVID-19 vaccine effectiveness against SARS-CoV-2 infection following a nationwide vaccination campaign: a population-based cohort study. 2021 (<a href="https://wissenaktuell.ages.at/impfeffektivitaet-in-bezug-auf-sars-cov-2-infektion-der-in-oesterreich-eingesetzten-covid19-impfstoffe/">https://wissenaktuell.ages.at/impfeffektivitaet-in-bezug-auf-sars-cov-2-infektion-der-in-oesterreich-eingesetzten-covid19-impfstoffe/</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r14"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Estimates+of+COVID-19+vaccine+effectiveness+against+SARS-CoV-2+infection+following+a+nationwide+vaccination+campaign%3A+a+population-based+cohort+study.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">14.</div><div id="core-r14" class="citations"><div class="citation"><div class="citation-content">Corchado-Garcia J, Zemmour D, Hughes T, et al. Analysis of the effectiveness of the Ad26.COV2.S adenoviral vector vaccine for preventing COVID-19. <em>JAMA Netw Open</em> 2021;4(11):e2132540-e2132540.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r14"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/jamanetworkopen.2021.32540" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34726743/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000714704800008" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Analysis+of+the+effectiveness+of+the+Ad26.COV2.S+adenoviral+vector+vaccine+for+preventing+COVID-19.&amp;publication_year=2021&amp;journal=JAMA+Netw+Open&amp;pages=e2132540-e2132540&amp;doi=10.1001%2Fjamanetworkopen.2021.32540&amp;pmid=34726743" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">15.</div><div id="core-r15" class="citations"><div class="citation"><div class="citation-content">Kojima N, Shrestha NK, Klausner JD. A systematic review of the protective effect of prior SARS-CoV-2 infection on repeat infection. <em>Eval Health Prof</em> 2021;44:327-332.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r17"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1177/01632787211047932" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34592838/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000705504500001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=A+systematic+review+of+the+protective+effect+of+prior+SARS-CoV-2+infection+on+repeat+infection.&amp;publication_year=2021&amp;journal=Eval+Health+Prof&amp;pages=327-332&amp;doi=10.1177%2F01632787211047932&amp;pmid=34592838" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">16.</div><div id="core-r16" class="citations"><div class="citation"><div class="citation-content">Crotty S. Hybrid immunity. <em>Science</em> 2021;372:1392-1393 (<a href="https://www.science.org/doi/10.1126/science.abj2258" target="_blank">https://www.science.org/doi/10.1126/science.abj2258</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r17"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.abj2258" target="_blank">Crossref</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000665860000026" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Hybrid+immunity.&amp;publication_year=2021&amp;journal=Science&amp;pages=1392-1393&amp;doi=10.1126%2Fscience.abj2258" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">17.</div><div id="core-r17" class="citations"><div class="citation"><div class="citation-content">Keeton R, Richardson SI, Moyo-Gwete T, et al. Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner. <em>Cell Host Microbe</em> 2021;29:1611-1619.e5.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r17"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.chom.2021.10.003" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34688376/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000718619900006" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Prior+infection+with+SARS-CoV-2+boosts+and+broadens+Ad26.COV2.S+immunogenicity+in+a+variant-dependent+manner.&amp;publication_year=2021&amp;journal=Cell+Host+Microbe&amp;pages=1611-1619.e5&amp;doi=10.1016%2Fj.chom.2021.10.003&amp;pmid=34688376" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">18.</div><div id="core-r18" class="citations"><div class="citation"><div class="citation-content">Fact sheet for recipients and caregivers: emergency use authorization (EUA) of the Janssen COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19) in individuals 18 years of age and older. Horsham, PA: Janssen Biotech, 2021 (<a href="https://www.janssenlabels.com/emergency-use-authorization/Janssen+COVID-19+Vaccine-Recipient-fact-sheet.pdf">https://www.janssenlabels.com/emergency-use-authorization/Janssen+COVID-19+Vaccine-Recipient-fact-sheet.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r18-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Fact+sheet+for+recipients+and+caregivers%3A+emergency+use+authorization+%28EUA%29+of+the+Janssen+COVID-19+vaccine+to+prevent+coronavirus+disease+2019+%28COVID-19%29+in+individuals+18+years+of+age+and+older&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r18-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r18-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] the fact sheet associated with the label. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r19" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] that were identified after marketing began, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">19.</div><div id="core-r19" class="citations"><div class="citation"><div class="citation-content">Shay DK, Gee J, Su JR, et al. Safety monitoring of the Janssen (Johnson &amp; Johnson) COVID-19 vaccine â United States, MarchâApril 2021. <em>MMWR Morb Mortal Wkly Rep</em> 2021;70:680-684.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r19"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.15585/mmwr.mm7018e2" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33956784/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000647643800004" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+monitoring+of+the+Janssen+%28Johnson+%26+Johnson%29+COVID-19+vaccine+%E2%80%94+United+States%2C+March%E2%80%93April+2021.&amp;publication_year=2021&amp;journal=MMWR+Morb+Mortal+Wkly+Rep&amp;pages=680-684&amp;doi=10.15585%2Fmmwr.mm7018e2&amp;pmid=33956784" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">20.</div><div id="core-r20" class="citations"><div class="citation"><div class="citation-content">See I, Su JR, Lale A, et al. US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021. <em>JAMA</em> 2021;325:2448-2456.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r22"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/jama.2021.7517" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33929487/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000645632000002" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=US+case+reports+of+cerebral+venous+sinus+thrombosis+with+thrombocytopenia+after+Ad26.COV2.S+vaccination%2C+March+2+to+April+21%2C+2021.&amp;publication_year=2021&amp;journal=JAMA&amp;pages=2448-2456&amp;doi=10.1001%2Fjama.2021.7517&amp;pmid=33929487" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">21.</div><div id="core-r21" class="citations"><div class="citation"><div class="citation-content">Rizk JG, Gupta A, Sardar P, et al. Clinical characteristics and pharmacological management of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with cerebral venous sinus thrombosis: a review. <em>JAMA Cardiol</em> 2021;6:1451-1460.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r22"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/jamacardio.2021.3444" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34374713/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000684941200001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Clinical+characteristics+and+pharmacological+management+of+COVID-19+vaccine-induced+immune+thrombotic+thrombocytopenia+with+cerebral+venous+sinus+thrombosis%3A+a+review.&amp;publication_year=2021&amp;journal=JAMA+Cardiol&amp;pages=1451-1460&amp;doi=10.1001%2Fjamacardio.2021.3444&amp;pmid=34374713" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">22.</div><div id="core-r22" class="citations"><div class="citation"><div class="citation-content">Rosenblum HG, Hadler SC, Moulia D, et al. Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson &amp; Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna): update from the Advisory Committee on Immunization Practices â United States, July 2021. <em>MMWR Morb Mortal Wkly Rep</em> 2021;70:1094-1099.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r22"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.15585/mmwr.mm7032e4" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34383735/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000685284200006" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Use+of+COVID-19+vaccines+after+reports+of+adverse+events+among+adult+recipients+of+Janssen+%28Johnson+%26+Johnson%29+and+mRNA+COVID-19+vaccines+%28Pfizer-BioNTech+and+Moderna%29%3A+update+from+the+Advisory+Committee+on+Immunization+Practices+%E2%80%94+United+States%2C+July+2021.&amp;publication_year=2021&amp;journal=MMWR+Morb+Mortal+Wkly+Rep&amp;pages=1094-1099&amp;doi=10.15585%2Fmmwr.mm7032e4&amp;pmid=34383735" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">23.</div><div id="core-r23" class="citations"><div class="citation"><div class="citation-content">Thomas SJ, Moreira ED Jr, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. <em>N Engl J Med</em> 2021;385:1761-1773.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r24"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_24_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2117608&amp;key=10.1056%2FNEJMoa2110345&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34525277/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000696036700001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+the+BNT162b2+mRNA+Covid-19+vaccine+through+6+months.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1761-1773&amp;doi=10.1056%2FNEJMoa2110345&amp;pmid=34525277" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">24.</div><div id="core-r24" class="citations"><div class="citation"><div class="citation-content">El Sahly HM, Baden LR, Essink B, et al. Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase. <em>N Engl J Med</em> 2021;385:1774-1785.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r24"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_25_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2117608&amp;key=10.1056%2FNEJMoa2113017&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34551225/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000697804800001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+the+mRNA-1273+SARS-CoV-2+vaccine+at+completion+of+blinded+phase.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1774-1785&amp;doi=10.1056%2FNEJMoa2113017&amp;pmid=34551225" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">25.</div><div id="core-r25" class="citations"><div class="citation"><div class="citation-content">Centers for Disease Control and Prevention. Omicron variant: what you need to know. 2021 (<a href="https://www.cdc.gov/coronavirus/2019-ncov/variants/omicron-variant.html">https://www.cdc.gov/coronavirus/2019-ncov/variants/omicron-variant.html</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r25"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Omicron+variant%3A+what+you+need+to+know.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">26.</div><div id="core-r26" class="citations"><div class="citation"><div class="citation-content">Gray GE, Collie S, Garrett N, et al. Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26.COV2 during an Omicron COVID19 wave: preliminary results of the Sisonke 2 study. December 29, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.12.28.21268436v1" target="_blank">https://www.medrxiv.org/content/10.1101/2021.12.28.21268436v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r26"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Vaccine+effectiveness+against+hospital+admission+in+South+African+health+care+workers+who+received+a+homologous+booster+of+Ad26.COV2+during+an+Omicron+COVID19+wave%3A+preliminary+results+of+the+Sisonke+2+study.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div></div></div></div><aside data-core-aside="right-rail">



        
        <div id="DTM_Position_MedRectangle" class="ad">
 <!--emptycomment-->
</div>




        
        <div class="ng-page_layout-sidebarSpacing"></div>










    
    
        <div data-widget-def="relatedArticlesWidget" data-widget-id="8206d5cd-cb8c-4ff9-8c46-3d22e0dee215" data-location="recirc_curatedRelated_article">
        



        
        

        </div>
    





        
        <div class="ng-page_layout-sidebarSpacing"></div>




        
        <div id="nejm_jobs" class="nejm_jobs"> <!-- top red rectangle --><div id="nejm-widget" class="nejm-widget" style="display: block;"><div class="nejm-widget_logo">	<a target="nejm-win" href="https://www.nejmcareercenter.org/?query=fjw">		<img alt="CareerCenter" src="https://apps1.nejmcareercenter.org/images/nejmCCID-JobsWidget.gif" width="140" height="36">	</a></div><div class="nejm-widget_cont"> <!-- content --><div class="nejm-widget_title">PHYSICIAN JOBS</div><div class="nejm-widget_date">June 10, 2025</div><div class="nejm-widget_item"><div><span> West Hartford, Connecticut</span></div><div><span>Hematology / Oncology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/886963/hematologist-oncologist-regional-cancer-care-associates-west-hartford/?query=fjwp&amp;rid=5696">Hematologist/Oncologist - Regional Cancer Care Associates West Hartford</a></div></div><div class="nejm-widget_item"><div><span> Texas</span></div><div><span>Urology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/889584/urologist-texas-urology-specialists-dallas-methodist/?query=fjwp&amp;rid=5696">Urologist - Texas Urology Specialists Dallas Methodist</a></div></div><div class="nejm-widget_item"><div><span> Hicksville, New York</span></div><div><span>Internal Medicine</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/888997/internal-medicine-or-family-medicine-physician-optum-ny/?query=fjwf&amp;rid=220874">Internal Medicine or Family Medicine Physician - Optum NY</a></div></div><div class="nejm-widget_item"><div><span> California</span></div><div><span>Anesthesiology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/893287/physician-anesthesiology-santa-cruz-ca-/?query=fjwf&amp;rid=845671">Physician, Anesthesiology, (Santa Cruz, CA)</a></div></div><div class="nejm-widget_item"><div><span> Seattle, Washington State</span></div><div><span>Hospitalist</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/890059/hospitalist/?query=fjwf&amp;rid=6691">Hospitalist</a></div></div><div class="nejm-widget_item"><div><span> Massachusetts</span></div><div><span>Pediatrics, General</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/878325/pediatrician/?query=fjwp&amp;rid=165114">Pediatrician</a></div></div></div> <!-- content --> <!-- footer --></div> <!-- nejm-widget --></div><script src="https://apps1.nejmcareercenter.org/?width=300&amp;sp=all"></script>




        
        <div class="ng-page_layout-sidebarSpacing"></div>










    
    
        <div data-widget-def="literatumAd" data-widget-id="001e4aa7-b6fe-4b21-9d5b-5bde81227c67" id="ad-article-right-rail-300x250-1">
        



        
        



    
        <div class="pb-house-message adplaceholder exists">
            <a href="/action/clickThrough?id=128720&amp;url=https%3A%2F%2Fstore.nejm.org%2Fsignup%2Fnejmai%2Fregister%2Faifallpdf24%3Fpromo%3DOAFQF4NA%26query%3Dcm-rr%26utm_source%3Dnejm%26utm_medium%3Dcm%26utm_campaign%3Daifallpdf24&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2117608&amp;pubId=41284234&amp;placeholderId=101337&amp;productId=1007" target="_blank"><img src="/sda/128720/NEJ-AI-Fall24-300x250---002.jpg" width="300" height="250"></a>
            
        </div>
    

    

    



        </div>
    





        
        <div class="ng-page_layout-sidebarSpacing"></div>




        
        <script src="https://widgets.nejm.org/onepub-widgets/loader/webcomponents-loader.js" async="" nonce="94d6c2dc21f201c0-SJC">
<script src="https://widgets.nejm.org/onepub-widgets/loader/polyfill-support.js"  nonce="94d6c2dc21f201c0-SJC"></script>
<script src="https://widgets.nejm.org/onepub-widgets/more-like-this.js" type="module" nonce="94d6c2dc21f201c0-SJC"></script>

<more-like-this class="onepub-widget" dataid="onepub-more-like-this" collections="catalyst-article, clinician-article, evidence-article, nejm-ai-article, nejm-article" headertitle="More Like This" maxitems="5"><!----><div class="more-like-this onepub-more-like-this_"><!--?lit$758304517$--><onepub-fonts><wc-fetch></wc-fetch><!--?lit$758304517$--><div class="mlt-wrapper"><div class="mlt-header-container"><div class="mlt-header-content-left"><div class="mlt-header-title-container"><span class="mlt-header-title">More Like This</span></div><!--?lit$758304517$--></div></div><div class="mlt-body"><!--?lit$758304517$--><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$758304517$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$758304517$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$758304517$-->Mar 10, 2022</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2117128?query=recirc_Semantic" target="_self">Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina</a></div><div class="mlt-article-authors"><!--?lit$758304517$-->D.-Y. Lin and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$758304517$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$758304517$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$758304517$-->Jan 13, 2022</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2116063?query=recirc_Semantic" target="_self">Covid-19 Vaccine Effectiveness in New York State</a></div><div class="mlt-article-authors"><!--?lit$758304517$-->E.S. Rosenberg and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$758304517$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$758304517$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$758304517$-->Oct 07, 2021</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2110362?query=recirc_Semantic" target="_self">Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings</a></div><div class="mlt-article-authors"><!--?lit$758304517$-->M.G. Thompson and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$758304517$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$758304517$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$758304517$-->May 20, 2021</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2103055?query=recirc_Semantic" target="_self">Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant</a></div><div class="mlt-article-authors"><!--?lit$758304517$-->V. Shinde and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$758304517$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$758304517$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$758304517$-->May 20, 2021</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2102214?query=recirc_Semantic" target="_self">Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant</a></div><div class="mlt-article-authors"><!--?lit$758304517$-->S.A. Madhi and Others</div></div><!----></div><div class="mlt-footer"></div></div></onepub-fonts><style>:host{display:block}@keyframes fadeIn{0%{opacity:0}100%{opacity:1}}.more-like-this{max-width:25rem}.more-like-this *{font-variant-numeric:lining-nums}.mlt-wrapper{animation:fadeIn 1s}.mlt-header-container{border-bottom:#4d4d4d solid .0625rem;border-top:#4d4d4d solid .125rem}.mlt-header-title{color:#1a1a1a;display:block;font-family:var(--sans-serif);font-size:1rem;font-weight:700;letter-spacing:.02rem;line-height:1.5rem;padding-bottom:.94rem;padding-top:.94rem;text-transform:uppercase}.mlt-header-description{color:#333;display:block;font-family:ff-scala-sans-pro;font-size:.75rem;letter-spacing:.05rem;margin-top:-.5rem;padding-bottom:1rem;text-transform:uppercase}.mlt-article-container{border-bottom:#e5e5e5 solid .0625rem;margin-top:1.38rem}.mlt-article-container-header{font-family:var(--sans-serif);font-size:.6875rem;letter-spacing:.04em;line-height:1.125rem;margin:0 0 1rem;text-transform:uppercase}.mlt-article-type{font-weight:700;line-height:1.25rem;letter-spacing:.04rem;text-decoration:none}.mlt-article-type:hover{text-decoration:underline}.nejm{color:#f30}.nejm-ai{color:#006197}.nejm-catalyst{color:#5708a6}.nejm-evidence{color:#69a323}.mlt-article-site-label::after,.mlt-article-type::after{border-right:1px solid #e5e5e5;content:'';display:inline;padding:.1875rem .375rem .125rem 0;margin:0 .375rem 0 0}.mlt-article-pubdate{color:#666;font-style:normal;font-weight:700;line-height:1.25rem;letter-spacing:.04em}.mlt-article-authors{color:#666;font-family:var(--sans-serif);font-size:1rem;font-style:normal;font-weight:400;letter-spacing:normal;line-height:1.5rem;margin-bottom:1.38rem}.mlt-article-site-label{color:#666;font-style:normal;font-weight:700;letter-spacing:.04em}.mlt-article-title{margin-bottom:.5rem}.mlt-article-title>a{background-image:linear-gradient(#f30,#f30);background-position:0 90%;background-repeat:no-repeat;background-size:0 0;color:#1a1a1a;font-family:var(--quadraat-web);font-size:1.25rem;font-style:normal;font-weight:700;letter-spacing:normal;line-height:1.8rem;margin:1.5rem 0 .35rem 0;text-decoration:none;transition:background .25s ease-in-out}.mlt-article-title>a:hover{background-position:0 98%;background-size:100% .125rem;text-decoration:none}.skeleton-card{box-shadow:0 0 4px 1px rgba(0,0,0,.1);margin:1rem 0;padding:1rem}</style></div></more-like-this>




        
        <div><div class="pb-dropzone" data-pb-dropzone="col-0" title="col-0"></div></div>










    
    
        <div data-widget-def="UX3HTMLWidget" data-widget-id="ad06db99-f228-4c92-9ad7-c4ae0fdbdbf1" id="bc-web-rec">
        



        
        <!-- BlueConic TEST empty HTML widget with DIV wrapper with id=bc-web-rec -->

        </div>
    

</aside></article><div data-extent="article-wrapper"><div class="core-container"></div><div class="after-credits"><div class="core-container"><a href="/doi/pdf/10.1056/NEJMoa2117608?download=true" id="downloadPdfUrl" data-doi="10.1056/NEJMoa2117608" data-behavior="trackDownloadEvent" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2117608.pdf"><span>Download PDF</span></a></div></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1056/NEJMoa2117608"}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><div class="articles-nav"></div><template id="figure_nav_template"><nav><a href="#" title="Open in viewer" class="open-in-viewer"><i aria-hidden="true" class="icon-expand"></i></a></nav></template><template id="fv_panel_template" data-sharesocial="Share"><div class="fv__panel js--hidden"><div class="fv__panel__text"><div class="fv__panel__contentTitle"></div><div class="fv__panel__contentText"></div></div></div></template>
<template id="fv_directory_template" data-overlay="View figure"><div class="fv__directory"><div class="fv__header"><nav class="tab__nav"></nav><a href="#" title="Close figure viewer" class="fv__close"><i aria-hidden="true" class="icon-close"></i></a></div><div class="fv__content tab__content"></div></div></template><template id="fv_directory_tabItem_template" data-figures="Figures" data-others="Others" data-tables="Tables"><button role="tab" data-toggle="tab" class="tab__nav__item"></button></template>
<template id="fv_lightbox_template" data-sr-back="Go to figure location within the article" data-sr-closealt="Close" data-sr-download="Toggle download panel" data-sr-download-pptx="Download PPT" data-sr-info="Toggle information panel" data-sr-panel="Close panel" data-sr-share="Toggle share panel" data-sr-zoom="Zoom" data-text-close="Back to article" data-text-nav-figures="All figures" data-text-nav-others="All others" data-text-nav-tables="All tables" data-text-viewall="View all material" data-title-back="Back to article" data-title-closealt="Close" data-title-download="Download" data-title-download-pptx="Download PPT" data-title-info="Info" data-title-share="Share" data-title-zoom="Zoom"></template>
<template id="fv_toolbar_template"><div class="fv__toolbar__info"><strong class="fv__toolbar__contentTitle uppercase"></strong><p class="fv__toolbar__contentText"></p></div></template><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-return"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-return"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-return"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--secondary"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-references="References" data-figure="Go to Figure" data-media="Go to Media" data-more="More" data-original="Go to original" data-table="Go to Table" data-inviewer="Open in Viewer" data-allinviewer="Open all in viewer"><svg data-tags="copyright" viewBox="0 0 24 24"><path d="M12 20.016q3.281 0 5.648-2.368T20.016 12t-2.368-5.648T12 3.984 6.352 6.352 3.984 12t2.368 5.648T12 20.016zm0-18q4.125 0 7.055 2.93T21.985 12t-2.93 7.055T12 21.985t-7.055-2.93T2.015 12t2.93-7.055T12 2.015zm-.14 7.125q-1.876 0-1.876 2.718v.282q0 2.718 1.875 2.718.704 0 1.172-.398t.469-1.008h1.781q0 1.172-1.031 2.063-.984.843-2.39.843-1.876 0-2.86-1.125t-.984-3.093v-.282q0-1.921.937-3 1.125-1.265 2.906-1.265 1.547 0 2.438.89.984.985.984 2.297H13.5q0-.328-.14-.61-.235-.468-.329-.562-.469-.468-1.172-.468z"></path></svg><span>Request permissions</span><i aria-hidden="true" class="icon-open_in_new"></i></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template>

        <div role="navigation" aria-label="Sticky Navigation" class="st-header"><div class="st-header__content"><div class="st-header__item st-header__menu"></div><div class="st-header__current st-header__item"><div class="st-header__label">Now Reading:</div><div class="st-header__title">Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S</div></div><div class="st-header__share st-header__item"><div class="share-dropblock dropdown"><a id="sticky-header-dropBlock" href="#" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" class="dropdown-toggle"><span title="" data-toggle="tooltip" data-trigger="hover" data-original-title="Share options"><span class="sr-only">Share</span><i aria-hidden="true" class="icon-share"></i></span></a><div aria-labelledby="sticky-header-dropBlock" data-location="share_tools_article" class="dropdown-menu"><ul class="rlist--inline a2a a2a_kit" style="line-height: 16px;"><li><a href="/#facebook" aria-label="Share on Facebook" data-id="article-share-facebook" rel="nofollow noopener" role="link" target="_blank" title="Share on Facebook" class="btn btn--facebook a2a_button_facebook" data-interactiontype="social"><i aria-hidden="true" class="icon-facebook"></i></a></li><li><a href="/#twitter" aria-label="Share on X (formerly Twitter)" data-id="article-share-twitter" rel="nofollow noopener" role="link" target="_blank" title="Share on X (formerly Twitter)" class="btn btn--twitter a2a_button_twitter" data-interactiontype="social"><i aria-hidden="true" class="icon-twitter"></i></a></li><li><a href="/#linkedin" aria-label="Share on LinkedIn" data-id="article-share-linkedin" rel="nofollow noopener" role="link" target="_blank" title="Share on LinkedIn" class="btn btn--linkedin a2a_button_linkedin" data-interactiontype="social"><i aria-hidden="true" class="icon-linkedin"></i></a></li><li><a href="/#email" aria-label="Share on email" data-id="article-share-email" rel="nofollow noopener" role="link" target="_blank" title="Share on email" class="btn btn--email a2a_button_email" data-interactiontype="content_email_click"><i aria-hidden="true" class="icon-mail"></i></a></li><li><a href="/#bluesky" aria-label="Share on Bluesky" data-id="article-share-bluesky" rel="nofollow noopener" role="link" target="_blank" title="Share on Bluesky" class="btn btn--bluesky a2a_button_bluesky" data-interactiontype="social"><i aria-hidden="true" class="icon-bluesky"></i></a></li></ul></div></div></div><div class="st-header__nav st-header__item"><div class="content-navigation"><a href="/doi/full/10.1056/NEJMoa2110275" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><div aria-hidden="true" class="content-navigation__hint"><div class="content-navigation__hint__content"><h6>PREVIOUS ARTICLE</h6><div>Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants</div></div></div><i aria-hidden="true" class="icon-arrow-left"></i><span>Previous</span></a><a href="/doi/full/10.1056/NEJMoa2116130" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><div aria-hidden="true" class="content-navigation__hint"><div class="content-navigation__hint__content"><h6>NEXT ARTICLE</h6><div>Multistate Outbreak of Melioidosis Associated with Imported Aromatherapy Spray</div></div></div><span>Next</span><i aria-hidden="true" class="icon-arrow-right"></i></a></div></div></div><div class="st-header__track"><div id="progress-tracker" class="st-header__tracker" style="width: 0px;"></div></div></div><div class="fv figureViewer js--has-focus-mode"><div class="fv__directory" data-core-tabs="default" style="display: flex;"><div class="fv__header"><nav class="tab__nav" role="tablist"><button role="tab" data-toggle="tab" class="tab__nav__item active" aria-controls="#tab-pane-figures" aria-selected="true">Figures</button><button role="tab" data-toggle="tab" class="tab__nav__item" aria-controls="#tab-pane-tables" tabindex="-1" aria-selected="false">Tables</button></nav><a href="#" title="Close figure viewer" class="fv__close"><i aria-hidden="true" class="icon-close"></i></a></div><div class="fv__content tab__content"><div class="tab__pane fv__list fv__list--figures" id="tab-pane-figures" aria-label="All figures" tabindex="0" role="tabpanel"><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f1" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f1.jpg"><img src="/cms/10.1056/NEJMoa2117608/asset/2a351918-67a8-4aaa-b189-a3113a0fef95/assets/images/large/nejmoa2117608_f1.jpg" height="2556" width="2640" aria-labelledby="f1" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 1</div><div class="fv__item__description"><figcaption><div class="caption">Cases of Covid-19 According to SARS-CoV-2 Lineage (Full Analysis Population).</div><div class="notes"><div role="doc-footnote">The distribution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages among cases of coronavirus disease 2019 (Covid-19) is shown for each country in the trial over time during the double-blind phase of the trial. The reference sequence is defined as the SARS-CoV-2 Wuhan-Hu-1 sequence but with the D614G amino acid variation. At the time of the trial, sequences categorized as âotherâ were those with substitutions not resulting in another SARS-CoV-2 lineage or variant. âOther+E484Kâ refers to sequences with E484K but no other substitutions resulting in another SARS-CoV-2 lineage or variant. Next-generation sequencing was performed with the use of the Swift Biosciences SNAP Assay, version 2. Amino acid variants are defined as changes from the reference sequence. The last available visit date across countries was July 1 through 9, 2021, and the last available date of onset for a primary end-point case was June 26 (Argentina), March 24 (Brazil), April 22 (Chile), June 23 (Colombia), May 27 (Mexico), July 1 (Peru), July 5 (South Africa), and April 16 (United States). None of the cases were caused by the eta, kappa, theta, or C.36.3 variant. The alpha, beta, gamma, and delta variants were variants of concern according to World Health Organization definitions at the time of the analysis.</div></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f2" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f2.jpg"><img src="/cms/10.1056/NEJMoa2117608/asset/265bbfd3-9d04-45e3-999e-edd40e9251fd/assets/images/large/nejmoa2117608_f2.jpg" height="2659" width="2640" aria-labelledby="f2" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 2</div><div class="fv__item__description"><figcaption><div class="caption">Cumulative Incidence of Moderate to SevereâCritical Covid-19 and Vaccine Efficacy over Time (Per-Protocol Population).</div><div class="notes"><div role="doc-footnote">Panel A shows the KaplanâMeier cumulative incidence of molecularly confirmed moderate to severeâcritical Covid-19 with onset at least 1 day after administration of vaccine or placebo. Shading indicates the 95% confidence interval. Panel B shows vaccine efficacy against moderate to severeâcritical Covid-19 over time; dark gray shading indicates the 95% pointwise confidence interval, and light gray shading the 95% simultaneous confidence interval. The graph includes 95% of the events that occurred before day 189, with the hazard smoothed over 21 days. Participants were seronegative at baseline, as determined by reverse-transcriptaseâpolymerase-chain-reaction (RT-PCR) and serologic tests.</div></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f3" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f3.jpg"><img src="/cms/10.1056/NEJMoa2117608/asset/8dc13911-fa0b-4a22-9c69-fd33169ea821/assets/images/large/nejmoa2117608_f3.jpg" height="3148" width="2640" aria-labelledby="f3" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 3</div><div class="fv__item__description"><figcaption><div class="caption">Vaccine Efficacy against Moderate to SevereâCritical Covid-19 According to SARS-CoV-2 Lineage (Per-Protocol Population).</div><div class="notes"><div role="doc-footnote">Shown is vaccine efficacy against moderate to severeâcritical Covid-19 with onset at least 14 days after administration (Panel A) and at least 28 days after administration (Panel B). SARS-CoV-2 in the category of âLineages other than the reference strainâ were all variants of concern or interest, with âotherâ sequences excluded. At the time of the trial, sequences categorized as âotherâ were those with substitutions not resulting in another SARS-CoV-2 lineage or variant. âOther+E484Kâ refers to sequences with E484K but no other substitutions resulting in another SARS-CoV-2 lineage or variant. Vaccine efficacy was not calculated if fewer than 6 cases were observed for an end point. Confidence intervals have not been adjusted for multiplicity and should not be used to infer statistical significance.</div></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f4" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2117608_f4.jpg"><img src="/cms/10.1056/NEJMoa2117608/asset/9ae468ee-5f05-4f1e-8a57-2947f1f3dc0b/assets/images/large/nejmoa2117608_f4.jpg" height="2737" width="2640" aria-labelledby="f4" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 4</div><div class="fv__item__description"><figcaption><div class="caption">Cumulative Incidence of SevereâCritical Covid-19 and Vaccine Efficacy over Time (Per-Protocol Population).</div><div class="notes"><div role="doc-footnote">Panel A shows the KaplanâMeier cumulative incidence of molecularly confirmed severeâcritical Covid-19 with onset at least 1 day after administration of vaccine or placebo. Shading indicates the 95% confidence interval. Panel B shows vaccine efficacy against severeâcritical Covid-19 over time; dark gray shading indicates the 95% pointwise confidence interval, and light gray shading the 95% simultaneous confidence interval. The graph includes 95% of the events that occurred before day 189, with the hazard smoothed over 21 days. Participants were seronegative at baseline, as determined by RT-PCR and serologic tests.</div></div></figcaption></div></div></div><div class="tab__pane fv__list fv__list--tables" id="tab-pane-tables" aria-label="All tables" tabindex="-1" role="tabpanel"><div class="fv__item"><a class="fv__open-item fv__item__view" href="#fv-t1" data-type="tables" data-interactiontype="multimedia_click" data-multimedia-type="Table"><i class="icon-tables"></i></a><div class="fv__item__title">Table 1</div><div class="fv__item__description"><figcaption><div class="caption">Vaccine Efficacy against Covid-19 with Onset at Least 14 Days and at Least 28 Days after the Administration of Vaccine or Placebo (Per-Protocol at-Risk Population).<a href="#fv-t1fn1" role="doc-noteref">*</a></div></figcaption></div></div></div></div></div></div><div class="references-pop-up fade" aria-hidden="true"><div class="references-pop-up__heading text-dark d-flex align-items-center"><div class="references-pop-up__title flex-grow-1">Reference <span class="references-pop-up__heading-number">1</span></div><a class="references-pop-up__close text-dark" href="#" title="close pop-up" tabindex="-1" aria-hidden="true"><i class="icon-close" aria-hidden="true"></i></a></div><div class="references-pop-up__items citations to-citation__accordion external-links"></div></div></main>
    

</div>

                    
                        



        
        <div class="ng-page_layout ng-page_layout-fullWidth"><div class="container-fluid"><div class="row"><div class="col-12">



        
        




        
        <div class="ng-page_layout-contentSpacing"></div>










    
    
        <div data-widget-def="oneSearchMultiSearch" data-widget-id="778b3ad8-1a8d-43d8-8196-63b03df4a138" data-location="recirc_inIssue_bottom_article">
        



        
        <div class="os-ms os-ms-more-from-issue"><h3 class="ng-subsection-title"><a href="/toc/nejm/386/9" class="ng-subsection-title_link animation-icon-shift"><span class="ng-subsection-title_text">More from Vol. 386 No. 9</span><span class="ng-subsection-title_icon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-longArrowRight"></use></svg></span></span></a></h3><ul class="os-ms-more-from-issue_list"><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Mar 03, 2022</span></li><li data-toggle="tooltip" data-original-title="Video" class="issue-item_meta-item"><span role="img" aria-label="Video" tabindex="0" class="issue-item_video"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#tooltip-video"></use></svg></span></span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2110275" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">L.L. Hammitt and Others</span></div></div></div></div></div></li><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Mar 03, 2022</span></li><li data-toggle="tooltip" data-original-title="Video" class="issue-item_meta-item"><span role="img" aria-label="Video" tabindex="0" class="issue-item_video"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#tooltip-video"></use></svg></span></span></li><li data-toggle="tooltip" data-original-title="Visual Abstract" class="issue-item_meta-item"><span role="img" aria-label="Visual Abstract" tabindex="0" class="issue-item_visualAbstract"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#tooltip-visual"></use></svg></span></span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2114464" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">S. Finfer and Others</span></div></div></div></div></div></li><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Mar 03, 2022</span></li><li data-toggle="tooltip" data-original-title="Video" class="issue-item_meta-item"><span role="img" aria-label="Video" tabindex="0" class="issue-item_video"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#tooltip-video"></use></svg></span></span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2000803" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">P.J. Devereaux and Others</span></div></div></div></div></div></li></ul></div>

        </div>
    

</div></div></div></div>

                    
                        



        
        <div class="ng-page_layout-bottomAd"><div class="container-fluid"><div class="row"><div class="col-12">









    
    
        <div data-widget-def="literatumAd" data-widget-id="7e022d0d-4a48-44a7-af66-033cf5c13eb8" id="ad-article-bottom-FULLx320-1">
        



        
        



    
        <div class="pb-house-message adplaceholder exists">
            <!-- START: Circulation Footer 3 -->
<aside class="g-cta-subscribe">
	<style>
.bads_footer-banner24-ONJQNRF1{background:url(/pb-assets/contextual_messaging/footer-yel-background-2x-1513629627453.jpg) center center no-repeat;padding:20px;display:block;margin:0;min-height:inherit;background-size:cover;text-decoration:none!important;color:#1a1a1a;text-align:left}.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:42px;line-height:44px;letter-spacing:.2px;margin:0 0 20px;font-family:ff-quadraat-web-pro,sans-serif;font-weight:600}.bads_footer-banner24-ONJQNRF1-inner{max-width:1300px;margin:0 auto}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions .a-btn{width:130px;padding-left:12px}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{position:static;color:#000;font-size:18px;line-height:27px;border:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions{margin:20px 0 20px 0;list-style-type:none;padding:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login a{color:#0a68ad}.bads_clearfix:after{visibility:hidden;display:block;font-size:0;content:" ";clear:both;height:0}.bads_clearfix{display:block}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{float:left;width:50%;padding:30px 0}.bads_footer-banner24-ONJQNRF1-inner .bads_device-img{float:left;padding-left:30px;width:50%}.bads_footer-banner24-ONJQNRF1 .bads_device-img>img{display:block;max-width:100%;height:auto}.bads_footer-banner24-ONJQNRF1 .bads_h5{font-size:18px;text-transform:uppercase;line-height:24px;font-weight:600;margin:-15px 0 0;letter-spacing:.2px}@media only screen and (max-width:480px){.bads_footer-banner24-ONJQNRF1-inner .bads_device-img,.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{width:100%;float:none}.bads_footer-banner24-ONJQNRF1-inner .bads_device-img{padding-left:0}.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:20px;line-height:27px;margin-bottom:10px}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding-top:0;padding-bottom:0}.bads_footer-banner24-ONJQNRF1{height:auto}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions{margin:0 0 12px;list-style-type:none}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{line-height:25px;font-size:15px;margin-bottom:10px}.bads_footer-banner24-ONJQNRF1 .bads_device-img{width:280px!important;margin:0 auto}.bads_footer-banner24-ONJQNRF1 .bads_h5{margin:0 0 3px;font-size:14px}}@media only screen and (min-width:480px) and (max-width:1024px){.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:20px;line-height:30px;margin-bottom:15px}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{font-size:14px}.bads_footer-banner24-ONJQNRF1 .bads_h5{font-size:13px;margin-top:0}}@media only screen and (min-width:1025px) and (max-width:1200px){.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding:10px 0}.bads_footer-banner24-ONJQNRF1 .bads_h5{margin:0 0 5px}}@media only screen and (min-width:1401px){.bads_footer-banner24-ONJQNRF1 .bads_device-img>img{float:right}}
	</style>
	<div class="bads_footer-banner24-ONJQNRF1">
	  <div class="bads_footer-banner24-ONJQNRF1-inner bads_clearfix">
		 <div class="bads_subs-btn">
			<p class="g-cta-subscribe__title">Tap into groundbreaking research and clinically relevant insights</p>
			<ul class="g-cta-subscribe__actions">
				<li class="g-cta-subscribe__actions-primary">
				  <a href="/action/clickThrough?id=127716&amp;url=%2Faction%2FstoreProxy%3Faction%3Dsubscribe%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJMoa2117608%26promo%3DONFQNRF1&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2117608&amp;pubId=41284234&amp;placeholderId=101336&amp;productId=1035" class="ng-btn_primary ng-btn_iconRight"><span class="ng-btn_text">Subscribe </span><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#arrows-longArrowRight"></use></svg></span></a>
				</li>
			</ul>
			<p class="g-cta-subscribe__login">Already a subscriber? <a href="/action/clickThrough?id=127716&amp;url=%2Faction%2FstoreProxy%3Faction%3Dactivate%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJMoa2117608%26promo%3DONFQANR4&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2117608&amp;pubId=41284234&amp;placeholderId=101336&amp;productId=1035">Activate</a> your online access.</p>
		 </div>

		<div class="bads_device-img">
		   <img src="/sda/127716/footer-devices-2x.png" alt="Devices">
		</div>
	   </div>
	</div>
</aside>
<!--/END: Circulation Footer 3 -->
            
        </div>
    

    

    



        </div>
    

</div></div></div></div>

                    
                        



        
        <footer class="ng-footer footer__top" style="position: relative;"><div data-location="footer" class="ng-footer_columns"><div class="container-fluid"><div class="row"><div class="col-lg-4 col-md-6 col-sm-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">ARTICLE CATEGORIES</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item">
        <a href="/browse/nejm-article-category/research" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Research</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/review" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Reviews</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/clinical-cases" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Clinical Cases</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/perspective" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Perspective</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/commentary" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Commentary</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/other" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Other</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/medical-article-index" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Browse all Articles</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/toc/nejm/current" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Current Issue</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/loi/nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Issue Index</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">RESOURCES</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/author-center/home" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Authors &amp; Reviewers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/author-center/home" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Submit a Manuscript</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Subscribers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://tools.ovid.com/ovidtools/nejm.html" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Institutional Administrators</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/media" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Media</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/how-to-advertise" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Advertisers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/information-for-subscription-agents" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Agents</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/permissions" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Permissions &amp; Licensing</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/reprints" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Reprints</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmcareercenter.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM CareerCenter</span></a>
    </li>
</ul>
</div></div></div><div class="col-lg-4 col-md-6 col-sm-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title" aria-label="About us">ABOUT US</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/about-nejm/about-nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">About NEJM</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmgroup.org/" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM Group</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Products &amp; Services</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/editors-and-publishers" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Editors &amp; Publishers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/advertising-policies" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Advertising Policies</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/contact-nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text" aria-label="Contact us">Contact Us</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/frequently-asked-questions?#Accessibility" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Accessibility</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/frequently-asked-questions" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">FAQs</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/help" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Help</span></a></li>
    <li class="ng-footer_column-list-item"><a href="mailto:sitefeedback@nejm.org" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Site Feedback</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">SUBSCRIPTIONS</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS3" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Subscribe</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=renew&amp;product=nejm&amp;promo=ONFLNRR3&amp;prc=ONFARN52" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Renew</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=activate&amp;promo=ONFLNAA1" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Activate Subscription</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC4" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Create Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Manage Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=paybill&amp;product=nejm&amp;promo=BNFLPBA1" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Pay Bill</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.wolterskluwer.com/en/solutions/ovid/nejm-complete-collection" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Institutional Sales</span></a></li>    
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org/special-content" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Special Content</span></a></li>
</ul>
</div></div></div><div class="col-lg-4 col-md-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">STAY CONNECTED</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org/emails?section=NEJM" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Email Alerts</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC3" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Create Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Apps</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmcareercenter.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM CareerCenter</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/rss-feed/" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Podcasts</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/rss-feed/" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">RSS Feed</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/institutional-access" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Remote Access</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title" aria-label="Follow us">FOLLOW US</h4>
<ul class="ng-footer_column-list">
<li class="ng-footer_column-list-item"><a href="https://www.facebook.com/TheNewEnglandJournalofMedicine" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-facebook"></use></svg></span></span><span class="ng-footer_column-link-text">Facebook</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://twitter.com/nejm" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-twitter"></use></svg></span></span><span class="ng-footer_column-link-text">X (formerly Twitter)</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.instagram.com/nejm/" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-instagram"></use></svg></span></span><span class="ng-footer_column-link-text">Instagram</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.youtube.com/user/NEJMvideo" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-youtube"></use></svg></span></span><span class="ng-footer_column-link-text">Youtube</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.linkedin.com/company/nejm-group" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-linkedin"></use></svg></span></span><span class="ng-footer_column-link-text">LinkedIn</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://bsky.app/profile/nejm.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-bluesky"></use></svg></span></span><span class="ng-footer_column-link-text">Bluesky</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.tiktok.com/@nejm.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-tiktok"></use></svg></span></span><span class="ng-footer_column-link-text">TikTok</span></a></li>
</ul>
</div></div></div></div></div></div><div data-location="footer" class="ng-footer_journals"><div class="container-fluid"><div class="row"><div class="col-12">



        
        <h4 class="ng-footer_journals-label">JOURNALS</h4>
<ul class="ng-footer_journals-list">
<li class="ng-footer_journals-item"><a href="https://www.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">The New England Journal of Medicine</a></li>
<li class="ng-footer_journals-item"><a href="https://catalyst.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM Catalyst Innovations in Care Delivery</a></li>
<li class="ng-footer_journals-item"><a href="https://evidence.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM Evidence</a></li>
<li class="ng-footer_journals-item"><a href="https://ai.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM AI</a></li>
</ul>
</div></div></div></div><div data-location="legal" class="ng-footer_bottom"><div class="container-fluid"><div class="row"><div class="col-lg-7 col-md-6 ng-footer_bottom-left">



        
        <p>Copyright Â© 2025 <a href="https://www.massmed.org/" target="_blank" rel="noopener" class="ng-footer_bottom-link"><b>Massachusetts Medical Society</b></a>. All rights reserved, including those for text and data mining, AI training, and similar technologies. Electronic ISSN 1533-4406. Print ISSN 0028-4793.The content of this site is intended for health care professionals.</p>
</div><div class="col-lg-5 col-md-6 ng-footer_bottom-right">



        
        <style>
  #teconsent a {
    color: #666;
    text-decoration: none;
  }
  #teconsent a:hover {
    color: #666;
    text-decoration: underline;
  }
</style>
<ul class="ng-footer_bottom-list">
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/copyright-information.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Copyright</a></li>
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/terms-of-use.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Terms</a></li>
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/privacy-policy.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Privacy Policy</a></li>
<li class="ng-footer_bottom-list-item"><span id="teconsent" consent="undefined" aria-label="Open Cookie Preferences Modal" role="complementary"><a role="link" id="icon-id09499963487806208" tabindex="0" lang="en" aria-haspopup="dialog" aria-label="Cookie Preferences, opens a dedicated popup modal window" class="truste_cursor_pointer">Cookie Preferences</a></span></li>
</ul>
<a href="https://www.nejmgroup.org/" title="NEJM Group" target="_blank" rel="noopener" class="ng-footer_logo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/logo_group.svg" alt="NEJM Group logo" class="ng-footer_logo" loading="lazy" width="103" height="40"></a>
</div></div></div></div><div data-show-after="400" class="back-to-top back-to-top--align-right  "><button data-snap="footer__top" class="back-to-top__action position-relative p-0 m-0 border-0 d-flex flex-column align-items-center justify-content-center"><svg viewBox="0 0 36 36" class="position-relative"><path d="M18 2.0845 a 15.9155 15.9155 0 0 1 0 31.831 a 15.9155 15.9155 0 0 1 0 -31.831" class="back-to-top__action__ring-bg"></path><path d="M18 2.0845 a 15.9155 15.9155 0 0 1 0 31.831 a 15.9155 15.9155 0 0 1 0 -31.831" stroke-dasharray="0, 100" class="back-to-top__action__ring"></path></svg><span class="back-to-top__action-icon position-absolute d-flex"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-up"></use></svg></span></span><span class="sr-only">Back to top</span></button></div></footer>

                    
                        



        
        <!-- TrustArc: Banner -->
<div id="consent_blackbar"><style>  #consent_blackbar{    position:relative;    width:100%;    z-index: 999999;  }    #trustarc-banner-overlay {  background-color: rgb(0, 0, 0);   opacity: 0.3;   position: fixed;   z-index: 1000000;   width: 100%;  height: 100%;   top: 0px;   left: 0px;   overflow: hidden;}.truste-title {  /*font-family: "Source Sans Pro", sans-serif;  font-size: 23px;  font-style: normal;  font-stretch: normal;*/  color: #222;  margin-bottom: 20px;  text-align: center;/*  font-weight:bold;*/}.truste-footer {  margin: 0 auto;      }.truste-left {  margin: 0px 0px 15px 15px;/*font-family: "Source Sans Pro", sans-serif;  font-size: 14px;    */}.truste-banner { margin: 0 auto; }.truste-messageColumn {/*font-family: "Source Sans Pro", sans-serif;  font-size: 14px;*/  color: #666666;  margin: 0px;}#truste-consent-button, #truste-consent-required {    background-color: #FF1E00;    color: #F2F1F1;    padding: 5px 10px;    border: 1px solid #FF1E00;    border-radius: 0px;    cursor: pointer;    text-transform:uppercase;/*    font-family: "Source Sans Pro",sans-serif;    font-size: 15px;*/  }      #truste-show-consent {    background-color: #FF1E00;    color: #F2F1F1;    border: 1px solid #FF1E00;    padding: 5px 10px;    border-radius: 0px;    cursor: pointer;    text-transform:uppercase;/*    font-family: "Source Sans Pro",sans-serif;    font-size: 15px;*/  }div.truste-consent-track-class {  position: fixed;  z-index:9999999;   background: #666;   border: 1px solid #333;    /*padding: 10px 60px;*/    bottom:0px;    right:0px;    left:0px;    margin: 10px;}.truste-left {  margin: 0;}div.text-content {  display: flex;  flex-direction: column;  align-self: baseline;}#truste-consent-text {    /*font-family: "Source Sans Pro", sans-serif;    font-size: 16px;*/    color: #fff;    margin: 15px 0px;}.truste-footer {  padding-top: 15px;}#truste-consent-content {  margin: 0 auto;    padding: 0 10px;    max-width: 1366px;}.truste-consent-footer {  display: none;}.flex-container {  display: block;  align-items: center;  justify-content: space-between;}#truste-consent-buttons {  float: right;  margin: 10px 5px 10px 0px;}#truste-show-consent { background: #F30 !important;}#truste-consent-button, #truste-consent-required { background: #F30 !important; } /* MEDIA QUERIES */  @media screen and (max-width: 500px) {  #truste-consent-track {    padding: 5px 20px;  }  }@media screen and (max-width: 375px) {  .truste-buttonsColumn {    float: none;    margin: 0;  }  #truste-consent-button, #truste-consent-required, #truste-show-consent {    width: 100%;    margin-bottom: 5px;  }          #truste-consent-buttons {  float: none;  margin: 10px 0px 10px 0px;	}}</style><div id="truste-consent-track" style="display: block; opacity: 1;">  <div id="trustarc-banner-overlay"></div>  <div class="truste-consent-track-class">    <div id="truste-consent-content" class="truste-banner">        <div class="flex-container">          <div class="text-content">            <div id="truste-consent-text" class="truste-messageColumn">This site uses cookies and related technologies, as described in our privacy policy, for purposes that may include site operation, analytics, enhanced user experience, or advertising. You may choose to consent to our use of these technologies, or manage your own preferences.                       </div>          </div>          <div id="truste-consent-buttons" class="truste-buttonsColumn">            <button id="truste-show-consent" aria-haspopup="dialog">Manage Settings</button>      <button id="truste-consent-button">Accept</button>      <!-- <button id="truste-consent-required">Decline All</button> -->          </div>        </div>                <div style="clear:both;"></div>    </div>  </div></div><!--emptycomment--></div>
<!-- /TrustArc: Banner -->

                    
                        



        
        <link rel="stylesheet" href="https://cssjs.nejm.org/mmsWidgets.css"><script nonce="94d6c2dc21f201c0-SJC" type="text/javascript" src="https://cssjs.nejm.org/mmsWidgets.js"></script><script nonce="94d6c2dc21f201c0-SJC" type="text/javascript">var litSSO = {
    "ucid": null,
    "accessToken": null,
    "authState": null
};

var loginUri = '/action/doSsoLogin';
var logoutUri = '/action/doLogout';

displayAuthenticatedMessage();

mmsWidgets.init({
    clientId: 'qsra7g4d6jwdsgn3zbe6udp6r6278mr9',
    origin: 'NEJM',
    xdReceiver: 'http://www.nejm.org/pb-assets/sso/xd.html',
    isFullPageSignIn: isSignInPage(),
    debug: true,

    onReady: function (e) {
        console.log('<<<<<<<<<< client: received onReady event.');
        $("A.litSsoLogin").click(function (e) {
            if (!$(e.currentTarget).hasClass("noMd") || $(e.currentTarget).parents(".header_sm-login").length === 0) {
                mmsWidgets.signIn(e);
                return false;
            }
        });
        $("A.litSsoLogout").click(function (e) {
            mmsWidgets.signOut(e);
            return false;
        });
        $("A.litSsoCreate").click(function (e) {
            mmsWidgets.showRegModal(e);
            return false;
        });
        $("A.litSsoSubscribe").click(function (e) {
            if (!$(e.currentTarget).hasClass("noMd") || $(e.currentTarget).parents(".header_sm-login").length === 0)
                location.assign(e.currentTarget.href);
            return false;
        });
        if (window.doSSOLogin) {
            window.setTimeout(function () {
                mmsWidgets.signIn();
            }, 500);
        }
        ;
    },
    onLoginSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onLoginSuccess event.' + JSON.stringify(e));

        const redirectUrl = getRedirectUri(window.location.search, location.href.replace(window.location.origin, ""));
        document.cookie = "skipSso=; expires=; path=/";
        if (!litSSO.ucid || e.ucid != litSSO.ucid || !litSSO.accessToken || e.accessToken != litSSO.accessToken) {
            location.assign(loginUri + "?ucid=" + e.profile.ucid
                + "&accessToken=" + e.accessToken
                + "&authState=" + e.authState
                + "&email=" + encodeURIComponent(e.profile.email)
                + "&givenNames=" + e.profile.givenName
                + "&surname=" + e.profile.familyName
                + "&redirectUri=" + redirectUrl
                + "&uccLastUpdatedDate=" + encodeURIComponent(e.profile.uccLastUpdatedDate)
                + "&rememberMe=" + e.rememberMe);
        }
    },
    onAuthStateReady: function (e) {
        console.log('<<<<<<<<<< client: received onAuthStateReady event.' + JSON.stringify(e))

        var isMmsSsoAuthenticated = (e.authState && e.authState !== "anonymous" && e.authState !== "lead" && e.ucid && e.accessToken) ? true : false;
        var isLitSsoAuthenticated = (litSSO.ucid && litSSO.accessToken && litSSO.authState) ? true : false;
        console.log('           isMmsSsoAuthenticated=' + isMmsSsoAuthenticated + ', isLitSsoAuthenticated=' + isLitSsoAuthenticated);

        if (isMmsSsoAuthenticated) {
            if (!isLitSsoAuthenticated || litSSO.ucid != e.ucid) {
                if (window.skipSso)
                    document.cookie = "skipSso=" + encodeURIComponent(e.ucid) + "; expires=; path=/";

                if (!window.skipSso && document.cookie.indexOf("skipSso=" + encodeURIComponent(e.ucid)) == -1) {
                    location.assign(loginUri + "?ucid=" + e.profile.ucid
                        + "&accessToken=" + e.accessToken
                        + "&authState=" + e.authState
                        + "&email=" + encodeURIComponent(e.profile.email)
                        + "&givenNames=" + e.profile.givenName
                        + "&surname=" + e.profile.familyName
                        + "&redirectUri=" + location.href.replace(window.location.origin, "")
                        + "&uccLastUpdatedDate=" + encodeURIComponent(e.profile.uccLastUpdatedDate)
                        + "&rememberMe=" + e.rememberMe);
                } else
                    console.log('**** client: Skip SSO ****');
            } else if (e.accessToken !== litSSO.accessToken)
                updateLitSession(e.ucid, e.accessToken);
        } else if (isLitSsoAuthenticated)
            location.assign(logoutUri + "?redirectUri=" + encodeURIComponent(location.href.replace(window.location.origin, "")));

        if (document.getElementById("ssoerr-ucid"))
            document.getElementById("ssoerr-ucid").innerHTML = e.ucid;

    },
    onRegistrationSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onRegistrationSuccess event.' + JSON.stringify(e))
        document.cookie = "skipSso=; expires=; path=/";
        var uccLastUpdatedDate = '1812-01-01 00:00:00.1 +0000';
        location.assign(loginUri + "?ucid=" + e.profile.ucid
            + "&accessToken=" + e.accessToken
            + "&authState=" + e.authState
            + "&email=" + encodeURIComponent(e.profile.email)
            + "&givenNames=" + e.profile.givenName
            + "&surname=" + e.profile.familyName
            + "&redirectUri=" + location.href.replace(window.location.origin, "")
            + "&uccLastUpdatedDate=" + encodeURIComponent(uccLastUpdatedDate)
            + "&rememberMe=" + e.rememberMe);
    },
    onLogoutSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onLogoutSuccess event.' + JSON.stringify(e))

        document.cookie = "skipSso=; expires=; path=/";
        location.assign(logoutUri);
    },
});

function updateLitSession(ucid, accessToken) {
    $.ajax({
        method: "GET",
        url: "/action/doSsoSessionUpdate",
        data: {ucid: ucid, accessToken: accessToken},
        success: function (callData, textStatus) {
            console.log("Session accessToken updated")
            litSSO.accessToken = accessToken
        },
        error: function (jqXHR, textStatus, errorThrown) {
            alert("Your website session has expired and will now be reset.")
            console.log("Session update failed: " + jqXHR.responseText)
            location.assign(logoutUri + "?redirectUri=" + encodeURIComponent(location.href.replace(window.location.origin, "")));
        }
    });
}

function getRedirectUri(location, fallback) {
    const urlParams = new URLSearchParams(location);
    const uriUrlParam = urlParams.get('uri');
    if (uriUrlParam)
        return encodeURIComponent(uriUrlParam);
    else
        return encodeURIComponent(fallback);
}

function isSignInPage() {
    return document.querySelector('meta[name="pbContext"]').content.indexOf("customPage:string:/sign-in") > -1;
}

function displayAuthenticatedMessage() {
    if (isSignInPage()) {
        var div = document.getElementById('authMsg');
        if ("" === "PersonUser") {
            div.innerHTML += "You are already signed in to " + window.location.origin.replace("https://", "").replace("www.", "") + ". If you would like to sign in with a different email address, please use the form below.";
        } else {
            div.innerHTML = '';
        }
    }
}</script>

                    
                
            </div>
        </div><iframe name="trustarc_notice" id="trustarcNoticeFrame" title="Trustarc Cross-Domain Consent Frame" src="https://consent.trustarc.com/get?name=crossdomain.html&amp;domain=nejm.com" style="display: none;"></iframe><script src="https://consent.trustarc.com/asset/notice.js/v/v1.7-1576" async="async" crossorigin="" importance="high" nonce="94d6c2dc21f201c0-SJC"></script>
        


        
        

            <script src="/products/mms-nextgen/mms/releasedAssets/js/build.lazyload.bundle-c8c4e7d20884f81951fb.js" nonce="94d6c2dc21f201c0-SJC"></script>

        <script src="/products/mms-nextgen/mms/releasedAssets/js/main.bundle-3819a02ec7bc2aca01ec.js" nonce="94d6c2dc21f201c0-SJC"></script>
        


<div id="adModal" tabindex="-1" aria-labelledby="exampleModalCenterTitle" class="ng-modal modal" style="display: none;" aria-hidden="true">
    <div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered ad-promoLayer">
        <div class="ng-modal_content modal-content p-0">
            <div class="ng-modal_body modal-body m-0">
                <div class="ng-modal_header modal-header">
                    <button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#close"></use></svg></span></span>
                    </button>
                </div>

            </div>
        </div>
    </div>
</div>
<script type="text/javascript" src="/wro/1125813~product.js" nonce="94d6c2dc21f201c0-SJC"></script>








<input id="showLayers" type="hidden" value="true">

    <!-- placeholder id=null, description=ad-layer-config -->
    <!-- placeholder id=null, description=ad-lauchLayer-1 -->
    <!-- placeholder id=null, description=ad-layer-promo-1 -->

    <input id="firstAd" type="hidden" value="">
    <input id="secondAd" type="hidden" value="">

    
    
    

    
    
    <input id="IsInstitution" type="hidden" value="false">
    <input id="IsSubscriber" type="hidden" value="true">
    <input id="CustomerId" type="hidden" value="">


<script type="text/javascript" nonce="94d6c2dc21f201c0-SJC">
  jQuery.extend(jQuery.mmsLayers.config, {
    rules: [{
      "name": "Launch Layer Ad",
      "frequency": 30,
      "showOnPage": 5,
      "enabled": false,
      "cookieName": "MarketingLaunchLayer",
      "styleClass": "launchLayer"
    },
    {
      "name": "Promo Layer Ad",
      "frequency": 14,
      "enabled": true,
      "cookieName": "PromoLayer",
      "styleClass": "promoLayer"
    },
    {
      "name": "Interstitial Ad",
      "frequency": 7,
      "enabled": false,
      "cookieName": "InterstitialAd"
    },
    {
      "name": "Iperceptions - Ion Layer Ad",
      "showOnPage": 1,
      "enabled": false,
      "test": false,
      "cookieName":"Iperceptions"
    }]
 });
</script>

















    <script type="text/javascript" nonce="94d6c2dc21f201c0-SJC">
        $(document).ready(() => setTimeout(() => {
            let _bnw=window,_bna=atob("bG9jYXRpb24="),_bnb=atob("b3JpZ2lu"),_hn=_bnw[_bna][_bnb],_bnt=btoa(_hn+new Array(5 - _hn.length % 4).join(" "));
            $.get("/resource/lodash?t="+_bnt);
        },4000));
    </script>












    

    
    

    
    
    
    
        
            
                <script type="text/javascript" src="/wro/1125813~article-metrics.js" nonce="94d6c2dc21f201c0-SJC"></script>
            
            
            
        
    




<script type="text/javascript" src="/wro/1125813~full-text-analytics.js" nonce="94d6c2dc21f201c0-SJC"></script>


    


            <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94d6c2dc1f0e01c0',t:'MTc0OTUzNjQwOS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94d6c2dc1f0e01c0&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.5.0&quot;,&quot;token&quot;:&quot;f55e150c7a5f4a4ab9ef82f4a1c9c43c&quot;}" crossorigin="anonymous"></script><div style="display:none;" id="signInEmbedded" class="ucc-fullpage-signin ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Sign In</h1>
  </div>    
  <div class="capture_signin">
    {* #signInForm *}
    <div class="ucc-form-inner-wrapper">
      {* signInEmailAddress *}
      {* currentPassword *}
      <div style="padding-top:10px;">
          <div class="capture_form_item capture_form_rememberme">
          <label class="ucc-form-checkbox">                
            <input checked="checked" id="ucc-remember-me-cb-embedded" name="ucc-remember-me-cb-embedded" type="checkbox" value="true">
            <span>Remember Me</span>
          </label>                           
          </div>
          <div class="capture_form_item capture_form_forgotpwd">
            <a role="button" class="ucc-anchor-button" data-capturescreen="forgotPassword">Forgot your password?</a>
          </div>
      </div>
      <div class="capture_form_item">      
        <button id="ucc-sign-in-submit-embedded" class="capture_primary capture-full-width-btn" type="submit">Sign In</button>
      </div>
      <div class="capture_form_item capture_form_footer">
        <div class="ucc-no-acct-msg">Don't have an account?</div>
        <div class="ucc-no-acct-msg-2">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event); mmsWidgets.showRegAuto(event);">Create Account</a>
          <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
        </div>
      </div>
      <div class="capture_form_item capture_form_submit">
        
      </div>      
    </div>
    {* /signInForm *}
  </div>
</div><div style="display:none;" id="forgotPassword" class="ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Forgot Password</h1>
  </div>   
  <div class="ucc-form-inner-wrapper">
  <p style="color:black">Enter the email address associated with your account then click Continue. We will email you a link to a page where you can easily create a new password.</p>
  </div> 
  <div class="capture_forgotpassword">
    {* #forgotPasswordForm *}      
      <div class="ucc-form-inner-wrapper">
        {* forgotPasswordEmailAddress *}
        {* captcha *}
        <div class="capture_form_item" style="padding-top: 20px;">        
          <input id="ucc-widget-forgotpwd-submit" value="Continue" type="submit" class="capture_btn capture_primary capture-full-width-btn">
        </div>
      </div>
    {* /forgotPasswordForm *}
  </div>
  </div><div style="display:none;" id="forgotPasswordSuccess" class="ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Create New Password</h1>
  </div>    
  <div class="capture_forgotpassword">
      <div class="ucc-form-inner-wrapper">
        <p style="padding-top: 30px; padding-bottom: 30px;">We've sent an email with instructions to create a new password. Your existing password has not been changed.</p>        
        <div class="capture_form_item">      
          <button class="capture_btn capture_primary capture-full-width-btn" onclick="janrain.capture.ui.modal.close()">CLOSE</button>
        </div>
      </div>
  </div>
  </div><div style="display:none;" id="resetPassword" class="ucc-widgets-nejm-next">
      <div class="row">      
        <div class="col-md-8 col-md-offset-2 reset-pwd-info"><p>To reset your password, enter a new password twice and click the 'Reset Password' button.</p></div>
      </div>
      <div class="col-md-4 col-md-offset-4">
        {* #changePasswordFormNoAuth *}
          {* newPassword *}
          {* newPasswordConfirm *}     
          <div class="capture_form_item">
            <input value="RESET PASSWORD" type="submit" class="capture_btn capture_primary capture-full-width-btn">
          </div>
          {* /changePasswordFormNoAuth *}
      </div>
    </div><div style="display:none;" id="resetPasswordSuccess">
        <div class="reset-pwd-info">
          <div class="reset-pwd-success-welcome"></div>
          <p class="reset-pwd-success-msg">Your password has been reset. You will need to <a href="/signin" onclick="mmsWidgets.signIn(event)">sign in</a> again using your new password to access site content and features.</p>
          <p class="reset-pwd-success-nav"></p>
        </div>      
    </div><div style="display:none;" id="resetPasswordRequestCode" class="ucc-widgets-nejm-next">
        {* #resetPasswordForm *}
        <div class="capture_form_error">The link that you followed to reset your password has expired.</div>
          <div class="col-md-8 col-md-offset-2">
            <p class="reset-pwd-info">Enter the email address associated with your account then click Continue. We will email you a link to a page where you can easily create a new password.</p>
          </div>
          <div class="col-md-4 col-md-offset-4">
            {* signInEmailAddress *}
            <div class="capture_form_item">
              <input value="continue" type="submit" class="capture_btn capture_primary capture-full-width-btn">
            </div>
          </div>
        {* /resetPasswordForm *}
    </div><div style="display:none;" id="resetPasswordRequestCodeSuccess">
      <div class="reset-pwd-info">
        <p>If the address matches an existing account, you will receive an email with instructions to reset your password.</p>
        <p class="reset-pwd-success-nav"></p>
      </div>
  </div>

        
        
    

<div id="janrainEngageEmbed" style="display: none;"><div class="janrainContent" style="width: 380px !important; height: 156px !important; padding-left: 5px !important; padding-right: 5px !important; box-sizing: content-box !important; background-color: rgb(255, 255, 255) !important; border: 1px solid rgb(192, 192, 192) !important; border-radius: 10px !important; overflow: hidden !important; position: relative !important;"><div id="janrainView"><div class="janrainHeader" style="background-color: rgb(255, 255, 255) !important; font-size: 14px !important; color: rgb(102, 102, 102) !important; position: relative !important; height: 20px !important; left: -5px !important; padding: 5px 5px 0px !important; white-space: nowrap !important; width: 380px !important; z-index: 100 !important; border-radius: 10px 10px 0px 0px !important; text-align: left !important;"><div style="padding-left: 1px !important; font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important;">Sign in using your account with</div></div><div id="janrainProviderPages" style="padding-top: 5px; left: 5px; position: absolute;"><div class="janrainPage" pageindex="0"><ul class="providers" id="janrainProviders_0" style="float: left !important; list-style-type: none !important; margin: 0px !important; padding: 0px !important;"><li id="janrain-aol" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="1" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-aol" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-aol" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">AOL</span></a></li><li id="janrain-openid" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="3" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-openid" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-openid" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">OpenID</span></a></li></ul><ul class="providers" id="janrainProviders_1" style="float: left !important; list-style-type: none !important; margin: 0px !important; padding: 0px !important;"><li id="janrain-yahoo" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="2" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-yahoo" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-yahoo" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">Yahoo!</span></a></li></ul></div></div><div style="background-color: rgb(255, 255, 255) !important; width: 380px !important; height: 10px !important; position: absolute !important; left: 0px !important; padding-left: 5px !important; padding-right: 5px !important; padding-bottom: 5px !important; bottom: 0px !important; font-size: 10px !important; text-align: left !important; color: rgb(102, 102, 102) !important; font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; border-radius: 0px 0px 10px 10px !important;"><div style="padding-left: 1px !important;"><a href="http://janrain.com/products/engage/social-login?utm_source=mms.rpxnow.com&amp;utm_medium=Partner&amp;utm_campaign=attribution" target="_blank">Social Login by Janrain</a></div></div></div></div></div><iframe name="captureIFrame_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" data-transactionid="zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" id="captureIFrame_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" src="about:blank" class="" data-captureiframeloadeventbound="yes" style="display: none;"></iframe><div id="janrainModalOverlay" style="inset: 0px; position: fixed; background-color: rgb(0, 0, 0); opacity: 0.4; display: none; z-index: 1000;"></div><div id="janrainModal" style="width: 380px; height: 131px; position: absolute; z-index: 1000; display: none;"><a href="#" class="janrain_modal_closebutton" style="position: absolute; cursor: pointer; z-index: 1000;">X</a><div style="display: block;" id="signIn" class="ucc-widgets-nejm-next janrain-capture-ui capture-ui-content capture_screen_container" data-capturescreenname="signIn" data-captureventadded="true">
    <div class="capture_header">
      <h1>Sign In</h1>
    </div>    
    <div class="capture_signin">
      <form id="capture_signIn_signInForm" name="signInForm" data-capturefield="signInForm" action="https://mms.us.janraincapture.com/widget/traditional_signin.jsonp" class="capture_form capture_signInForm" method="POST" novalidate="novalidate" data-transactionid="zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" target="captureIFrame_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" accept-charset="UTF-8" next="{&quot;noop&quot;:&quot;&quot;}"><div id="capture_signIn_signInForm_defaultSavedProfileMessage"></div><div id="capture_signIn_signInForm_errorMessages"></div><input id="capture_signIn_utf8" data-capturefield="undefined" value="â" type="hidden" class="capture_utf8" name="utf8"><input id="capture_signIn_screen_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" data-capturefield="undefined" value="signIn" type="hidden" class="capture_screen_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" name="capture_screen"><input id="capture_signIn_js_version_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" data-capturefield="undefined" value="d445bf4" type="hidden" class="capture_js_version_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" name="js_version"><input id="capture_signIn_transactionId_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" data-capturefield="undefined" value="zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" type="hidden" class="capture_transactionId_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" name="capture_transactionId"><input id="capture_signIn_form_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" data-capturefield="undefined" value="signInForm" type="hidden" class="capture_form_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" name="form"><input id="capture_signIn_flow_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" data-capturefield="undefined" value="standard" type="hidden" class="capture_flow_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" name="flow"><input id="capture_signIn_client_id_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" data-capturefield="undefined" value="qsra7g4d6jwdsgn3zbe6udp6r6278mr9" type="hidden" class="capture_client_id_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" name="client_id"><input id="capture_signIn_redirect_uri_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" data-capturefield="undefined" value="https://www.nejm.org" type="hidden" class="capture_redirect_uri_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" name="redirect_uri"><input id="capture_signIn_response_type_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" data-capturefield="undefined" value="code" type="hidden" class="capture_response_type_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" name="response_type"><input id="capture_signIn_flow_version_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" data-capturefield="undefined" value="20240514181256512029" type="hidden" class="capture_flow_version_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" name="flow_version"><input id="capture_signIn_settings_version_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" data-capturefield="undefined" value="" type="hidden" class="capture_settings_version_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" name="settings_version"><input id="capture_signIn_locale_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" data-capturefield="undefined" value="en-US" type="hidden" class="capture_locale_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" name="locale"><input id="capture_signIn_recaptcha_version_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" data-capturefield="undefined" value="2" type="hidden" class="capture_recaptcha_version_zygfjjjm2myzemtz7dklndimj67xqfd11q4p7ute" name="recaptchaVersion">
      <div class="ucc-form-inner-wrapper">
        <div id="capture_signIn_form_item_signInEmailAddress" class="capture_form_item capture_email capture_form_item_signInEmailAddress" data-capturefield="undefined"><label for="capture_signIn_signInEmailAddress">Email Address</label><input id="capture_signIn_signInEmailAddress" data-capturefield="signInEmailAddress" value="" type="email" class="capture_signInEmailAddress capture_required capture_text_input" placeholder="Email Address" name="signInEmailAddress"><div class="capture_tip" style="display:none;"></div><div class="capture_tip_validating" data-elementname="signInEmailAddress">Validating</div><div class="capture_tip_error" data-elementname="signInEmailAddress"></div></div>
        <div id="capture_signIn_form_item_currentPassword" class="capture_form_item capture_password capture_form_item_currentPassword" data-capturefield="undefined"><label for="capture_signIn_currentPassword">Password</label><input id="capture_signIn_currentPassword" data-capturefield="currentPassword" value="" type="password" class="capture_currentPassword capture_required capture_text_input" placeholder="Password" name="currentPassword"><div class="capture_tip" style="display:none;"></div><div class="capture_tip_validating" data-elementname="currentPassword">Validating</div><div class="capture_tip_error" data-elementname="currentPassword"></div></div>
        <div style="padding-top:10px;">
            <div class="capture_form_item capture_form_rememberme">
                <label class="ucc-form-checkbox">                
                    <input checked="checked" id="ucc-remember-me-cb" name="ucc-remember-me-cb" type="checkbox" value="true">
                    <span>Remember Me</span>
                </label>          
            </div>
            <div class="capture_form_item capture_form_forgotpwd">
              <a role="button" class="ucc-anchor-button" data-capturescreen="forgotPassword">Forgot your password?</a>
            </div>
        </div>
        <div class="capture_form_item">
          <button id="ucc-sign-in-submit" class="capture_primary capture-full-width-btn" type="submit">Sign In</button>
        </div>
       
        <div class="capture_form_item">
          <div class="ucc-no-acct-msg">Don't have an account?</div>
          <div class="ucc-no-acct-msg-2" id="signInModalCreateAccountLink">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event); mmsWidgets.showRegAuto(event);">Create Account</a>
            <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
          </div>

          <div class="ucc-no-acct-msg-2" id="signInModalCloseLink" style="display:none">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event);">Create Account</a>
            <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
          </div>

        </div>
     
        <div class="capture_form_item capture_form_submit">
          
        </div>      
      </div>
      </form>
    </div>
  </div></div><div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">â</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">Moreâ¦</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><wgj-hofwxduvqxqw></wgj-hofwxduvqxqw><script type="text/javascript" src="https://api.altmetric.com/v1/internal-556fdf0f/doi/10.1056/nejmoa2117608?callback=_altmetric.embed_callback&amp;domain=www.nejm.org&amp;cache_until=3-10"></script><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div></body></html>